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Anti-idiotypic antibo~i~ s~ecin.c -lor. the c'ombining ' site ro~ ~h~ rir~t''an~ibody 
.... . ' • .. fl • ' • \ . . • 
could .exhibit similar tridimentional structure to t~at of the original epitope. With 
· t,his background, in~~nal .. image an~i-idiotypi~ antibodies. have ~een t~ted . by · 
numerous': ~r~Ups_ ~· .in:vesiigators_. in several biological systems,. Some or these 
· · ~ere· without a~y specific biol~gi~al activity bui otlfers. such_ as· ~nti-insulln·, anti-
. acetylcholine -and anti-beta adrenergic receptor .agonists have been. fpund -to have 
agonistic activ"ity at the level ·or their specific rec.eptors. 
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Graves' .. Dis_eaS'e js. an . autoimmune disorder involving ·th~ · thyroid gland. ·Its ' · .... . 
e96logica~ :~ge~~ ' IS th,ought. to .bJ a~_ -antibody ~it_~ ' ag~~istic: -·~ro~e.~~~es at if ~b~ .-: .. : .. :_: . :.·.:·:'~~-1·~··; 
level of _the · thyroid ~ stimulating. hormone (TSI:n receptor. ThEt recep_~or·· itselC .hM 
._ ' . .. . i' . ~ . . . . .-· . '. ..~ . . . ~ ·--......:....... ·: ' . . . ' .. . . . :. : ~ 
. Ifeh·~h?ug~~· ·~o ·· pe.' the antigen res~.~~sible r?r)he: pt?~uctio~ or _t~i.s ·a~~~Q~; ' .· ·' ~ _. ' ).:·:. 
Howe~~~-' . c~~side~~g ~-h~. :-a'1e ~enti~n~d . pre~is~s, it_ i~ · p~~sible · 't~ ·sp~~uiat~ · :.~-.-~--<~~~- .: ..... ·: 
.· that the ·~~rrpid s~imu,lating · antibody of ~r~~:v~sJ J?iseas~ could, at .least in_ some · .. ·. ' ' . ·. -'.~ 
~ t • • ' • • • • • . .... 
·c8Ses~ be· ~n anti-TSH anti-idiotypic antibody . . · ' ... , . . . . .. · . 
. . •i ·. . .... .-~ ' - ' ~ \. : : .. · .. ,, . 
_j'Jiis ,~or~· · was desi_gned .to investigate th·e p~ssibiiit; . or . producing anti-TSH' 
' I " • • . - : • • • • It • • • 
anti-idiotypic antibodies and to test· their· biolo.gical · activities. · Anti-TSH 
··- -· . -- --·-·-·--·-
· . . antib~dfes wer~ rais_ed by injecti.ng rats with highly purified.~T,~H. : ·This first 
i ~ . . . ·, ' . ' . 
. antibody was' later purified and ·used in the production-or anti-idlotypic aiitibodi.cs ._· 
/ ' . ' . . ' ·. ' .. · . - '. . ' ' - . 
: this time in. rabbits. The activity of the ·anti- TSH a.nti-jdiotypic antibodi~s was 
- I • • • ' 4 ~ ~ 
·tested in experiments .in vitro. It was-demonstrated that the aritibodics ·produced 
' : ' . . ,, . ~ ~ .. - ~~ . . . . . . ·: . '. . . ... 
· . .. were : true agonists at the TSH receptor ·level. Tli~y ·were cap·a~le·. of ·interfering 
o ,' o • ', , I o "' ' ' • I - • I '\ ' , ' o ' '. , · , '• 
/ with the·binding o( T~H t~ i.~s receptor, a,ctivatin·g·adenylate · ~~lase~ · promoting 
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. '· I adenylate .cycl~e .mediated ~elhila~ pro.cesses and re~og~izing_ .. the·. TSH: i'~ceptor . 
.. ... .. . . . . ' ( 




y • · 
P-rotein _in thyr_oid plasm_a.mejnbrane protein blots. 
. . ' 
~· A ~econd.group ·or··experi~ents explored. the a~tivity or anti-i_diotyplc. antibodies. 
. . . -. . . . . ' . ' . ' .. . \ 
. directed ~o · t~e .indi~idual . subu_nit~ ; ~~ the TSH ... · m~le~ule. The (.inforDlation· 
. ·. . ·' . I 
. . . ~··-·~ 
··' . 
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~t ' ',, .' :-:;_ > :' '? ; . : ·.; \f''" ; J i ·; : ' '• : ;'< : ' ~ ~ .,.,, _ .· < '. ·...  }t .. > :·  '. < :·. ·: ~: ?•~;-, ::·':'~'~':::4{~ 
' . . { . . . ' • . " . .. , .... , ...... ~· ;.·' ~btaine~ . apl?.ears:: to . ra~~.. ditteren~· . r~9uireineniS . ~or recept~~ binding . ana~ .. "i>is'i~:-... ~<i.;, : .: .~ \~ ~~~/~j 
::·:· · · · : t :· ~ · · . · · • · · · · ·.. ,. ; · ··. ·.o~ ~~'l· f 
f.·:_··; · .. ' · bi~tting events~ Ant~~o~i~ with_ ~ctivi~~ spe~ific ~or _:e.:a.cb or ~~e subunits .of.:~SH ~\~~-: ·_:, :~::;r~/ 
-~- ~ · we~e.· iridJvid_uaJJ~ ca~a:ble. of ~ind·j~g to thyroid: plasma .membranes .. . O~)~h~ · • .. ;V~. i~ 





. \ .. .. 
" ..... 
: ·· 
! . ~ 
. ~ .·' 
~-:· ·: . ~ .. / .. 
' · 
... . · .. 
~ .. 1 : . 











··:. ·, . 
· ' . 
• ,,···· t 
.:; i 
., .. 
.. . · .. 
. ..~.· .. 
, ... 
:'., . · , . 
~:· · .. 
1,•' , I 
·:·· .. 
:: · ' .. 
-~:·: 
·."' ·' ..... .'· 
:-<: ........ ' .. 
! : .. i ' 
.,.. '. -




.. · j , . 
. , 








. . . 
• •, . • • ' .\ ... o . 0 ", t'l'~ .~11.~ 
contrary, there was absolute requirement lor the participation or both · ltJlttho~ies ·: --~ ~~·~t 
' • . . . .. "' ~ •' ~ '•' ' ' oil .. ~~;; ~ ' 
lor ihe activati.on qr adenylate ·cyclase. - ~ I .... ;~· ··· .. ~<.· .• ~; ~f~·, j'~i~~t,!:;. 
i ' , •• ~ ..,:~Q •": u ~ 1 ~~d-;,1 (;: I \• I . ~ Q ~~ ' • .. ~ {)(~ ' 
, ., , .- ·, " ' •i:·'' " .• . ~·,_!._oil a 0 
o ' • Cl ., ' 41 1\ ~ (\ .C ,.. • 'l (, ) : o • ~· "\. I ~'\\0,; !)". 
, . l . a\\-:J . ~ ~--:;. '\. \ :· ...... ,Y ... ~ 
The t~ird p~rt o~ this ~ork ~x~lores_ the in~uen~e t~t TSH rna~ :~-~y~~~;_'!~~~3: " ~ ·i~~t~ 
~ynt~~sJs and . t,u~ove.r of. 1ts receptor. The~e expertments were. po~s~~l~, .~~~~*'~~~'\· ': ·., -"'"~ -~;~ 
,. detection systl!m .that be~efi~s . from the CQ.pacity or ' anti-TSH anti~ id,~i!Y·R~ ;1, \,, ' c . ~ 
. '· ' • ' , , -. e , \ _ ' I . ll~\\', . ~:,o' ' .: •=''"-'• •. "' , • ~ · 
antibodies to recognize the TSH- receptor on thyroid · pla.Sma membralie"oproteih,;~·Q~ .~ . o · - \' 
. . . . . • . .. . . .. ~ ',. • .. \ ·~ ~ <J~ '."'il r.- o~~· \~"!\".. o: 
. b~ots: _.Th~ · resul~ sugges~ed 4efi.nite partic'i~atien. ·of TSH in the regtl~t~~n~~:)~~ ~~:~~~ . . .. "-?,, ' 
_: rec~ptor ~y~thesis ~n~ tur'~o~~~· :Ts~ .. ~~celerat~s ·the sy~t~esis a.n(.p.rqi~A~~tr~~~~;~ ~~~l-~~.. . 
h lr l·r · r ·t .· · ·''· · .. ""' ~ · · a 1 eo 1 sown recep_tor. ·.·· : · · ,· · ... · · · . ~ . .., ·· · ~"~ i~~ \:t.:· : ·,_': 
. I· . ;"!' ' I - • ~· · '~~t~ fl . . .. 
·.· : • . r .,, ) II -~ • .; .· 
. . ~. . . . . •. i . ... ....-· • · • ··.- )~· ; . 
Jn· ·summary · this. work h'~ .demonstrated· that it is· possible to raise_ a.nti-TSH 
:~nt.i-idiotypie,' ·a.nti~ri~ies:, Th~· ~ritibodie~· produced · had~ ago~istic ~(fe'cts · a't· th'e · 
ie~e·l :or.the Ts~ · ~ecep.tor. Ifwa.S' al~~ sbo~n .that ' these' antib.odies . c·a~ be userui ' . ' 
tools. in~h~· ~~tec_tion o( ~-~~-ept~r. pr()te.in_s a.nd . in tb~ i~~~stigatiQn· ~r ihe · ho·r~on~ a " 
receptor 'nteraction·. · .- · · ·~ : ~ . · . ·.. · . · .. . , . 
~ . " ...... \. .: , 
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1.1. ANATOMY AND PHYSIOLOGY OF THE THYROID 
GLAND. 
1.1.1. Gross Anatomy 
. 
' 
The , thyroid gland, m man 'and many . other · mammals (Halini, 1 078; 
. " , : I 
Ekholm,l070; lngbar .and W.oeber,l98i) consists of tw~ pyramidal shap·cd -lobes 1 
•': '...~ cOnnected .by a n.irrow isthmus. It is localized in tli~ aDte~ior and l~teral aspec,ts \ 
. .. . 
... 
. · .... ··-: 





,. . · ~--- of the trachea .extendin~ rr~m the middle or- the _thyroid. cartilage, to the .. tirtli a~ d. I 
:: .. : . . .. ,< · ·. ~~~~ cartilagO rinr;s.: ~n the ~ormal human it ,w~ighs on .average- t\\l~nty irams . . ' S )' . · ··_ 
, . The t~yroid is a well va.scularized organ: Its blood supply derives from·. the 
', 
' .. ·~ 
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. · .. 
, .. 
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' . . ) · 
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. ........ .. 
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'•, ' . 
superior and inferior thyroid arteries, whic~ enter . the respectiv_e poles, br~nch . · 
profusely and form a complic~ted capillary network. The lymp6atic drainage 'is 
also 'rich. Th~ t~yroid is supplied by . nerves · of both the sympath~tic. and 
parasympathe.tic system~ . . The thyroid gland is surrounded by two capsules ~or 
connective tiSsue,- the . outer and inner capsules. The ~uter capsule ~encloses the 
.. .\ ' 
gl'and and · is cq,ntinuous with the pretracheal fascia. The · inner capsule covers the 
gland '·and emfts', prolongatioJs within the tissue. The space ·bet wee~ these two 
I, :lapsules co~n~ains the ve5sels, the recurren~ larynge.al nerv~s and ~he pa~athyr:oid 
. . ' . "' . 
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1.1~2; Light Ml_eroseopy r 
. . \ 
Under.ljght mi~roscopy (Halmi,IQ78; ~kholm,IQ7Qi ·lngbar_ ~nd Woeber,l~I) it 
is p~ssib)e t0 ;See that the thyroid gJJ~d is. divided into lobules surrounded by 
librous septa derived . i~om. the inner c~psule. The lobule~ are .composed of a 
. . . 
variable· number of,Coliicles. The folli~les are circular, sp"hericle masses in Which a . 
- . 
single lay~r of epithelial cells ' enclose·· a viscous proteinace~_us material called ~he· 
co.Uoid. The average diameter of the follicles is 200 pm" but there are considerable 
variations. Each Collicle-·is·surrounded by a basement membrane, ·a rich capillary 
. ' 
network, and sympatbetic and parasympathetic nerve fibers . . 









Two. types of epithelial cells are found _in the thyroid glan~ or man:tinals; the . ·. ,:.:·-: 
· f~llicul~r- and the parafollicular 'cells. The ·par~follicular cells ~re invoi~ed .hi "th~ · · -- · · · :::: 
p'rodu~~iott of th~ ~~m~ne calci~o~in.\~e foilicul~~ celis are. the .most ab~ndimt ·,· · : : ;: .. ::: 
a~d a.re involved . in thyroid :·h~r~on.e production. The thyroid fo.llicular. cells vary · : :· .. 
. i·n:· hei-~ht. depe~di~~ ·- ~n· ·th~ animal, ~p~cies ·a~~ - the· devee ,ot'-.thyrotropin · (T~H) .. ; : · ':·· . ·-' .. · · · ·. :·:_, 
· _stim~l~tio~. I!J m~n-~her ~en~rally .\'e.ry fro~ low _cu_~oid~l to tal~ ~ol~mnar. in the.;·. ,-··,·;···: :: _;·;.···: 
absence or TSH stimulation ·th'e. ·cells becorneJow cuboidal and the colloid content · · : · · ·;\ 
• ; .. . ' • < ' . • 
· incr~ases'. Under- ~arked 'TSH ~timul~tion follicular ~ells hypertrophy and colloid 
- . 
volume decrease~. 
·The nu~ieus located hi the basal pa~t-or the- follicular c~ll~ is 'large·,· spheroidal in 
. ' . . . ·. . . . . " . · •. .. ' 
shape, contains-.one or more nucleoli and has a low chromatin content . . 
I - i . 
' The cytoplasm· or the. thyroid follicular cell . is b~ophilic, -contains nu~eroi.ts 
· · ··ingested· lu~inal colloi~ ~droplet~, ~hich !itain ·po!iitiv'ely ~it~ ·th~ p·eri~dif;.acid . 
S~hiff'(PA.S) r.~agent.· Tlie .coiloid is_ also ,PAS po~itive due to the .bigh ~lycop~otein · 
content.or_its main compon.ent, thyroglobuiin· . . . .... 
. ... ' • '' 
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Electron microscopical studi~ i~ c~junction with several other techniques such 
as immuno-staining and autoradiography, have made it pos_sible not only ·to 
' . . ). . 
describe static structures present in the thyroid cell but also to establish the 
struct'!ral-functional relatiopship of the different cell <romponents (Fawc·ett1 LOng 
and Jones,1Q6g). 
The thyroid cell h_as well defined apical and basal aspects, this fact has b~en 
termed • pola.rizatioq • 
microvilli extend from 
.. 
and has impoTtant functional implications. Numero~s 
the apical aspect or the celJ into the colloid. The' apical 
. 
' - . 
plasma memh.rane is very dynamic. Under TSH stimulation it become~ expanded 
. . . .. .. . . 
by fusion with the material surrounding the newly synthesized thyroglobulin, and 
late'r . ro~rn~ p~~udopodia . that are i1vol~ed in th~ ~~d~cytosi~ of -~olloi.d, .which i~ 
tlie· first step ·in . th~ pr~ce~~ ~r horinone release. • 
:. : ·. .. . 1. . . . . ~ ·. . .. .' . . ·. ''· ' 
) 
. · Microtubules .·are numer~us :in the apical ·part of the . ~·ell, but a~o 'sls~:_ fo~n~ . 
el~ewhere, and run in~~ dire~tions'.taking stt~igbt ~r · s~ig~t)y.cu-;ved c-ourses.T~ey :·: 
have di~~~ters .. of ·~b~ut ··250 -An~tJ:ofus and ~re tho.ug~t· -t~ ~be. 1nyolved iri 
(m~ocytosis . {G~btion, 1g81): . ~olloid 4roplet~ ari sph~roidal _.stru~t~res formed . . . . • 
through ~~docytosis. They, vary in s,iZe, are .lhnited by !1: meJ]lbra!le similar. to th ~-
apical plastita -membrane and contain col.loid. · These drripte.ts travel from · tb_e 
apical cell region-· to the · ~·id~ll~ of the cell and ·.occasionally are seen around. ~he 
.. 't 't ' ' ,o • '• o I • o ' ' " ' 
basal aspect. Lysosomes are. diffus~ly distributed throughout he epithelial ·cell · · 
- 1 . • ~ • 
and often are ~los~ly as5~eiated with colloid droplets. These~ o st~uctur.es hav~ ' 
., 
:. 
been .~bseryed tO. ~us~. ~ion allows for the pept.idases. contain ~ i~ t~~dysoso~es 
. . . ' . '-... . . . 
to degrade ·thyroglobulin and ac~ieve the release or_ free, j.e. on-peptide linked;. .. 
hormones like· .tetraiodothyronine and 'tri-iodothyro~ine and 
. . . . ' . . 
-~ d~iodotyrosine and ~onoiodotyrosine. ··-. 
. . 
The basal ·cell -"membran~ . has . he.en implicated in .,_or 
capillaries: Although . ther~ iS ~no 'dire~t evidence tha_t 
\.' ·, 
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involved, · microtubules. arid microfilaments ar-e th<?tight rto contribute to th~ · 
_process (Wolf( ~nd Willia~, 1973) . . ~ecent e~perimental data has shown that ;the 
· basa.l cell membrane probably contains the sodium/potassium dependen~ ATPase 
\ system known· as the iodide pump and the TSH receptor-adenyJate cyclase system I (Chambard, Verfi~r, Gabrion ~nd'Mauchamp,1983) . . 
In th~ active follicular cell the inost .prominlt cytoplasmic stru·cture is the • 
-rough· endoplasmic reticuium (RER); its distrih!ltion is preferentially basal an.d 
. . ~ 
perinuclear. The cisternae ~r the ~ER are . wide and contain · a mod~rately d_ense 
material, mbsi likely thy·roglobulin ·components. The thyroglobulin peptide chains. 
. . . ' 
produced in tlie ribosom~ are transferred into the cisternae of the.RER.where the. 
sigmil peptld.e i~ cle~v~d . . The alm~s~· fuUy pro.cessed th;rogJobulin is. tranf~rred ·to_-
- . ' . . . . 
~ th~ . Golgi app~~atus by .JJ, process· or fusion. The Golgi . complex~s are r~und 
. . . . ~ 
apiC'~llr to the nuCleus,· they cont~in ·a varied · number or Golgi saccules and stnall 
1 • : • ' ,' • • • • ! . . . 
vesiCle~ ... Most of- the thyroglobulin carboliy<irate ~s~ c~ains.,se·e.~ to be added .. · 
~~tliin the' ~olgi ~pp~ratus.·- rhyrogl~b~Ji~,' .~hen r~iiy p·~o~esse~, is ~ran~ported to ~ 
. · t.he ·. api~~l aspect or the cell . in ve~icl.es. These exocytotic ~esicles fuse .. with . the 
: . ~ . ~ . . . . . ' . : . 
· apic~l .membran_e as previously ~escribed arid e~pty. their content. into th·e lum.en 
I • . , 
,where. it is sttired. Mitochondria, the other important ceUular organelles, are 
-4f . .. ~ • ·. . ~ . ' • . . 
~catter~d . ~~~rough~ut, th~. cy~opl~m. . rhe nucleus .. or the thyroid cell, under· 
~Jectron rliioroscopy, does not exhibit' any unusual charaCteristics. 
1 • I ' -
; 0 
i 
I, . . 
· ~.1.4. Thyroid G.land Ph7elol~gy · 
. ~. 
I· . - . . . ·- '"' . 
\Production of thyroid hormones is the maili ·runctioli or the thyr_oid epithelial · .· 
~- . c~ll. (Taurog,IQ78'a; Taurog, ig7sb;.:ingbar ·and w~~ber,uisl.) Their .synthesis· ... 
c~i be su~marized · u :roll~ws: th'~ trap~ins .ofiodid~; th~ syn_thesis a~d i~dination · I I . • • . • . . . • • . 
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t~: __ .... . . . ·. The _thyioid . gland .... is very ~rricie~t In' t'he ·_ ~se or i~did'e, ilsica.lly due to its . . ·. ,,:}: 
~: 't •. I . · · · . ~ · . · · · ~ • - .\:, 
rt·r . ,)' limited av~lability ;n the na.tural environmen't; particularly :in areas located away ·_ .... .:-;. 
~~~- .: . · , fr'om the sea: The ~n_c~trati~n. of io4id0 by the thyroid gfand involVes, an_aCtiv~ · :;:1 
tt-'""tr.' ~.- , I I 0 > • 0 • • , ·~~ 
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' trans)lor: ~echanism. The exact biochemical eVetits invoived ~~.; hot yet fully- <$!') . ::":~ 
· · understood but th~re' seems to be' a participation or the. ~odi~ot~ium- . .: :./ 
. _ ·-
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' !'-
dependant -ATPase .pump. Sodium, with the involvemeiit of .som~.1ne~brane _·::: 
' . 
phospholipid carriers, is able lo in£.f~Sse the infiux and decrease .the . efflUx _or 
. . 
iodide. Concentration or iodide requires cellular integrity, oxidative metabolism, 
- . . 
phosphorylations and occurs against both cQncentration and electrical gradic~ts . 
. . 
Tra!l~port is inhibited by certain ions such as pwcblor_atef pertechnetatc and 
-- - thiocyanate ... It is ·also influenced by an internal autoregulatorY. system based on 
the availability of iodide. TSH and cyclic 3'5' adenosine monopbopba.te (cAMP) 
' . - .. - .. , 
also play an · important role; these aspects- will be discussed·Iater. 
·. ' . ' - · .. ' - . ·- . ·. . . 
: i 
Iodide (r) enters the thyroid gland and -is c~nver.te.d _to an oxidised Corm by a 
• ' I . • ' . • • ' - • 
.thyroid peroxid~e. Tyrosines in ~ully mature' thyroglobu.lin are iodinated .by this . 
~pro4uct. The pro~ess or iodin~ti~Ii se~ni~ to -t~Jee place. ~t the. ceil-collold · ~terrace·'. 
very cl~se to . t,he: ~pica) m~mb.rane (Taur~g, t97~; ·Ui, 1Q74). ·The iodi~~tion .. or 
~hyrogiob~lin . i~ inhibited ·acutely and, transiently -by Jii~~e -amounts or iodide. A. 
-- . 
nu~ber or mechanisms haye_been proposed. rhese .. iQclude i~hibition or thyroid 
' . \ . . . . . . . -
peroxi~ase catalysed · iodination or alterations in ·the p_eroxidase generation · 
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' · : 
systems..: Iodotyrosine co~ piing mechanisms· are dependent ,on the i~tegr"-"'i"""ty~o..__r =th,__,e=-----__:·~·.· . · 
native ;tructure or the thyroglo~u}l~, erficfent iodination, and the C~\lpling 
" . . . . . 
catalytic e~fecf or thyro~d pero~idase. ,T~o fi.l~cbanisms for. ~o,ling ~ave ·bf~-
proposed: mtramolecular -couphng and mtermolecula! couphng. !!! !J.!!2, . ~~t~-
• 1 • • • , •• -~ ..... .... \ 
seem possible; m vivo, intramolecul~r coupling seems to be favored (T~u·rog, 
-# . . 
. ,.,...,-· 
~ . ~ 
. . : Hoimorie tel ease is initiated by endoCytosi~ of iodinat~d thyr~globulia from the ~ . ~ 
# • • • • • • I 
follicular -lumen.· .Endocytotic vesicles· migrate from the apical tewards the basal 
as~e.cts or tb.e _cen:· N~merou~ · iysosomes migrate ~~ard~ - these . ves~cles and .. tbe· : 
' . . . 
fusion or these struet.~res ' permits . the access .. or _prot,eolytic enzymes to the . 
' . . ' . . . . . . . .... 
thyroglobulin~ Subseqilent digestion or thyroglobulin leads to bormone rele_ase. _ :_ 
-· The main ·prod~cts secret~<i b); the thyroid stand are. t~tr~iodothyronin~~f~4); .· ·.: 
: . . '' . . . : . . . . . . . .. . . . - . 
~) · .. · .. 
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:.·c .. , . 3,~,3'trii~ot~yro~e (T3) ~d-~m,all qu~tities of 3,3',&'triio othyronine (revers~ ' .• -·- .: h 
f( , . . T3). lodotyrosines, ouch as ~Ono and di-iodotyrosine, ha~e a 
1 
o been detected in .~· ' .. 
h . . serum but they ·are mainly retained inside tb'e .thyroid follicular cell where . the);: . . \ · . 
. ·· ·are deiodlnated . . ~hy~oglobu~in is m~~D:lY intrathyr~id-al ·but ~t\ has been detecte~ 1 .-; 
extrath~roi~ally in. t.he lymp~~tic drainage, and iii small amo*nts in the serum; · 1, 
.. 
'. ~ . 
' 4 . 
,, 
·' 
·, ; ~- . :-
i : ' 
. ~ - : . ' 
· .. . 
, J•. 






.:. , . 
... . . , 
{;I • : 
f~ . . 
t '- ). ' ' 
~~:. 
,·, 't 





--~ _: _... .. ... , 
... .. . '· 
,1• • •· 
' " ,• 
·~_' : ~ r . 
'/. ', .: 
. . , . I 
even in normal individuals, I ~ 
. " TSH · is involved in the -c<mtrol or thyroid hormone 
. . 




secretion; it stimulates 
I 
' 
. • • , ' ll • I ' .. ~ 
- · 
., s;mpathetic stimu]ation ~~d syrnpathom,imetic · amines ·are· capJble of increasing 
. _bormoDe . se~fetioD .. under certain eici>erimeot~l. ci;cil';,.t&nce." ~r.~ldstei~; 1966; . , _ 
Melander, . 1970; · Ganong,. 197 4). Their rofe unde{ phY.siological conditions is. ·. 
u~ccrt~in and. still . ~em&;ins · u~~~r -.~nvestl~atio~ {Wi~liam~,· ie~o1l-;tz, ~ at"''•"•· .· . Ha.tbaway Jl.Dd Besch, Jg77; Baleziktan· and Loeb, 1983) · . . . : · , - · - . . . ~ . • . . , . . . · . . . ·. . I . "' ' . . I .· . ' - . . 
. . .. . .· . L 
· 1.;1.6. Control ·Qf Thyroid Gland "Aetlvlty . \ · /, . . . . ... ·. . . -. . .. F. ·l 
. . S:everal. f~ctofs are i_n~~~~:d !~ th_e conirol~ ~r thY{~~d glan~ activ~ty (Dumo~·t . 
_ ·_ .:_.and.:_Vassart,l978; -.- ~ngb~r . f!.Dd Woeb.er,l981)'. Anfohrtflese· are 1 T~H, .t~yroid 
h~ormo~es, :odide ·su~plr, ch~linergic agen~ aDdcate~holamioes: _. I ' 
Sr. far, the- most i~portant of tl:lese regulators is,_the gly~op.rotein_ hormone TSH, 
. - . . . . . . . . \ 
sec.reted by .. ihe pituit~ry ·gt~nd. TSH (Pierce-and Parsons, 1981) i$ c6mposed of . 
. ... / ~ . r . . . . . . ·. . ... . . • .. ' . ... .. 
. · t.Wo ·different ~copeptide ' subunits designated as a and {J. ' ~.sJ suhunits. are 
... 
t l , • · ~· 
.\ 
1'\ : • ~ 
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·.. · · hel~ ~o~~ih~tb~ stron~ ~on·c~yaleo{rorce~: . Wi~hin the ~aijle an~~l'·s~_ecie~ the ·. · 
. . a.mino. acid ~~quence of th~ .. a ~subunit of TSH is almost identical _to _11tb~t of . the_ ·a: . 
, ·sub units . ot : othe~ : · glycop~ot~in . hormone~ .. [Iu teini~ ing -·hor~on e : {LH),: · romc)e-
. ·~timul.ati~g. ho.rm.one .(FSH):·abd ~h~rionic g:O~adcitropin (CG)f.·tho~g~ with minqr: . ·. · ( >" 
.. ~. ' . . differeJ;»Ces in, iheir oliges'a~cbaride componentS. The composition or. th~ {J subunits . . [/('_ .> ·. ol' 'th~e h~~mones als~ . shciw certain : b'~mol6gy', but. the diff~re~=c~ ob~~r~ed ar~ . . 
[~} ; · . ; -~ore · e~i~ent. i~an thos~ described -'ror th~ ~ s~b~nlis. . .. .. _ 
~r~·~: ~ ~.. . . . ~. . ·_. . _. . :· . . . . . , .· ...  :.. 
~~.:,,;f;J,{;: i;i,;,(~ ;,\-~ . :: .... ;,>j:,r: ,: +::0:::~ .:.;: ~/ .; ,i;, ,-: : ··. :,;:, ·  •,: ~ •·.  ,: :.,-;· ;:.·, ~~ .· :•'.\ : .. ~: .i.: . ·~ - .:~, : :.... :.~ ;., ·~·L•ti~ 
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The dissociat~4 TSH subunits are inactive. Hormonal activity is expressed only · 
. . 
after re-associatipn ~~tween the a and fJ subunits. It is or' interest to men~ion that 
recombinant hormones produced using a and {J chains of dircerent hormones, aS 
I fl o • ' ' ~ 
well as of differ~nt s.pecies are active.· The biological ~ctivity ·of the .recombinant i~ 
*dictated by the p~ fJ ~ubunit present, suggesting that this · subunit 
determibes thv . hormone specificity . As to how this speci(icity is mediated no 
-
clear explanation has been presented . 
.. 
Thyrotropin's actions on thyroid follicular ceUs can be divided into rapid-and 
'• -
slow effects. _,Rapid e_~re related to the activ~tion of secretio~ o~ ~yroid 
hormon.es witb. acceleratioQ. o( exocytosis, . ps~udopod formation and· e~docytosis:. 
There i~ dlso incre~ed . binding ·oi organic iodide, incr.eased iodothyronine 
J • • • \ ' , o'4 • • • 
ror~~tion ;'and ac~iyation . or cellular metabolic -proces~es . such- 8s t~~ pe_~tose 
phosphat~' shunt BJid mitochondr~al r~spiration .. ~l~w ~SH effects are related to 
- . /· . . -in~reased : ribonucfeic ada (RNA) accumula·tion. due to .activatiqn or transcription, . 
. . ' .• . . . . . ' : ; . ... . . ,. 
increase~ pr~tein .. sy~thesis a~d cell :division. ~ ___.:... · · · . · 
. . TSH~' bpth exogenous and e~dog~nous, is known to increase the ratio . or---
- . ' intrathyroidalfseru~ iodide, demonstrating increased thyroidal · intracellular 
. . 
iodide accumulatiog.. This increase was observed, however, to be pre.ceded by a 
di~tinct drop of the intr~thyroidalfserum iodide ratio. suggesting that the TSH 
~ . . .. ~.. .... . 
ef(eCts on iOdide uptake are ~iphasic' (llalmi et al,-1960). Later studies c_~rried ~ut 
ill.. vitro· using cultured-- bovi.ne- thyroid cells also 'showed increased intr~cellular 
.. . . .. . . . . . . 
iodide accumulati<¥1 after .TSH stimulation (Knopp, Stolc.~nd · Tong, 1970). Th~se 
0 : . . \ . 
authors sugge~ted that_ these actions we~e mediated through cMfi> and ·proba~ly 
required tbe. participation or some enzym~tic products eapa~le or e~hancing the 
·a-ctivity or' ~ertain ~e~brane bound. iodid~ _carriers. · 
..... 
. - . 
~·TSH . actions are. initiatecl. by its binding to a specific receptor localized in' the 
plasma membrane· of thyroid .cells.' T~is binding . appears . to · produce 
. ' 
. ·' 





. . ·. . . ':.'~ 
~.':: 
I ' . \ ' · 
. . :· 
. .':( 
.. ·. ' . i· 
· ' 
' : ~ 
> 










~ .. I· 
· .. 
' ' . . . 
.. ~ . : 
~1;;~;'Hl: : ; ~: •':-rj:, '''::' : : ·:r ·'-< ''':.' ''':~' :~· :"'''''' ' ,;, ~r~:?\ '~'' : "•~'t'Y' · ··::·::;:' ' • ~'·' '·' :'· : ' ' :' ''"' ~. :; ·: :: ~,,,: tW~~ 
·~· -· . - . ·, . I . . \ ;;/ :· · ~ ,_ -..-:...-- . . 
i . . : ·. re_g~latory·. protein with. subsequent' activation of membrane-bound a.denylate 
"... cyclase. This activation ~eC.uires t-b~ presence ot divalent cations, mainiy. calcium, 
•, . ~ 
· .:. a-nd guanine nucleotides such as guanosine tri-phosphate. '(G.'rP) to actiiate the 
' t • ·"'.. • .... 
regulatory pro;sw (Saltiel, Powell-Jon~, Thomas and Nayfeb,lg81). Adenylate 
. ( c~clase . acts o~ its substrate ad"enosine tr.i-pb9sphat~ (ATP) to produce c~, the 
: :· I -.-...- , ~econd ~essen~er for.·many .. TS~ ~cti~;Cycl.ic ~ activates c.AM:P-dependent · 
- ..... .... "' 
protein kinases which phosphorylate ai~Je.s of other .enzy~es or pr9teins which 
. ' - • _.1 • • ' 
ar~ thus either activated or inactivated. cAMP's action is terminated as a result of 
\.·. ·~ - · ·- ~ ~-, ,. ','it;~~grad~tion by 'intracellula~ pbosph.odiest~.rase~ ..; "'" _ 
) I : 
(,' 
\ • . 
..... ·. 
. (· . . 
':·.· 
,, . 
: .:,., = . . . 
--
Even though cAMP is ·an important m_edi~tor of thyrotropin's aCtions, it is 
.. 
. · • u~Jikely_ that all hormonal effects_ depend on its generation.' So far, the ~timulation~ ' 
' .... 
or phosphat!dyl 'hiositol : turnover and glucose oxidation . hav~ be~n ~otind: to . be 
cAMP independent processes.' .. The. impo~tance or cAMP :it:l . gro~th prornoti~g 
acti~s ·und~r ~pb·y~i~logicai · con~itions .is·. still un~le~~· ·S~nie stu~ies ·. !!! vit~o li~ve • 
' • ' • ' • • ' 1 ' ' • : ~ • I ' 
-shown that cAMP is capable or promoting imreased transcription and protei~ 
· sy~thesis (Wils~n~ .Ragh~~hy, Tono;e · a~d 'fon~, .10.68; Adiga, .:Mtirthy and Me· 
' . ' . . . .. .. ' "' ' . 
Kenzie,lg71),· Other ,rec·ent studies using cultured thyroid ~ells suggest t~at th.~ 
. . . ' . 
TSH effect on cell 'growth- is 'independent of the activation of adenylate cyclase 
. . . 
(Va~ente, Vitti, Kohn,· Brandi, · Rotella, Toccafondi, Tramontano, Aloj and 
- ' 




·:· ·:~ ', : . . 6 \ l.l.,. ~hatacter7 of thy~old c~lls In culture • , ·. . 
:~~:: : · C~ltured thyroid epitheli~l ce1ls are ·u~eru'i ... ;tools in the-s~udy of the . strQcture an_d 
c;:,·.- -. ·_ ·. tb~ physiology or the ·thyroid ,gland. Isolated cells -i~ monolayer cul;ures ·retain 
;·. .. . . . -· . ' ' .. . - . . . . . . -·· ~·i .. _.-: . . ·r· n\any: functional and. morphological characteristics of · e dirte~:enti~l.;ed thy.roid · 
·:~·=·· . . . . . . . ~ ' . . . . . . . · ~ . 
!/-- . · cell wlthi1:1 the intact organ~ Addition of TSH~o primary ·eon . t cultures--leads }'~:· ' . . .· . '. : . . : . . .• . . ' . . . . . . . ' \ .. 
k~·.·;·. · t_o_ -the fQr.mation ~~ follicle-like structures: These follicles. concent~a e iodide and 
,.... . ' ' ' . . . . . . \ .. 
"Jo.;_ - ~ynthesize.· thyroglobulin and thyr<;>id · hormone~. As in. normal follicles the apical f£ :·:· . . ' . ' . ... ... . ' - .. . . 
'li,)C ,. ... • • • • • • • ' - • .. • • • • \ 
1;\ .·. .. pole ~r the :c·~~~ . ra~~ the follicular cavity .in whteh thyroglo~ulin~ accum~lates 
~~:~~::·~ -.· · . (J(~.rkor,' ··Long ~d Chiakorr,i064; Fay~t, Pa~heco and ' Tixier,l91:0; . Kondo;·~ 
~~~(. ··. - : · :·- . · -Horiuc.hi and.In~ue, ,IOSO).: ~- . . . . . \~ . 
if5( :' : :_ . \._, ·. '.\. 
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When cultured in _ the absence of TSH, ~ells organize into a uniform monolayer 
a:~d appear to lose th~ir capacity to con'Centrate iodide and to p~oduce thyroid 
hormones~ Thyroglobulin synthesis continues but at a very low level. TSH 
/ . -
responsiveness is greatly depressed but the cap·acity to ~roduce TS_H·responsiv~ 
aqenylate cyclase is maintained. In these cells the basal aspect races the culture 
plate. and the apical aspect faces the culture medillm. This -inverted orientation 
rna: at l~ast par_tially · exo/hin the loss of ce?tain physiological responsivene~s Jo 
TSH (Mauchamp,~Margotat, C~~bard, CharHer, Remy and Micbel-Bechet, 1g7g; 
Cbambard, Gabrion and Ma.ucbamp,lg81; ttThambard et al., H1831 . 
. Ultrastructurally, · isolated thyroid cells maintain th'e gene-ra.! chatacteristics 
previously described. Cor the thyroid gland. 
\ 
. . . 
1.·2. THE THYROTROPIN RECEPTOR 
1.2.1. Characterist_lcs ot hormone reeep~ors _In general 
. ' ~ 
· ,;. " Receptors are speciaJiied ~ellul~r. molecules capable of recognizing spc'cific 
ligands and binding· them with high affinity and .specificity (Baxter at:~d 
-Funder,1Q79; Lefkowitz and Michel,IQ83). After binding, hormon~specific signiils 
are transmitted tq trigg~r the appropriate .pbysi_ological r·esponses. According to 
. 
!- their cellular' localization, receptors can be: cyt~solic receptors which following 
.• their binding to specific _ harmon~ migrate to the nuclep_s ~o · interac~ with 
. . ' 
chromatin, nuclear receptors which are present in chromatin even in the absence : 
' . . . ........... . ...._ 
.. C?f specific hormone and plasma membrane-bound receptors. 
. . . . 
Activated hormon~rece~tor complexes interacting with chromatin regulate the 
>(' • ~ • 
. levels or specirfc ~messenger~. As a consequence the~ _change ... the rate .2L_ 
~sxnthesis or .Prot~ins coded 4:>r by these hormone-regulated messengers. · 
M:embran~bound recep~rs bi,nd hormone and the ho~mone-receptor complexes 
transmit si~als. ~hrough changes in membrane ino~ili~y __ -to . activ~te •second ~rriessenger~•. cAMP is·- t~~ best studied se~ond ·messe~ger, otb~rs like cyclic· 
• • • • ~ (p ~ • • 
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involvein,nt has been less extensi~ely studied. S~~o~~.messengeW, princip~ly .. 
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·cAMP, ar.t ·known to activate protein kinases thsl fiiitiate protein and enzyme· 
. ... . ' 
. . .. . 
ph~phorylati1>.ns, activating Gr· ~naetivating them, tq elicit further physiol<?gical 
. ~esponses. . 11/1 
Many me~~rane ·bound hormone. receptor complexes have been observed -to 
internalize 1!8 endosomes after aggregation. The r~le .o( internalization is still pot 
clear. It is thought to be associated in some instancest with hormone degradation, 
~ ~. . : . . . . . . .. _/ · . 
. 
) · ,,.. _ ~receptor degradation, ma.y b~ followed by r~ceptor recycling, or m~y be necessary " 
for t.be acti~ation of ~ertain bioiqgic~l r;spo~ses (Hopkins, 1Q83). . -4. :, 
. .. - . . . . \ . \ 
Recepto:~ ar~. continu~usly: bei~g. syy;1t~~s!z~~ ~~d degra~d~dr Synthesis of cell 
surface receptors as ·well a8 ·other re~epibrs~ is thought to re~emble t~e pro~ess 
. ~ . . .. . . . . . . •. 
involved in the sy,nthesis. or .•exp6rte4. proteins. It starts ~n ribosomes .associated 
. .. wit~ . the R~R,' p~pc~ssing. cori.ii~u~~-'i;~- th~ · c~st~i'nae of the RER_ arid. lat~r _in the ~ 
·o·olgi complexes. Assciciation tir ·recep.tor subunits and asso_riation. of the receptor 
. . ..... ' . ' . 
~it\ th~ membrane proteins are s~ill being investi,gated. 
• • 0 t 
' 
Radiolabeled bG>rmones or drugs have eontribut'ed greatly t.o 'th~ study of 
. . ' 
receptor-ligand interaction .• Data obtained from these studies h~ve traditionally 
" ~ . . 
. . . 
been analyzed witt( ibe \i :e of Se~tchard plots (Scatchard,HJ49). Better 
• .. • ,... t . t " • 
in~erpretatj~n of d~ta' is no·· . . }eing ?bi~ined with innovativ_e co~puter-ass~ted . . . 
. • non-lin~ar: least square c~rve i til,lg progr_a~s · that apply·the f~w or mass a~tion itr 
. ~ore dir~-c~ _an~ acc~·rate f~hion· (M~~son f~nd Ro~bar.d, 1980).rigand-bind_i~g ·. , 
stud~es ha~e Jielded 'in_formation-relate.d . to receptor number aD:d . arrini,ty' under . 
. . . . ... . r 
, v~ried circumstances. Through .t_hi~· irif~rm·aqol\,it is now kno~n that the num~·e[ . . 
~t:~~~ ;. ·.- . o( rec~·p:~rs f\un!d-in_ a ce.tt~- ~~t-~constaht~ tb'-~ · num~ers are d~~~~ically -re~lated . :. ·, 
' 
~ 0 • ... . 
· \ 
' ' . 
. y 
·. 
. . . 
.. 
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:I~}·;·. .. thr~ugh ·ligand binding. It is· · a~o known tha\t these variations in· numbers 'ca:~ : 
~'(•·: ""'""""~-. · · __ ..-- --~di;t~te. the ·sensitivity 'or the · c~l .to sti\nul:aiion. Changes. hi affinity c~n ah;o . \. '.
,. ,.. 'i ... • ~ ,. . \ \ . • . - . ~(f~:: .'_ ;!. --: oec-~r, -even th~.~gh -· they. a~e. -~1~ r~e~ue~t, the pheno~J!enon of --- ~oeg~tive . , 
" .J .. 
I ' • ·, 
•,o .· .· · . '· 
;~; ·.. . , . . . . ·.· . . I . ...... 
~i;;· ;:-~ . .. : · eoo~~~ativity• :~an example ~f'su~~ c~ang~. .. _.., 
'{j.<J I • : J • . • 
.:..;-_,_;.:. 
.Qo1-... .., ' 
, .. 
~ ...  .: 
I }•1 ~-~~ .. ··l\ ~ . , .... ·~· \ \ .,• . . -- .;A -\ • :(;--~-· . . •• ' · ·• ·:· ,',·'.:~·-.·.i. ;;;.~~;'· ·, ', ,• . : .. . . . . . . ~ ,. 
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Th;· ne"'f· step in _ the. ' st~d.y - ~·~ _recepto~ is ~he determination or _their molc~ular 
and . .Strultur~ oh~racter~tic~·o'· _ ln several systems t~is hB:S bP.en ac~ieved •by 
purifjcatioli 'or by .tb~ir- identification witb:irrev.-e~sibly .. hpund liga~ds. . Through 
. ~ - l • • . 
~xperimental prp~edures like affinity. chrom~tography (Lowe, 1079;· Drummond., . 
'McQuade, G~unwald, Tb~mas~ and Nayfeh_, lQ82), pbot~afCinity labeling (Hazu~, 
_,. . . .. 
1983); and anti-receptor antibody-receptor inte~actions (Van Obl,>erghen, .Knsuga, •• 
.... .. , . , . ., . . . 
Le Ca~, Hedo: .. Jtin and Harrison, 1081), the str1.1cturai char4cteris'ti~s or several 
. ·....:... .. . . . . . ... 
receptors are~ow known. '_This ,~nowledge has lead to the construction of 
hypoth~tkal models of these~ receptors. These models hav• proven very useful in 
the. interpretatio~ .or seyerat·physiplogical -e~~nts. .. 
-, . .. ":'... ,.-
.. 
1-.2~~. Str1;1t.ture ·bt:'tlte Th):r~tropln Receptor· :: 
.. . ., . ... . 
• f'-. 
.. . 
Thy~Wo~in . bind in~ · acti~ity i_s almo~t ,sx~l-~siveJy localize~ .to. thy.roid- follicular · 
~pithelial eeU~, but extra~liyroid&l binding .sit~s·-have al~~eeii described in testes 
. . . 
. . . .. 
(l)ayies,· ~ee~-Smitk And 'Hall, 1Q7S); ad~pose tissu~ (Teng, Re·es-Smith, Anderson 
. . ' . · ~ --' " . . . .. . . . . . . 
and Hall, 1075Yand lymP,hocytes ~Pekonen and Weintraub; 10.78). Bindi_Jtg at non~ 
' -
tll;'roidal site~ seems' to exhibit different .characteristics frbm thyroidal' binding v . ' ' . 
according ''to .the ~u~hors q~oted ab~ve;. Re'cently certain structural simil~rities ~ 
0 •• ' 
well as differe..5ces. b~twe~n tb~ adipose and .t~yroidal re:cepto~s have been · 
d~scrib41d (~c~_land . an.~ Re~s . ~ri_lith, }g84). The pbysiologi~al role of . these 
· textrathrr.oidal.sit~s is still unknowJ! . 
. -., . . ·: . ' . . '- -
Radi~iod_inat~d liga~d bindin_g studi~s ·h~ve heiped iplthe identification of.TSH 
. binding site~ in- th~ sur( ace ·of intact thy.rocytes in culture (Lissitzky, Fayet, 
I '# .. . • ' • • 
'Vernier, Hennen aqdJaquet,IQ73), in th-y:roid cell membrane preparations' (Mehdi 
-and Nussey ,1975 )'....-and in· detergent:soluf?ili~e<t cell membranes (Manley,_ Bourke. 
. . . ~ -' . . . . ~ . 
and .Hawker,lg7~). Sc~tchard~-a~~lysis of TSH bindjng at near physiological ·pH 
. and. salt c.oncentrati~~s was found to give a curvilinellr· plot s~ggesrl~g t~o ~las!Jes 
. . . ... 
... . · of liindlng sites, ·bigb . t!lfi~ity sit~s and low affinity· si~e~ '('fate, Holme~, Kobo and 
-· 
' 
_ q ' Wina~d, l~75; Pei·erson,. Da~es: Ree8 ~mith ·and Hall, .iQ77; lid a, Konishi, Kasagi~ _:_ 
'" - ikekl!bo, 1\uma and· Torizu~ ~9~1); The physiological .involveme~t .or each or 
. , . , . r . . . 
. . 
' (\ 
.. . ' . . 
' ; '• 
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these sites is difficult ·to usess but it .seems that t~ high affinity site represents 
' . . ~ . 
the bioto~ically relevant TSH recep~~ and the low afrinlty site is related to the 
·high ar(inity site eith~r : as _a precursor or by aggregation (McQuad_e, Thomas- and 
Nayfeh,· IQ83; Islam· and Farid, IQ85J. Occupancy of the receptor by -Jigand 
., 
appe-ars to .be involved in . the regulation o( receptor numbers. Studies of thyroid 
I 
cell responsiveness to repE!ated TSH stimulation in vitro have demop.strated that 
. 
this response is hi phasic, at low doses ther.e. appears. to be a constant stimulation 
whereas at h!gh concentrations· there seem~ to be a desensitiiation with 3.: le.sser 
·-number or receptors available .for. binding (Takasu, Charrier1 Mau~hamp and. 
~ . . .. . . 
Lissitzky, 1978; Davies and Catt, 1978; Witte and MG Kenzie, 1Q81). The_ different 
. ~ ; ' ~ 
degrees or. cell Jesponsiveness to TSH stimulation are reflected in changes· in 
cAMP generation. 
. - ·, A -- . 
· It has been ~aintained that·TSH-receptor interaction_ was tran~ent and readily 
reversible.' . . $tuclies with ~ thyrojd- plasma men:tb~ane preparations. have 
.'deritonstrated that this is not so; the inte~action ot TSH ~ith 'its: receptor .becomes 
. . ' -- . . . . 
. m<?re stahl~ with· time (Brenna~',. Peter~on, i>eterson, _Rees Sniith and· Ii~il, : l9So).' 
~ ·P'" . • • • ~ • ~ • • ' ' • . • . ' • 
These·Ji~djngs·.~tiggest a· in or~ 'permanent as~ociation ·· b'e.tween _the. ~orinone and ~. 




. .,. . : . . . . . - i ' . 
. Studies involving · cytological techniques with.· rhodamine conjug~ted TSH have · . 
. ~ . . 
. . 
-- den:tonstrat~d .tha.t TSH receptors are_· diffusely di_;;tributed in the surface · of 
thy~oid cells. Dinding of, hormon~ ·tO its receptor is followed by aggregation and 
endo~itosis in ·a man~er typical of many othe~ pepti~ hormone recep~ors (AYivi, 
Tramontano, ·. Ainbesi-Impiombato and · Schles:;inger, Jgsi). The.-. role or 
. , . . . .. ' 
.. ... . . 
i~tern~liz~tion· is·still -to be fully inves~i_gated, a~though' it has been suggested t~uJt · 
i.i js. associa.t~d with the · termination .. ·or 
. . . 
. . 
Hradek, Wong'a1.1d Moob~y, 1978) .. : \ . 
. . 
the AC activation (Goldfine, ·Jones, 
Several atte~pis by. cliffer~nt -~o:ups of inv_estigators ·io establish-the ·biocfie~ical . 
. ' . c. . ' .. ' ' ' • \.. . ' . ' . ' . 
. •. · strueture or the. TSH receptor have yi~lded a ·number or-conflicting results; none·· 
' : . • • • .. • • • \ • • j • • 
'or w_hich has give~ - unequivocal_ data'as to its molecular m~· or its organi~atioii_ . .. 
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The molecular size has been reported to be {,-om 15,000 Daltoos (Da) to 500,000 
Da (Manley et al., 1974; Tate et al.~ 197·5; l)awes, Peterson, 'Rees ~mith.and Hall, . 
. . 
1Q78; Czarnocka, Nauman, Adler a~d ·Kietczfnsld, 1979; lida et at.; 1981; 
? -
Koizumi, Zakarija and Me Kenzie, 1gs2; Iida, Konishi, Kasagi, Endo, Misaki, 
. 
Kuma and Tor-izuka, 1983. Buckland and Rees Smith, H)84; Pekonen and 
Weintri).ubJ lg7iJ). 
1.2.3. Structure of the porcine thyroidal TSH receptof 
,4 __ _ 
The Thyroid Research Laboratory at Memorial University of Newfoundland ba.q • 
been involved hi th~ study of the 'structure ·or the _porcine thyroidal TSH,.eccptor 
(Islam_ and Farid, 1985). Some exp_._erimentaJfprocedures are d~cribed in a detailed· 
fashion in this subsection ·because or the close relationship between these results 
and ~.he work t~ be described in t~is tbe~is~ 
' I 
The purific~tion procedure~ briefly described, is as follows: ~o~cin·e .thyroid 
plasma membrane. p-reparations were solubilized. with lithium, diiodosalicylatc, 
. , • ' • I? . I 
applied' to a DEAE-sepbacel column a_nd ·eluted with 1 M NaCI. After desa.lting 
, ' - I • • ' , ' . - . , • 
th~ eluate was next, applied- to .a second DE~sephacel column and furth()r eluted 
'with a' 0;0- 1.0 M NaCl gradie~t: Sever~) prot~in p_eaks' ~ere obtai.ned. Peak Vlll, 
. ·.. .. . . . . . ' . 
which eluated .between 0.35 ·and· 0.56 _M N.aCI, ·cont!Lined ~h~ _ 12~1-bTSH binding 
- . -·- . ~ . . 
activity. 'Peak Vlli was further purified by applying to a TSH·Af~~gel eolumn and 
. - . 
eluating with 3 M: NaCI. Alter desalting the product was made isotobic in 2 M 
. . 
sucrose. The prepa~atiOn was resolved·~ 7.5-15% line8l grad.i~nt sodium .dodecyl 
sul~ate polya~ryla~ide gel . electroph~res~ i~ the absence. or red~ctant and ~ta~ned 
with silver nitrate. _The predomina:nt product obtained . was an Mr,....., 1~7,000 
polypeptide . which corr.esponds. · to the -_ holore~eptor. ·The recov·ery or . thik . 
polypeptide ·was 'greatly dependent on the butrer os~olality .- Several other minor 
bands. were als~·· observed. at ~Mr,....., 130,000; ldS~OOo; 70,000 and 66,000; these. ~ere 
ro~nd to. corr~~nd to-different .receptor break_d~w~ produets .(Figure Ll:a). The· 
·~-ubunit co~po~ition or the ~e~eptor -w~· stu.died ,by r~olving the 'eiuted ,product 
-by eleetroph?res~· in a 10% sodju~ dod•e.cyl~ ~~lpbte .po_lyacrylamide gel· in· the 
\ 
, ·', ·. ":' 
. .~ :."· .. 
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Figure 1-1: The TSH Receptor (from: Islam & Farid, 1985) 
a) Electrophoretic pattern of the TSH-affinity column purified 
thyrotropin receptor. 
b) Hypothetical model of the TSH receptor. A heterotetradi1ncric 
glycoprotein composed of 2 subunits, delta ( o) and epsilon (E). 
~?}'~f': ;,~ :·:·:, , ; '; ' :': ::t<;;''':"'~';·· •' · ·. '·' •· "' >,::~· ; ~f: ;::-.,;·: ,·"'1>':1\';";·.·'-~: \Y '''J'';; : ·: ';·, ,:;; !!! ; •:ifP'1?o" '?t;·: .W!f'':I;:y:~p~:'<;f1'·~~~t')~ 
·' . 15 . · . . .: . :-;r. 
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presence and in the absence of P-rnercaptoethanol. Under non-reducing conditions 
. . 
. .. - ---
the Mr...,., 70,~ and the Mr-.. 66,000 were identified; These peptides maintained .. 
a 1:~ stoichiometry. Under reducing conditions the Mr ....... 66,000 persisted, while 
the Mr."" 70,000 disappeared and a new band at the level or Mr"" 35,000 wns 
observed. 
I' '·-' ~ . ~ . 
It was therefore concluded th"at the holoreceptor is a glycoprotein 
' 
heterotetradimer with a Mr......, 200,000; It is composed of two different 
. ~ 
glyco_protein subunits, tlie first with a . Mr"" 66,000 and the second with a Mr"" "; 
35,000. , Two 35,000 subunits are linked by one or more disulfide bonds to give a 
. 
70,000 form. The 66,000· and 70,000 subunits are ~eld together ·by stro~g non-
covahmt forces. The integrity of the disulphide bond was round t:o be essential ror 
. . 
the integrity or the holoreceptor and Cor hormone binding confirming previous 
studies which demonstrated t~at 1~51.-bTSH binding is di~inisbed. i~ the presence 
. . 
of S-S ·-bond r.educing agents ; (Ozawa, Chopra, · Solomon and Smith,. 1Q7Qt 
' ' • I ' ' I • 
Ginsberg, Rees. Smjth and Hali,_ 1Q82). Moreove! the, ~ccupancy Qf the r~ceptot. by 
TSH :protec.ts- it' against the disruptive effect of the_ reducing. agents (Davies and. 
: Platzer, 1Q8l). 
Using all the available information··acqu.ired and considering· the stoichiometric . 
ratios ded~ced from the relative degree of radiostaining ·or ·the two reccP,tor 
. 
components, a model for · the .rec_eptor wa.S proposed (Figure l .l :b). Surface 
. . . 
:-" labeling of viable-thyrocytes with ,radio-iodine showed that both re~ptor chains 
are e~posed on the. surface of the thyroid follicular. cells (ISlam, Brioncs-Ur~­
Bako and Farid, -1gsa a): . l 
~""'*" 
. ,.; . 
~ t : 
.' Severa\ lines of evidence bave _supported the conclusi?n t~at tpe TSH 
holoreceptor is a 'glycoprotehi with a Mr ........ 200,000. J~ative and radiolabeled TS~ 
. . ~ .· . 
bind specitically to· the Mr-..2oo,ooo polypeptide on nitrocellulose paper thyroid 
. ., . ' 
. . .. . ... . . . . ' 
plasma membrane protei~ blots· (Islam. and .Farid, 1Q85). When ~pis po~ypeptid~ · 
. ' . 
'*a.s . cr9ss-linked_ covaleritJy with: r~dio-iodibated . TSH, ' the ·interaction was · .. 
· : in_hi~ited quantita~ively by ·n~tiv~ TSH but ~ot by. other harmon~ (B~ko, ·u1a~ 
. ~· 
. ·.·~ 
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and Farid, 1085). In a 8oiid~phase· -radiometric ·assay., 
prepar9:tion exhibits only one high affinity binding site with 
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1.3. A~TO~UNE THYROID DIS,~DERS 
1.3.1. Autolmmunlt)' and disease 
... 
. 
· . The prima~y role of th.e immune. system is to recognize • non-setr• within the 
oontext of •self•. Under certain circumstances the immune system becomes 
• aut<raggressive• attacking self determinants, a. process that ·bas been called 
autoimmunity. 
One important question that bas to be addressed is whether autoimmunity itsctr 
is necessarily an abnormal or pathologica~ process. It ~has been. suggesied that the 
capability of reacting against self is part of the .normal immune response. 
. ' . 
Ac.cording to this hypothesis, it is sugg.ested that recognizing non-self is closely 
. _,; . . . . 
-.../ . . I . . . 
·related to·· the. capacity of recogniz~ng self. The· production of· low t'itres of. auto-
. . ' . . . ' ... . 
· antibodies can- ·be viewed as a normal physiological process. Exaggerated 
• • .. " • • • • :0,. 
responses, often associ~ted with tissue inJury,· result in· autoimmune'·disorders. 
The '··normal .im~une .response. is ~·a!ntained by . a de~i~ate balan.c.e . of imll},U.n<r .-
. • . ' . . . 7 . , . . 
r.egul~tory mechanisms. ·This pr_inciple has been supported, by the d~monstration 
that the potential for autoimmunity . is present in .all .·qorm.al indi~iduals. Ma.b·y 
healthy 'subjects·. haye antibodies 'io several normal body components ·(DNA and 
. . 
thyroglobulin among oth~rs) but that pathology will only develop, in a limited 
n.umber or cas~s where an alter'ation or' the normal b~lanc.e occurs (Talal, 1077). ~ 
. .• ... . 
Immune-responsiveness is determined, among other factors, by immune. response 
genes and ~fficient imm~ne regulatory rlechanisms. The imm_u;o~ompetent cells 
involved in the im~une re~ponse include · -~ntigen presenting cells (m~crophages, 
. Langer hans .,.Jd ~n·d~.t~elial cells),· T-:-cells .(t~ymus dep~n~.~nt ly~phocrt.es) .and B. . 
cells (bursa <lerived l.fmphocytes in birds and bone marrow derived' in mammals).'· 
Subsets ~LT~~~jls .elther .helper or suppr~~sor are capabl~ or· regul'atiog B-celf 
C~nction (Julius; . H)82). Heiper T~cells . tri~er. the differentia.ti~n of .B-c.ells . into 
. \ . . . . . . . 
antib,ody producing cell (Saxon, St~vens and AShman, lg77). Suppressor T·cells on 
.the other hand •down-re-gulate• an 9ngoing. iinm.une response or ensure that such 
. .. . ( 
l • 
. ·.~ ... 
. ~ ~ :<i' 
.. 
' ... -, 
·, :. ' ~· . 
, . . 
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respons~ does not occur at all (Golub, Jg81). Excessiv:e help or deficient 
suppression . lead . tO the expre5ston or abnormal antibody and cell-niedia.ted 
imm~'hity; ldio_typlc> anti-idi~typie) networks ha~e bee~ dem~n~trated to .be .very 
important in immuno-regul~~ mechanisms. Their characteristics and 
• .. • Cl j. 
pa.rticHpation will be d~cribed in a later . ~ection or this introduction. . 
Immun~ responsiveness ·~_epends greatly on the expr~ssion or the products or two 
c)ust~rs or gene~·: the Major . Histocompatibility Complex (MHC) and the 
-· . 
' Immunoglobulin (lg) system (Bianden, 1980). Genes . or the MHC encode for 
molecules .. ~hat ~ontrol_ interactio~s between -ma~rophages and T-cells a~d between -
helper an~ suppressor T-cells and B-cells~ This commupication r.f.iuires that the 
inte·~acting ~eJis have i~entical MHC structures . . The · MHC-coded ·g~ne products 
~re highlY' polymorphic · t~a~smembrane glycoprotei~s which. are identkal in the 
' ' ' ' . ~ . . . 
, same individual, althbugh distinctive determina~ts ·may J:>e ~press~d not only by 
. . ,• . . 
difierent T-cell subsets but also in di.frerent tissues . . 
..., 
Molecules encoded· by · lg genes control ~peciCic i~tera.ctions between the different 
. ·' ' . .: . f"("'". · . . . ' _.. ·_, . . • - . 
clones· or lymphocytes.· Apparently several immune· respons~ (Ir} genes map clo~e 
. . . . 
. to lg .heavy chain gene chlst~rs and at least' in the mouse, on~- or more of 'th'ese lr 
' . . " ~ . . . . . 
genes determine .the idiotypic repertoire or the antibody r~ponse (Bach, Greene, 
-Be~acer.rar, ~nd Nisonorr, 1979; Hirai, arid Nisonorf, 1980)_. · 
Theories expl!ilioing the origin of autoimmunity: are.·multiple and tb.eir· concepts 
·have· changed througbo~~ ~he y-~~rs (T.ala:l, 1980; Fauci; -Ig81; Rose, i98l) .. These ·· 
. . . · ( . 
i~ciude th~ _•-forbid'den clon·e,• _!_heo'ry and the •clonal abortion • theory (Burnet, 
. . ,\ . · .. ' . . . . ' . . ' . . . . ' . . 
'1969); cross-reactive antigens due 'to tissue damage c.aused by bacterial or viral 
in~ections ~n~/~r · toxins· (AJ~,_Ig77) a~d ~~sor<,iered i~~une re~lation (Tal~l, ·· 
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reqecting their polygenic nature. Certainly, in autoimmune thyroi~ cHsease there 
w; ~js evidence ror.an interactive pr~disp~ition link.ed to MHO alleles and IgG .he_avy. 
chain markers. Decreased or increased efficiency in foreign antigen recogniti<>n in 
• ' • L 
association with so~e MHQ _a.ll.eles is probably the basis of the· ~ariations in 
· immune responsiveness that can potentially predispose to pathological 
autoimmunity: 
Failure or immune regulation cah occur after functional.alter~tion or any ~r t~e 
~r~e groups of cell populations involved in tliis response. Most of ·t~e attlmtion· 
. . 
ha.ci been concentrated on th~ole of· the T-cell as . potential: cause of the 
regulatory ~derangement. Experi!tentally, suppressor T-cell . deficien-cy. has been 
. ' . . .• . ' .. 
documented .in some autoimmune disorde~s: It is stm·argued whether in several 
hu~a~ diseases. and their : ~~i~~l model counterp~rts . thts defeet 1 iS : s.econda~y to 
I tl f ' ' • ' • 
. ""the a:uto-im~une. respons\ or_.its. ~~usati~e~. B~cause ~celf resppnse t~ ·_seir 
an1:'gefs 'is _hi_ghly ~ependent . on T-cell r~g~l~tio\,._.immuno-regulatorr: ·T·_~elt 
dy function may_ le~d . to alter~ control or B-~en_· function with increased antibod~ . 
. .. 
· I P•f dQCtion. ~~ditiqnal .~erectSj r· the ability O( B-celJS to respond tO SUppreSSOr 
signals ha~e also been. postulate~. · · · . 
I . 
. 
·,, - . 
The fact that som_e orga.~s - ·~~ mote PJ:One than others to the attack by .au~o-
ahtibodies has lead to the belief that ther.e are some special characteristics that 
make these tissues more susceptible to this type or .. destruction. Little information 
. . . 
is available to explain this _auto-antib~dy specificity. for certain organs. Recently 
• . • . . . f - . 
ail aberran! ~xpression of HltA.-DR antigens on· the surface of thyroid c·ells of 
pa:tients w_ith Graves' .. Dise~e was. found .(Hanafusa, Pujol-B&-rell; Chiovato, 
Rus~ell, . Doniach a~d ~otta~z91 _ 1983). Thi~ findi~g suggested :_ a. ne1 p9t!!nti'a.l 
-explanation as tQ how. certain organs trigger tbe production or autoan-tibo<Jics ·by 
. - ' . . ( . . . . . 
presenting th~ir' own· ailtigens within . t~e . context or 'these· aberrantly . expressed . 
. . . . ~ 
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:MHC, antigens. 'Th~e· autO-antigens can infiuence th~ imm~ne-r~p~nse by·. · . . .- .. :· 
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.. . ' 
_aberrant e~pr'essions ·of DR antigens (Bottazzo, Pujol-Borrell and Hana.fus~, 1Q83) . 
... 
. -.- . ' 
. . ~ ' ~ . 
It is ppssible,bowever, that tpe induction of DR antigen expression iS secondary 
k, the ?rga~·-ies~~ ~he. autO~muile process. It is bnportant ~ m~ntion 
that_..eyen-tbough it is ·generally though't that autOantibodies reaCt o~ly against 
,, 
specific target ·tissues, patients .. suffering (rom certain organ-specific autoimmune 
disease~ frequently . have au~antibodi~s,di~ected against organs other than those 
. \ . 
primarily . ~fleeted . . Natu!ally oecur~ing . multiple organ: autoimn:mnity . is well 
.... · documented. {Allison, U~77}. ·j;xperimeJ)tally, polyendocrine ·disease with 
I - ' • • ' 
pancreatic anti-islet pcell, anti-anterior , pituitary, anti-thymus and ·anti.-gastric 
m_ticosa antibo~ies has been .P~~d_uc:ed _in .reoyirus infected ~ice (Onod.era, Toniolo, 
~ay, Jensen,· Knazec apd ·Notkins,-_ lg~i).'. In, the search for ·.an expl~na.tion _fo_r the . 
' ' . :. • ~ ' ·' c • • ~ . • 
· _ origin ·or .·multiple ·organ autoim.niu.ni.ty, monoclonal .antibodies ·were .raised . using . 
·.spleen cells ~r · ml~ ~ ·\ \Vith multi; .- .~n.d~cdne · aut~i~rri~mr .d.iso~.ders. Th_ese ... 
. . . . . ,, ' . . \ . . . . . . . . . ·• 
·antibodies cross-reacted with antigens ·'in miiltiple .. endocrine tissues., .Further 
studi~s; usin~· -~o~o~iorial a~tibodies. p~~pa~ed' from · ly~pho~yt~~ fro~ .. p~tients 
. . ·. ·, . . . . . \ . . . : · . . . . . •. ·_ . 
.. with' pQlyendocrine . diseases, we~e 'also .found to react with. multiple normal-
endocrine :4ttd nOJi~e.ndo~rine h~inan tissues. It i~ conceivable_ then, ~h~t molecU:ies' 
• -~ • . • .. ' ,. !;\ . • 
. : - specific to · one organ can share common antigenic determinants with molecules 
j': : \ specitic to oiher :·org~ns~ Tb_e anti~odies r~i.sed against. the first organ .can cross-
::':; . \ . \ rea!t with. ·a·ll ·other similar mole~ules. These Cind_ings ~u, at least partially; 
.-.~ · · \ ex-piain .th~ appeartmce of m11ltiple · organ autoimm~nity (Haspel, · Onodera, 
, ; ·. \ . . f~~bh•k•~ Me' Cu~tok~ E~ani, Ray, Y agihaShi an!~ NOtidns; l~saj. Despi~c th~ 
. :·.. :.· .· . evidence descrio~~ ·above suggesting that'cross-r~actiyity is one g_f ~he major issues 
... 
. ; .· 
... . -;· 




··. ' · .
.. · 
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.-··. 'in tli~ ' ilevelpp~ent·· ~r multiple a'rgan ~utoimm~nity, sev~raf ~uest~oris re~ain . · : \ :.:··;} 
~_:;_: .. . ··: ·. · una.n~wered>One of :them-relates to. the discordance in the time ~r o~~et of the - - :_·. :; 
· ;::·· . .. · • different . autoiliu~uri~··diso~ders.in ~h~ ~~me:·indi~idu·a~.~night ~nd K~igh't (1Q84) -~ · ~,!~ 
.f, .' ·.f •. h~ve c~mnieni~d- 0~-;th~ inipo~~~n~ that ho~~relat~d. -~nd g~~etic~lly i~fluenc~d .' . . :>~ 
:! ' . ·. . ' ' . ~ ; ·- ' . . ·.. . w • • • • .. • • ' . : ._.l.j.. 
l;~::· :~ : . so~a.:i~>m~~a.tio.n~ ~~~ .- .~av~. _- .~n.-· P.roducing _an . array_\9.t ~irrerent ~n~ibody _ .-: ?) 
~': ,) . ·. 'generating clones or .  c~lls~. Th~~- ~ugge5t. that_ th~e clones are likely to have arisen I .. ,:;~;; 
f-.::,:'··, I • • • ' ' ' ' ; • .. t ' \ t • j j * ' · )."":, 
:·· ... ,·. # < • ' \ • •• •• ~· .. . w • • .. .... . r 
~ ~ ~ .') 
.'; · ,.: ' • • • .... • • ~ ' ~ • • • • 0 • •• . : 
~~~~{"~· ... ::,.:; ,-j;~:,;,.):,f; ;~i,;'; ~: ~ ; ; ' .. ;.~. <.;::. ,,; :: ....• ::·:.,;,; '• :)·.·: ... ·... .·.·•· ';;.· ;, ··;:; :.:; ;;:.: .. ' .. · . .. •..•. :.. . •.. : .•. >:;, , )~~ ~~~:·'k~.~f.\f,'f't'-'~~;\&.4.l1' .r I' -~,~·)~~ ~;il~f)J~;;-.,i'·,.~~:-:,··_\'~ :,~:Ai.~"' ... ·';·~.!ri\..~,-.f.!t ... >~.~i:.,l ; _ _ij~~F ~.~·~ t~~·~.:·:. ,,~~.~~~~-~.r:t~·?~·~.:::; ~ r;~;"~f;j ~·)· ·:~ ...... ,.~:~ ~:.;.\:).':._, ;;~; ~~.)' ~~: .. :}t~: i·!~~l· i::;.~;_; ~ ):~:·~,:::~~:.~·iY . ·?)~'}-·~ti'~'" 
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by separate somatic mutations from either a common or a 'separat-e precursor pr . 
. . . 
precursors. .Their antibody products could, then,· share· -~orne :idiotypic 
det:rminants that are dire~ted to closely related antigens. This .th~ry c~uld at 
. ' 
least explain · the time lapse in between the appearance of the autoimmune · 
problems affect1ng different organs and also the cross-reactivity observed during· · 
experimental work. ,. 
The development of autoimmunity' also requires !he presence or environmental 
triggering factors. The role of bacterial and viral infections, a8 well as some other 
~ . 
environmental elements. may· 'prove of great importance in many disorders. Some 
\other ~ost related .factor~ des_erve _mention. Under expe~imental condi~~ons, it bas ~ 
been ·found that sex hormones inriuence the immune re~ponse and antibody . 
production in certain strains of mice ·susceptible to autoimmunity. This inOuencc 
.,.:;.. .... : . . . ' 
of sex hormones has been . related. more to the . absence of testosterone than to the 
' ' ' I I ' 
· · . . · pre~~~ce or est~o-gen (Th~ofilopoulus· and 'Dixon: '1981; Steinberg, Huston, Taurog, 
. _Cowder~ and Rav~~be, 1981; Roubinian, Talal, ~~eenspan, Good~an . ~n~ ·_Siiter '· 
1078). The hi_gher susceptibility· to. autoimmun~ease present· ·in fewtles, as 
compared to males, seems to· ~ir~e· with thes~ findings. · Aging, with its ass.oc.iatcd 
decrement in feedback regulatton of immune responses, may ~y an important 




In conclusion, autoimmune responses alone do not necessarily . lead to 
. t.. 
autoimmune disease. Pathological changes occur .only when a variety or· factors ... 
coin~ide in the same individual. • ~ . ' 
• ' ' ' 'II 1.3.2. Hashimoto's Thvroldltis . 
. ~ ~ . . 
- Hash~moto's,· f)r) chr~n·~~-- lymph~c~ti:~· thyroiditis, is one or the mosi common 
end6crine orgaij-specifjc.~utoim~une disorders (Volpe,.l978; Werner, 1078; Kidd, 
. ·. r ,!,.._ • • . . • .. • • , . ,, 
' 
. ,,,. . .. 
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Okita, Row and .Volpe, 1080; Kahn and Fli~r, 1980; lngbar and Woeber, 1981). 
; . . I . . . . . . ., 
::;·· .. ·~ . .. . fj · .. :- .· ... -O~inica_l~y·~t- mo~t. com.~~~ly. presents ~itrh g~iter . . ~~out :70:% of~ p~tien~s ~arc . . .. . ·: 
:,;". · · . . . .: .. : · eu.thyro1d, -29% hypothyroid ~nd .IP% hyperthyroid ··at the ·tim\ of cb~ucal · ·. /_-~:~ 
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diagnosis. There is 'familial aggregation or cases. ~o. clear association with HLA-A 
or -B l~cus has been d~cribed. However, a signilic.ant association or HLA-DR5 
. . . . ' . ' 
'Nith· goitrous thyroiditis (F'inid~ Sampson, Moens·and Barnard, 1Q81} and HLA-B8 
and. DR3 with atrop}lic t}lyr.oiditis (Moens, Barnard,· Bear and Farid, 1Q7Q) wa.S 
found in ~tudies performed in .Caucasian inhabitants .of Newfoundland. 
~istologi~ally the affected "glands demonstrate the P.resence of small follicles 
depleted of thyroglobulin·. The tbyroid epithelial cells are abnormal in size antl 
shape. Nortna.l tissue IS extensively replaced by inliltrating · lymphocytes and 
fibrous tissue. · 
. - . 
· · Circu]ati.ng antibodies to different components of the thyroid· tissue have been . · 





" :. ~ 
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· round in these cases. Approximately QO% of patients with Hashimoto's ~hyroiditis 
· ~ a~e -po~it~v-~ Cor _an,ti~ihyrogl_~bul~n ant1bodie~ wb~n ~xamin~~ · _.by th~ ta~ ~~~ . . . 
ceil agglutination test (Hall, 1962). .Anti-microsomal . antib6dies have been . 








de~ected by a. :variety .or tests inCluding eorriph~m~nt 'fixation, imniunofiuorescenc~, -
· .. im~un~p~~oxidase and .hemaggtuti-~a;1on. when te~ted by ih~· t~tter ~ethod .. up to 
iJO%, · oC . pati~nts were . round to1 be -~ositi~e for these antib~dies .(Irvine, 
1Q7G).Antibodies · to the· second c6_Uoid antigen (Irvine, 1_975) and t<;> ~uclear 
c_q_mp?nents (Hall, 1Q62) have al~o been described. Positive titers are variable, but 
; . . }. 
· in the adult . ~~pul~tio;D, titers . higher that l:l~O· ~ of 'diagn~fc significance. , 
Antibqdi~s ~ ~hyroid . cell surface a~tigens have ·also b~~tected iri ~~e sera. of . 
. patients with Hashimoto' A· thyroiditis . using immun~e5cent techniques and. 
·human thyroid ~ells in culture (Fatraeus"a.nd ·. Jo~sson,. 1070; Khoury, ~Hammond, 
I . ' . '. . . . . 
·_:,·· · Botta·zzo and ~Doniach, · lOSl). Using . an · assay ~based on the ability of · .. 
}':. :· i~m~~~,lohulins or ce~~ain . ~_a.tlents . to. co;pet~. with ~adio-i<tfi~ated · TSH ·for 
;~,::·., . . .binding io. its rec~ptor 'or to human thyroid plas.ma. membr~nes, it-was. ro~'nd . t)lat' . 
:( up ·.to _·~~~-. of __ p~ti,en~ · wi:tb ~as~~mot~~s . t~yr~iditis . ~a~~ ~tibodies ·_c~pable, of 
-~::· ~ - 1 inhibiti~~H -binding (Endo, Kasagi,· Konis~kobu, .OkunO,. Toked~, Mori · ~ 
!: ' I • , . , ' , " , n , " \• • , , , :. 0 ' 
}·: .. . and T~ri$ilka, · u~78). .These. fmdmgs suggeste~ the possibility that.S9me of the 
'' /. . . ~ . . .:,~ ' ' . . ' . . ' . : . . . ' .· . . . . . : . . . ' ' . . . .. . 
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~:·:~: ·'· .· '. an_tibQdies pr~ent ~D piiientS with Has.himoto's thyrOiditis are directed against . 
;_.,· .. . ·. .... , . · ' · · · · · • . . . I · . ·· . : :1 
~r~--: · · - ~ the. TSH .reeepior." · . ~: · · ·· ·· ._ • · . ·. .. . . . _. , 
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The mecba.ni$ms by which antibodies to . different thyroid cell compone-nts 
deveiop i~ still unk~own. Theories that _suggested tha.t thyroid . antigens normally 
have no access to ·immunocompetent cells have been invalidated ·by the 
. I 
demonst.ration or circulati~- thyroglobulin in the serum of normal subjects. 
Alterations in thyroid compone11ts due to viral. infection have been proposed as 
etiological factors in Hashimoto's thyr~iditis since under ~lectron microscopy 
particles that resemble viruses have b"een obser.~ed (Kahn and Dale, }g73). On 
th_e other hand, certain disorders known to be c·a.used by infective organisms, like 
subacute ihyroiditis, do not predispose to autoimmune thyroJditis. However, the 
additional participation of certain types of viruses 'in a p~edisposed host cannot be 
excluded as. behig · resp~nsa.ble~ for ~~anges leadi~g to chronic .lymphocyt~c 
thyroiditis. 
Cell-mediated immunity ha.S . a.lso been implicated in. the pathogenesis of 
. . 
._ Hashimoto's· thyroiditis. Enhanced mitogenic respo~ses of circulating lymphocyies 
. .. . . .. ; . . . : ·. . . 
to thyroid antigens and/or thyroglobulin have been observed (Ehrenfield; Kleiri' 
.... ... 
a?tl Benezr!J., 1971) as we.ll as .i~crease~ ~umbers of circulating. lyrnphocyt_es-
( capable of· binding thyroglobulin and thyroid microsomes (AJlison, 1976). The 
total number of T and B cells in the peripheral blood of these patients wa.s not 
found to be different from i10rmar6y some authors (Kid{{, et al. 1Q80), while 
others found a qecr.eased number ofT-cells (Fournier, Chen, ~ger a11d Charriere, 
1983). Dir~c~ ~y'totoxic effects of_ T-cells hav:e also been experimen'tally observed 
(Calder, Me Leman ·and Irvine, 1Q73). T-cells of patients with Hashimok>~s 
thyroiditis have been found capable of producing· migration inhibition factor 
• (~) in the pre~ence of crude and d~terg~nt solubili_zed thyroid an~igens (0~ 
Kidd, Row and Volpe, 1980), suggesting antigen specific T-cell sensitization in 
·~ :. . .. 
~utoimmune thyroid ~iseas' --.. 
. _., 4 " . 
~- ~\ . ·~· . ~ .E~idence for the inv~lvement of ·both ·cell-mediated a.nd humoral immunity in 
- . .. . . . .. . . ' . 
~he .aestruction of the thyroid gland in chronic lymp~ocytic thyroiditis _ha:s been 
: P..r~ented. An antibody.-dep(md~nt-.cell ~ediated ·cytotoxicity·: may , bowever, 
• I . 
· . .:··.: 
. ·. 
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prove to be the most important mechan~rn fpr tissue injury in this autoimmune 
thyroid disordd( (Des$lUnt and Weme~u~ 1QS2). In this system killer cells, l>eari~g · 
... 
the Fe re~eptor, ~ill bi_nd .the F-e portion of the iQ1mun_oglobuli~ l?lolecule for~ng 
part. of an· antigen-antibody complex local!zed on the surrace of thyroid cells ' and 
. . 
wiJI pro_mote ~he lysis of the latter. 
Since demonstrable abnormalities in b.oth cell-media~ed and humoral immunity 
... 
are -observed in Ha.s'bimoto'_s thyroiditis and· because humoral immunity is highly' 
dependent oil T-cell function, possible. alterations in inununo-regulatory T-:cell 
subsets in . these patients were fuvestigat.ed. Sever~J,l aut~ors found mitpg~n-
. . ( 
trigger_ed_ suppressor :T·cell. function to. b·e· n:ormal i~ ~t~en~ w·it.h Ha5himo~o's . 
thyro,iditis {Ao.ki, Pi~nama!leni and De Grootl~ l~e:}h and Kruger, 1Q7Q; .Me 
L·a~hlan, ·Wee, 'Me Gregor, Rees Smit~ ·and Hall, '~gs_q). On the contta~y, when. 
-siudying 'antigen-specific .T·ceU . function inhibition· ·or mi.gratio"ir ~ T-cell~ . in 
·res~ons~ to ~rude thyroid antigens. wils d~scribed. (Okita, Row: and Vol~e, IQSl) 
- • , ·' . _..!, 
Determinations or T-cell numb.ers in Hashimoto's thyroiditis have also yield~d . 
~ conflicting results. Wh~n detected by subset-sp-ecific monoclonal antibodies, . a 
0 • 
decreased . ratio. of cir~ulating suppressor to ·helper T-cells "'as found by ,me 
authors (Thielemans, Vanbaelst, De Waele; Jonckbeer and Van Camp, 1981; 
Sridama, Pacin~ ~nd De Groo~, 1982). but not by othe~ .(Jan,sson, Totterm~n, 
Sallstrom and Dahlb.erg, IQ82). T·cells bearing lg receptore,were enumera.teCI and 
found norptal in· autoimmune thyroiditis. (Canonica1 Bagnasco; Maretta;·· Cocco~ 
Fer~ini . and. Giordano·, lQSl):· AS observed, the results reported in .the lit~rature 
regarding T-cell . fu~ction ~!!~· n~mb~r are_ quite confl~ting. Definitiv~ answers to 
. . . . . . . 
" . 
. ; · 
', • 
. i 
.. • . · .. ·. 
.... 
.· 
·,· ' ' ·: 
... 
(~. . these questions require further investjga.tion. ~/'· ', ' . .• . . . . . . . . . . ; . ~. h·. 
L-; · Severatother vari_a~ts,- of thyroidit_U! d~·erve ment~on. _ Pri~ry hy~otpyroi_~is~ •· . .. ;· 
!'! ··· .·.. associated with an -atrophic thyroid .is the most comin9n .. ·Despite the absence of ·1 
~~::::. · ;, ' I go_iter? • - ~~~ _hist~l?_gic~l and ': imm~~ol~gi~~~' char~ct~ris~jc~ : ~re• .~ery s~~~~r to• J' <. ) 
~;(: .: :. . . Hashimoto's ttiyroiditis. The fibrous yariant of Hashimoi<?'• Jhyroiilitis' can l?niY · ·. :. · . 
~':-.. :. ', .. . -be .. dfrrerenti~te_d : from th~·. lymphocytic _:variant th~ough biopsy·· a.'nd~ -bec!i-ilse . it is . .·. . . . ·:· : .. : 
.,. ' • . . 9 ... • 
~~~~_:: ~ :~ .· . 
tj . ','f.:':~. 
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more .frequent in the older· ~ge group: Transient postpartum hypothyroidism .; :;:: 
,. 
• • a. ' I) 
occurs three· to five mQnths postpartum in women who bad previously noted ' to 
. . . 
have a 'goiter. This syndrome ·often follows' ,a tr~nsient hypertliyroid phase-related 
• ~ 1t ~ 
,. ~the release of stored thyrogiobulin. The reasons for the trans~ent nature ·or this 
disorder and the temporal relationsh~p to pregnancy are still intriguing questions . 
1.3.3. Graves' Disease 
- ·, . 
Graves' disease (Werner, 1Q78b. Kidd, et al. IQ80; Kahn and Flier, IQSO; lnghnr 
and Woeber, 'lgsi; F~rid, "tQ81; Strako~K, We~zel, no~ and V~tp·e, 1QS2; Far~d, 
Bri~nes.Urbina .and Bear 1Q83) is an autoimmune, multisyst~mic disorder wieh ·~a 
prevalence of. appr~xima."teiy I% of th~ ·general p~~ulation:: It h~~ ~bree ·mai~ 
~· . . .' . . .. 
comp~nent~ · hyp~rtbyroidism, .~n~ilttative opht~alm.opathy and infiltrAti~e 
de~mopathy. Thes~ "com'pmients -~a~ ... co~xist ~r may· app~ar individually. 
\< 
'Che hyperthyroidism of Gr~es' disease is ass~ciate~ w\th diffuse enlargement of 
the t'hyroid gland. ··The cl!nica~. ~y.mpt9m~ ·_and signs in~~~de heat intoler~nce, .. 
. increased nervousness,. weight loss despite' incr~~ed fo~d intake, polyuria, 
polydy~sia, i~creased he~rt "ra,.te .and brisk teflexes. ·T_h~se symp-toms are thought 
to be directiy dependent on increased levels· of th~ thyro~d l,lotrp_ones, thyroxine 
t ' • . 
· and tri:.lod9tbyro'nine. It has also been auggested that so:we :Of t~ese sy_!Ilptoms 
. may be· ·due to the amplification ·of -ti~su. · .r~sponseS" ~~- ~he actions of · 
·. .. . . 
catecholamines but rio dire~t proof is readily available :(Landsberg, 1Q77; 
M~l~nd~r, Wes_tire~, Eric~oil ~nd Su~dler, lg77). T~e .major ·manifestations of 
· Gr·aves' ,ophthalmopathy are proptosis, ·periorbital -~dema and chemosis. 
- ·~' Opthalmopatl:ty can ·.occ·u~ wi'th or_'. wit~out-· .hyperthyroi~ism. The d~rmopathy, 
·\ ~ ~ith pretil~tal · my~edema · occurs. fn 3·· to. 5% ol patients ~ith Graves' 'disease. 
• < 
. "' .. ' . 
Alll}ost· all t~ese patients have· cqnco!Jlitant optlialniopathf . . 
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; · • . . A farnily history of Graves' disease is fairly ~o.hm~n .·among . these patients. ' .. 
!; .. • Despite· this f~milial association and stu~i~ tha~ have included 'large numbers of- :: 
~<· ·. . ,. ,•( 
h>: . . . patients, .no ~lear inherit,an~e patterns for ~he -dis~~e have been f~und. The risk of · .. i" 
.-- • 6 t •'' 
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26 
the siblings and parents of propositus patients for developing Graves' .disease has 
. . . 
been repott~d to be of. about 2-8 % (Friedm!ln and ·Fialkow, ·tg78). However, 
studi~ carried out at The Memorial University or Newfoundland have analyzed 
the incidence Q( the diSease among first-degree relatives of 624 patients with 
Graves' dise~e an4 bt\re foun,d that the occurence ot this disor~er is not · higher 
than 3% (Farid, N.R ... , personal communication). Twin studies have demonstrated 
that about .50%_ or monozygotic. pairs are <!oncordant for byperthyroidis_m, as 
comp~red to le5s than 5% or · dizygotic pairs. Thes~ results demonstrate the 
• I 
importance or the genetic invoJvement but. also imply the participation of non-
• • . • • & I 
genetic elements in the development of the dise~~rid, 1081). 
. . . }. 
The ·association or Graves' dise!se with . liLA antigens has been extensively 
/
._studied (Fari~, )gS1~-Fa~id and B~ar, ~Q81). Several groups ·of investigators h,a-ve 
round in~reased frequency or .HLA-B8 in caucasian individuals ~ith Grayes' 
. . ~ . 
di~ease. An eve~ closer . te.lationship bas bee~ found between· this dis~ase and the 
·. presence or HLA-DR3 (Farid, Sto~e, Joh.nson,i }g8o; F~rid,· 1981). In' ~tber. etb~ic·· 
. . . . . 
groups, however~ Graves' ·dise&Se has b~ei!jojind .to be associated with other .HLA 
• I ' , t ' 
an.tig.ens (Farid ·and B~ar, 1~81; Stenszky, Ba.lasz, Kozma, Leovey and Farid, 
.·. 1~11-
' ...... l 
-The hypertbyr?idism,of Graves' disease-is caused· b-y . the overstimulation of the 
t~yroid. gland. by. a ci~ulating. i~muno_g~~bulin-"direc~ed- against the TSH rec_eptor 
· _ (TS Ab) (McKenzi~ ~nd. Za.karija, 1Q78. Kid~, et &:1., 1980). The first evidence of a. 
• • • • • <> • ... 
--....:...:._circulating thyroid stimulator was established by ·Ad$ms and -Purv·es ·in . IQ56 • 
·(Ad-a;nsai1d. P~rves~ ·tgsa).' ~ The assay dep~nds Oil the ability of patient's ·sera. to . 
. .... .. ' . . . . . . ..... .. . 
'cause. release of radioa~tive iodine ·rrom _13~1 prelabeled gUinea pig tby~oid-glands 
.fl . ~ ~ivo:_ ~-simiJar ·. ~ay. ~~ l~ter deve~~p~d . ~sing ~c~. (McK\n.~ie,. -~_9?8) .. · Sin~~. 
. ,_ ·.TSH caused a peak re!ponse at 2 hours and Graves' disease seruni at 9-12 hour~ · ,· 
in-: the .mouse the acti~ity . w~ . ,called .long;.aeting thyroid sthnulato~ . (LATS). 
• . • •• - • • • : - " \. . J • • . 
LAT~ Was : )a~er. ~har~cterized -89 'an . ·immuno~lobulin or the G ~~~ (Kriss, __ 
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up to Sj)% of patients with active Graves' disease-had a negative response in the 
Mc'K.cnzJe assay, the importance of this immunoglobulin .as the etiological age~t of 
the disease was in doubt for some time. -The immune basis or the disease was 
. I ' . ~ 
again favored when IgG from up to 9_0% of .. patients with Graves' disease · was 
found t.q •protect• a _LAT8-positive serum from. being absorbed ~y human thyroid 
extrads. It was conCluded that these sera contained imrriunoglobuiins which, even 
tho~_gh unable to bind or stimulate mo~se thyroid, could bind t~ human thyroid 
and competitively~ inhibit the binding of other thyroid . stimuUlting 
immunoglobulins (Adams and Kennedy, 1971). 
An assay based on the ability of serum or immunoglobulins of patients with 
Graves'disease to compete with 1251-bTSH for binding sites on the receptor of 
-
human thyroid ~embranes was developed. Sixty to !}De '• hundr~d percent or· 
Graves'· diseas~ ·patie~~s sera 'showed evidence or ·anti-TSH receptor ·antibodies as 
_ ma_n~fested by 'inhil;>itio~ of TSH binding-_(Rees Smith and Hall, IQ74; E~do · et at, 
1978). So~e 'normal sera, ~owever, showed ~major irihibi_~ory effect ·on the·TSH- · -
receptor interacti~n (Sato, Zakarija and McKe~zie, 1Q77). Non~specific binding · 
. . . . 
was suggested, but it is also possible that some normal individuals have low levels 
. . ' . 
. of anti-T~H-recepior antibodies but e~hibit no ·pathology._ Some actions or the l . . .. 
thyroid sti~ula.ting an~i~odies have been measured . in ~iffer..ent systems: _ It w~ 
found that they are capable of stimulating cAMP production (Onaya, Kotani, 
: I • 
Yamada and Ochi, 1Q73), radioactiv·e iodine· uptake (Endo-et .aL, 1978) and colloid -
I . . I 
,odropl~t form~tiop (Onaya et ~1., H}7~},· all known ef,ects or TSH. PersistentlY. 
present TSAb aft~~ treatment has _been said to be ·useful in predicting relapse oC 
the ~ise~e (Zakarija, · McKe~zie_ and Banovac, 1gso; Karlson. an_d.Dahlberg, uisl). 
\ . - ,' 
. . . / 
Despit . tjle :·i_nitial Jin~ings that dem?nstr~ted normal )3!eel~ pro~o-rtions· 'in. 
patients w1 . Gra"es'diseas~ (Mulaish~; Abd~u and Utigfr, 1975; ?alrer, Irvine, 
Davidson ~n . Wu, U)76; Lundell, w_7~~man, Granberg and -Biomgr~n, 1076), 
sever:al _ investigators Ii~ve rec~ntly djcri~ed increased ~~~hers· or . B-cells ·whe~ ·. 
defected by eithe~ EAE-rose!te format,on or _speci~c monoclonal antibodies (Mor~, 
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~ino, Iwata~\ K~butoin~ri, Asari, Motoi, Miyai and Kumab!ra, 1gso; Fourni:er, 
et al., 1983) • 
' ( 
Apart from the hu~oral abnormalities descrilJed above, the involvement or cell-
. .. 
mediated immunity. has also b'een suggested for the hyperthyroidism or Graves' 
disease. T-cell production of lymphokines in response to crude thyroid antigens 
. ,
(La.mki, Row and Volpe, 1g73) and the mitogenic effect of ·thyroid· membrane 
preparations on lymphocytes from patients with Graves' D~ease support this 
belief (Makinen, .Wagar, Apter, von_- Willebrand and Pekonen, lg78). As in 
Hashimoto's thyroiditis, alterations in the b~lan~e be~ween suppressor an.d he~per 
T-lympbocytes has been propose4 as responsible for autoantibody prod~ct1on in 
' ' . ' 
Graves' disease. Again, results have be.en confli~ting. Several reports poi-nt to 
. . .. ~ ' , 
defects in suppressor _T-Jymphocyte function in Grav~' disease. Mit<;~gen-triggered 
' 
· ·suppressor T-cell function was !ou~~:4 to be ~mpaired in these p~ients (Aoki, et al., 
ui79; :aala~~, -~:Leovey and Bordan, 197Q) .. A good correlation bet~een the clini~al 
st~ge of . th~ . disease. a~d th~ degree or T-celi ~y~fun~ti~n was described. 
Furthermore the defects were normalized after . adequate treatment with. ~nti-
. ' ... . . . 
thyroid drugS. _Inhibition of migratton or T-cells from patients with Graves' 
disease in ~esponse to thyroid antigens also suggest antigen-specific defects lD 
sJppressor T-cell function (Okita, et al., 1981). 
Regarding · supp~~ssor T-cell. numbers; some authors have reported a decreased 
' . 
proportion -or cir~lating suppressor T-cells relative to helper T-cell's when tested 
wi_th subset-specific monoClonal anti~o~ies (Thiclinans, et al. 1~81; Srid~ma, e~ 
al.,. 1gs2). Contrary to these findings some authors;ha.ve found suppressor T-cells' 
' 
to be normal ·-both in number . and function (MacLean,-Mill~r, Brown and Reichlin, 
.:•.· .· -~ .' · 1~1 ). -So. far, _·bowever '.most or the evid~nce a.ccum~lat__ed supp~r~s t~e existence· 
;-~- .  · of .sup~~essor ~~~eu~·aysfunction in _Graves' disease. ·This dy,unction. seems ~ be 
· -~ . antigen-specific to the extent that lymphocytes from patients. with autoimmune 










~ .:·  · . , · disoi'd~rs other· than thyroiditis haye ·been able to correct the T-cell defects 
~--· ·-.-. - ('1\.plisS, How,' Strakqsch; L~wis, Row and -Volpe, 1982): Recently,' sub~pulations ' _.· 
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" 
o'flymt>hocytes derived from patients with Graves' disease were enuinera.ted using 
specific mo~oclonal antibodies. The a_utbors found .that a subset· or -~ndu~er T-c~ll$ 
iS diminished in these patients. B~ed on thls, they hypothesized that. the missin~ 
cells niight be part or a s~~population necessary in the activa~io.n or ~~ppressor 
cells (Fournier, et al. 1Q83,.,u~.tber studies wi~l be necessary to confirm or refute 
this hypothesis. Defects in T ... cell function and ratio in Graves' disease appear~ 
( 
be genetically linked, and possibly related to organic and emotional stress 
(Monjan and Collector, 1Q77). 
Ophthalmopathy and dermopathy associated with bypert~r<;>idism appear to be 
• .• (!, ~ 
closely x:.clated but independent immunological disorders. These 2 proble s ba.ve . 
. . 
also been considered to be autoimmune in origin and involvement or bot . cellular 
\ . . 
and humoral immunity bav~ ~een sugge~ted (Jacobson a~d~Gorma.n, }Q84). 
• • It is very importan,t t address the close relation~hips existing ·among diCC~ren.t autoimmune thy oid _dis~rder(ln. all of -~hem~ alterations at 'the level .of 
both humoral and cellular immunity have been demonstrated. However, a · major· 
~ ~ ,1 • • • 
problem that re~a:i~s to be solved ·is th~ origin or ,tb~ antigtmicity or arrect.ed --
tissu_es. New · findinp se m . tf b;ing s'ome light with r~gards to· this ptobleni. 
Rec~ntly, thyroid Collfcula ep.i~helial c~lls from patients with autoimmune thyroid 
disorders were found to . berrtntly express HLA-DR an~ig~ns (Hanafusa; et al., 
1gsa). According to this y'po~besis, increased DR antigen expression in. thyroid' 
• I • 
. I . 
epi~helial cells· will Cacili ate ~be p~esent.ation · or local !utoantigeos_ to · T-cells;_ 
certain T-cell s~bsets pr liferate and' re~laie B-c.ell maturation into _anti.bo~y-
. . 
. . 
producing cells. These fi dings, however, have, not excluded the possibility that 
. . . . - . - . . . 
. 
the induction of "aberrant DR antigen expression is secondary to the appearance or 
. . ' . . . 
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. 1.4. IMMUNE-·REGULATION VIA 
IDIOTYPIC-ANXI,;IDIO'I;YPIC INTERACTIONS 
. " ' Communication among the diCferent components or the immune system is very 
. . . . . ~ 
important for the maintenance of an adequate hilance a~ong immunoregulat9ry· 
pathways. This •cross-talk • is achieved thro.ugb complex interactions that in~olve 
. . . . 
immun~regulat~ry T·cells, their solubl.e mediators,efrector T-cells, B-cells as well ' 
as immunc;>globulin molecules produced by plas[\la cells (terminally differentiated 
' . 
S.c~lls) ·(Row~ey, tgso; Miller and Schwartz, 1Q82). 
; 
• 
T·ccli/B-cell interaction and antigen recognition are dependent on specific cell 
' ~ . 
membr.ane surface .recep~rs.~und ·in these two types of cells. · Both types o~ cel1s 
. . ~ ,, . .. 
recognize .the same antigens, ·however, the antigen domains that are identified· 
' ' 
appe~r · to be different (Cone, 1Q81). . • 
. ' 
• . Most. T -cells simultaneously recogni ... ntigen and a self molecuie coded for by 
genes or the Ma.Jo~ Hi~.tocomp.atibility, ' Com~lex. MH~estricted ~-~eli re,ceptors 
.' . . . ' . ' .. ....... . . . . 
have been recently .identified with th~ help or highly specific anti~odies (Haskins, _ 
. . . ' . . 
Kappler, Marra~k, lgB4i. Samuelson ·a~d S~hwartz, 1Q83; K_aye, :Porcelli, Tite, · 
Jones .and Jane~ay, IQ83)._ Cellular products ,preci~itat.ed by these antibodies were 
·analyzed. Disultid.e .linked . pr'oteins . with molecular. weights between ·80,000 and ; 
. . ·. 
90,000·Da. were identified> and thought to constitute. the re~eptor ~or ·.antigen .on 
WIC.res.tricted ·T-cells. Peptide mapping of these pr~teins h~ shown that this 
receptor consists of both. const~nt and· variable peptide regions (Acuto, Meuer,_ 
Hodgo~, · Sc~lossman an·d Reinbe~z, 1083). · . 
·· } .~he mol;eular geneUcs o·r the T-c:~n·recept<?r Cor antigen .has been appr·oa<:.hed 
by ~slnf · ~ubstr~cii~e . or ~ dirrere~·tial bybri;lizaiion ~e~hniqu~s·. . IIi .U~S4 . two 
. independ'-ant groups ~r in~estig~tbrs publishe·d the · flrs.t. -~~qlt~ d~sc~ibing i-c~li · 
' ' ' o . • I 
. 
' 
' . ' 
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specific. eDNA clones that encode for protelns that have an extensive· sequence .. ~ . . -~ 
' •• • • • • • • • • • • • : •.. - · . • • ' • ' • :"' "' l 
. . homology . with' the light chain of( the immunoglobulin molecule ovet tb'e entire. ·''· 
6'- > • ' . • l~h of, th.~ ~afiable, joJ~iog an~ ..;ns\an t r~gion~ {y anagi, : O.hik,ai, i:eggetl; . , . ~ ::; 
~:~ ' • .... : • .. • •• •• ~ t . .... 
... , • .. • • t . • • ' "; 
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1~-~- ;r~,:: :.i·.~~; • .,:·:.~~ :, ..:.;~b:" ,,.},·" : :::. . .. , : :,; . . i" · , ., "''i .:·, ~. . . .. ;: .: , ~ • · ..···: '· ·. ·. ... ..i .. :.. . , ·.: >,,;A~ ~~~} .. w~~.\'"t\!~flt~~~'-{~\t{' ~~~~-at:.;· "t. ~.t<-· . .-.~~t~ .. \-~~\}:~':1~:~:~: l;J .:1 .• ·.ri·.~· ~~ . ·-~~::~_,:·:ti.t. ·~~ ... ~:1~~a ... ~ •. ~~ ·~ .;~::~~-.~:"t \'f:;-\;.~: ~~1t.l4:t "::~t:·~  . ., ~-~~\f" ·i-('"' Jt~J)' .. ;·~ :-~~·=~~c~~-~;..:~~'1 .-.} ~~ .. , ·: ~·~~ .. : i Jl., 1:-~1!/.!.t4j 
~:"*>"'~ ~;::;;~;:•, .. ~' i ·' ~- ;; '' ~.· .. c : '"' ';''''?'. :''''. "'' .~"':iO~"l",J~{!1~~?~~r~ F'~f >' ':· ··? •r·~•:'"'')"f<'? '':'i'jj?' '!:'' '!}1 t:H~~~'1~:~ 


















·- ~· , 
' . 
, . 
Clark, Aleksander and Mak, 1084; Hedrick, Cohen, Nielse~ ~nd Davis, 108.4). · . 
· · Since. that time a number or research groups have published ~aia concefning· the· ... 
. ' . 
T-cell receptor. Most or these results hafe been re'cently reviewed by Kro~nhorg, . 
Siu, Hood a~d Sh~tri (1Q86j.' In summary, ~he genes ~ncoding ror the a and p 
chains of. the T-cell· r.eceptor and t~e 1 gene have been clone-d, their s~rl!.cturc, 
organization as well as their patterns ~r rearrangement and diversification / a~e 
now understood. Many similarities • have been found between the a and ·fJ. 
' heterodimeric T-cell receptor and the immunoglobulin mol~cule, ho,~ever, marked 
differences regarding the mechanisms of activation and antigen recognition arc 
known to be prese~t (Kronenberg, et al., !Q86)'. The recently acquired know.ledge 
of the structure of the .T-cell ~ecepto.r for antigen has still not pro.vided with the . 
. a~swer. aS to hoW • this reCeP.tO~ re<;c;>gnizes a foreign antigen in · association With 0. 
' ~ .,. . 
MJ:IC antigen. Reseach in this field co~tinues, _for now, this area' remains 
controversial. 
B-cells ·are ~imulated by the helper -Subset· of T.:cells t~!ough the · mediation of 
I . 
4 specific growth !actors ·to. djf!erentiate into plasma cells 9r antibody producing 
;ellS. Th·e ~~is for antibody . ~ive~sity, which involves three clusters_ of ~enes4>nc 
heavy chain and two light chain clusters) derive~. from the "re-arrangement . or 
' . . s~lect~ble s~matic eleme.nts into functional immunoglobulin. ·molecules of \a g!ven 
. specificity (Leder, 1Q82). 
Immunogl~bulins (lgs) are Y shaped mo~ecules formed by two . i~entical light 
.chains and two identical heavy chains, held together by disutride bridges. All 
' . . 
" 
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·' 
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• variable domains or the heavy clla~n are created by .the co~bin~tion of thre~ types·· 
or germJine . genes, the V, D · and·· J genes. . T¥se genes undergo multiple · fe- · 
. . 
arrangements .resulting in the expr~siOD O( the 1lDtibodydiversity required · (c:Jr 
highly sp~ciric _a~tigen 'l'eco~iti_on (Binz, W.igzell a.nd Bazi.n, 1976; Kraig, 
Konenberg, Kapp,· Pierc'e, Abruzzini, Sorensen, Samelson, Schwartz and Hood, 
• ~ • It' ~ . • • 
108~3; Kr~mmer and ~ichmann, 1Q7?')· V H and V L chains form the antigen· 
binding portion of the im~unoglobulin molecules; as well as the recepto~s for 
. . . 
antigen on t~e surface of B lyn1phocytes. 
To explain the mechanisms through which the different groups ~f immu~o- · 
- competent ~ells and their products _ interact, J_!!rne :proposed the •Netwo~~/ ­
Theory~(jern~, . 1974). He·~ugg~sted fhat specific immunoregulation is cqritrOlled ·" 
' . .. .. . ·. .. . . . . - . . . ' --
by a network or idiotypes and-anti-idiotypes 'tha_t·exhibit complement3,ry V~region · 
str1,1ctures. ·.Prior ·tO explainin-g this theory; it is important to: ti~fin~ certain terms .·· . 
• ' t ' • '"'• ' ~ • • ~ • / , •• ' ' ' I 
which were introduced . bt J erne. . Epitope was ··'ifescrib!!d as the anligenic . 
. . ... - . ,. - ' 
· deterni'iriaot or. haptenic site. on an a~iigen· m~lecule. -Paratope is. the ~c~ntact~ · 
area or'. the antig~n-oinding site .or ' ui;· antihody 'molecule. ldiotope (idiotypic 
• I ' . ' ' ~ . : ·· ·~ ... -· . • . • • 
determinant) is the .epitope· or an antibody molecule .. ldiotypes are coll)plexes of . 
. idiot~pes. Most idiotypes re~uire a ·c~~rect combioati.on of heavy and ligh~ ~h~fns 
. ro~ their expressi~n. Ariti~ldi~ty~es are antitodies r~ised against the (diotop.e of an 
immunoglobulin· molecu]e and they can ·be monoclonal or .p~lycl(mal in origin. 
' ' . . . .. .. 
· (Green, 'rlood a~d Gershon, 19_~; 'Raj~~sky a~d T~kemori, 19~). 
' ' 
' • ' • • IIi Vi _ . . · •• • ' According Jo J~rne's~. theory, when a foreign antigen enters th_e organiim it is , 
.. . . . . .. . . . . . . : - . ' . . ' . . . 
~-- _ recc:>gnized by _antib.ody ~olec~les (Abl) and· the· clones;- _or .B-cells .carrying the .· 
:~_ · ·.. rec'ept~r. (or t~is antibody ·~re .expan_ded. 'T~e .variable regiori-·or Abl presents ·.· 
:; ~· . · · ·certain idiotypes that ~re . also rec~gnized 8.s ·.antigenic--and $re .capable · ·of . 
;;> \. triggering .: the prod~cti~n ·or' anti-:idiotyp~s (Ab2). T.~is reaCtion does not 
~ .. ~ '"', ~· . . . . 
',. ·. - .·neccessarily stop'. 'there, . i~iotopes of Ab2:. trigger . the production· of anti-anti-
;·,;: · ' -. . . . . . . . ' < ·. . . . . ' 
: :·~. : .. ·. l . · ldiotopes (~b3). ~ome. A:b3 mo~ecul~ . a~e .capable ~f· interact~ng·_'wi~h the _e,pitope 
r::~: · . t~~t. orig,ina~ed the firsi . ~espori.se· (Figure 1.2). The -ulti~ate rple ~r ~uch .idiotypic .. . 
~ 't . ' - ' . ' ~ ' ' .. 
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. !...__ idiotope ( Ab-1) 
Figure 1_:2: · Sche~~ rep~esentation of the interaction of the 
Antigen/Jdiotypic/ An~i-idiotypic Networks. 
(Jeme, 1974) 
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modulation is to •dowil·re~~~· · ~he ~niti~l antibody, re5ponse and_ e5tablish a 
new •steady state•. In this i;ay ·an~ibo.dies and B-cells on whose surface tb'ese 
antibodies are expressed are subject to continual suppr~ssive e£Cects by 
complementary antibodies . 
. · Antigen/idiotype an it idiotype/anti-idiotrp~ interactions~re dependent on the . 
. tridimensional structures or their combining' sites. If the tridimensional structure 
. - . ' 
of tb~ coinbining site or the id.iotype •fits• the epitope as well as the anti-idiotyJ>~ 
(Ab2), t~e anti-:idiotype should in~ibit the binding or the antigenic epitope to the 
. .. ' jd{otyp~. Such· I anti-idiotypes •. carry, an internal image of· the 'antigen:, They are 
..~~!-erore called ··internal iQ1ag~•· ~nti-idiotypes. · . · · 
. ':;,a-~~1·:.,: .~ - -. ' . . . ... • ' • • 
-. 
' T-c~ll .me~brane surface r,ecepto~s allow'.these cellk to· recognize .and respo~d to 
: .. • ' .· - : .. ........ . . . . . ·... . . . . . . 
· antigen· stimulation. S~veral reports have shown -that many . of .the known· 
\r~nctiO~SI : types or T-Cel~ · have idiotypo-lih stiuctU~es on t~eir ~~cept~rs, a~td 
_ ·th·at· · th~se can trigger· anti-idiotypic · antibody responses (Janeway, Sak~to and 
Ei~·~n, ·t·lg75; Binz ·and WigzeU, 1g77; .·£jewsky .and Ei.chman, H)77). ~Thes~ 
rlndings . incorp~~~te the ~hole ·. T~cell syste~ into the· network regulati~~ concept. 
. . . . . ' -t• t~iotypic determinants ·have -been .identified in both helper and . certain classes oi 
' ' . ' . . ' . . . . 
suppressor T·cells. Suppressor T-cells with anti•ldiotypic determinan~s have now 
also been described . 
\.~ 
S..cells se.em t<:> ·respond to antigen with two clusters of receptors, one that 
·recogil~zes epitqpes .. and. tJ.te second -active in mitogen recoiuition a.nd ~ T-cell 
. . ' . .. 
comm~njcati9n. ·These receptors .'carry ididtypic d~terminants and have also. been. 
~dentified · aS .c~pable- of triggering ap~i-idiotyp~~- · reaction~ (~na, ,Pernis, '1984). 
; . ~ . ' 
' .. .,. . . . . . 
Many studies ·.have cle~rly _. demonstrated · .. the · operation .of: :_immunqlogic!ll 
. . .. ·\ ~ ·; . :--'\ . . 
.. 
,----,.- .' -· . . · . 
"'. , . 
. . . 
. . . 
. · .. 
.,;.. ~~ . . . . -. . . . . :. . . . 
{,\: · . . : : networks· ·under · experimental · · .. conditions. Fewer · ·studies, however, . have · .. 
_;:.: : :. ·.. doc~~ent~d ihelr imp~rtanc~ ·in ' the nor~ai regulation. of the. hnmu~e· ~e8ponse. ·:·; - ---.: . ·. '.~ 
!':~ . : • • ,. ,' . . , ·, .. . ' ~ . r' ' , • \ I • . ::. 
~f.:·~ ·,. ,. ·.< .'.;:. ·.· . . : . , I , . • , , · . . ·; . ~ ~ .• -:··· .. · ~= " ·tn th'e ·tast ·few years, evidence supporting : regulati~n· based ·on struc~ural ~.tJ:~,' ·. . . . . .. . , • ·. -. I . . , ', .· . . . . :....: ; • . . •, . . :,:_i} 
~-; -.,· .. . ·. ·. . •, . . ,., 
~;~(?~~Z<r,:)r,.!;i ,,):,~ · o<.• -~:\ ·1~'-~' :J:s;>.•.•••: . • ' '·• :,.· .·, .-.•• ; ·.::: .•. .. · >:-:': i ;, .• :: ~ 1; •.; • ·• : ..• •• :.·;, ,. , ~ ;; .~ '• .. ... · • .•:., · .•.• ·•• ....•• , • ·•' ;·::, ' { ~:: ;l~ ~· 1\ij..~~~~~?:~l~-\~~~~~1~~~~:~~~~t~ht\~~ .1!~t)~~f~j~~;ij ;'·n:~! .~;·~~·~;~ 'f'·-\;;~~~}.~·~~-~S;".(>.fo~/~~ r.:~.)~';r,.~;!f•·',\' ·\·~i~,f,.{:~--~:;_ :--:..-,~~··~:.\ .· .~~'\ £.~~ <~d~~! ~~~~~~~--~t:~~·.J!~~~.f;i~-:.·:.'.:~~~~1}!;;;{J't;~ 
rr:: '~7' ~' ,,:·: •o;;• i',:;::z·;~:-,:::7::~''?'"~'~! ·:1 .. ,, "'t r~ ":'::~P:~~:-:· 'f,~ "~(0:"'{?':~"':''~':/t~ ~·"~';"'.':(\ ~~~:;:: rff::·: ;\:)r'ry.~\1 
·: . · · · as·. · ~~ · .. .... 
• ~ f' ' ' ~: • \ \ ' ~·- • I <~ 
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characteristics within the immune system has h~e me overwhelming (Rodkey, ::~; 
1980). The ·expeti~ental basis for .the idiotypic n twork is well ~tablisbed. -:~; 
. ·- . 
~up port has further increased -with .the identificati n or ' nat~rally o.ecurring 
net~ork m.ediated regulation jn several · systems. It w first demonstrated that· 
no~mal outbred animals have both th~genetic and the l?iosyntheti~ capacity to 
mount auto-anti;;.idiQtypic antib~dy r~sponses .specific .for tlie in.4*iduals own 
previously synthesized antibody products (Rodkeyl 1976). To avoi~ changes in " 
antigenicity due to manipulation,' a different approach was tested. This tii'M the 
carbohydrate antig~ns of Micrococcus lyso~~ikticus were injected into ~abbits. In 
a ~irst rotm~.) ant~.- M.lyso<feikti~u~ . antibodies (idiotypes) ~ere detec~ed~ Seve~al 
weeks later a second type of antibodies .were detected, thi~ ~ime they ·were specific 
~uto' anti~idiotypic antibodies as determined by affinity ~hromatograpby (Brown . 
. . . . . \ . ' ". . . . ., . . ' . . . 
and Rodkey; 1g7Q). Other authots immunized rabbits with h.uman serum albumin 
.. . . . . 
and .huma:~ lact_oferri~.· Auto anti:-ldiotypic antibody producing celb were detected ·. 
. with b~th monovaleht ~nd bi~alent specificall~ p~rified ·and fiucir~cbrome l~bel:ed 
"' idiotypes. The· number-of anti-idiotypic positive· cells ranged from 0.7-44% in 
. ' 
different animals (Jackson an~ Mestecky, 1979). Furthermore, after immunization 
with !tetanus toxofd antigens, anti-idiotypic' anti~o<!ies were detected in ~umaos 
(0eh~1 1982). It has also been shown · that auto-~nti .. idiotypic antibodies .and idi~type specific supp~eSS<?f T ce~ls can e~res~'. either idioty~e­
synthesis by_ B-cells.or even. effector ~cell Junctions (Rodkey1 )980). 
• .i . 
A. ne'Y and potentially usef~l experimental applic~tion for tbe · principl~ of the 
. . •netw,ork theory• w~ developed by Sege and Peterson (lg78). Antibodies raised 
. • 
in rats against insuli~ \Vere aCfinity purified ind lriJecfed into ·rabbits io raise ~nti· 
i11sulin anti-idiotypic . antibodie~.' · J'he exp~ctations 'that the;~ .anti-id~otyplc. 
' . 
antibodies ·~ould be c_apabie ~( r~c6gnizi~g ~t~e hormone receptOr with ·a." certa~n ' 
degree . ~r spe~ificity were tested. The a~ti-idiotypes. were found to lnh'ibit the __ 
' ' I • ' ', ' • •- II! ' ' • • ' ' ' 
-birfdiiigt!Of -1261-insulin -.to-its . re~eptor,· · and to mi~ insulin actions in· me.diating 
. ' ' . . , , . ' 
. ' . . . . . 
... _ ..;: 
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1 e .:. ~a~lno~~ut;r!.c aci~. upt~~.~ b~ t~ytnocy~es. ~his w~ ~be first stud~ prop~e ·. F ·;.· ., that ~tl-ldlotyplc ":'\dx>dles ~t~ ,r.eeogn~ze a hor~~ne receptor. ~'lu•l•oneer~dJ ·. : ,: ; . ' • [ 
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... ork odemonstrated t~e 'potential use of antihormone anti-idiotypie antibodies as 
. ' . . . . 
anti-receptor sp~cific antibodies. Thi,s' initial lead,· however, was not immediately 
followed because of ·th~ low bioactivity of the anti-idiotypes raised, and als~ 
·because i~ was observed that ~ormal' immunoglobulin type G (lgG) was able to 
produce some or the in~ulin erre~ts exan'tined.-
. Further studies on ~ther systems, ,8-adrenergic receptors (Sc~reiber~ Couraud, 
. ' . . 
Andre, Vray and St~osberg, 1080; Homey, Rockson and Haber, lg82) a,nd 
··acetylcholine recepto~s (Wa8ser_m-ann, P:enn, Freimuth, Treptow, Wentzel, 
.. • • ' 0 
Cl~vela.iid ·and ErJa~ger, 1082; Dwyer; Bradley, Kendrick Ur.quhart and Kea.rney, 
• • I : • • '. • • • I . . - . . ~ • ' t . • •• 
· 1g~) \have conlirme~ this or,Jginal · co~cept .. Applyh,1g the ·~network theory's! . 
. principles, ·a new·'- ~xperimentai · . approach to ' the' study . or ligand-recept~r 
intera~tions ._h&S .. bee~. ac.hie~ed. . . .. 
. .. 
~· . ' 
1.5. OBJECTIVES · .. 
The principles .i~troduced by the •network theory~ ·or the. immune system 
. . - . . ' 
. (Jerne,_l!)74)_.aQ.d t~e dat.a accumui~ted demonstrating the pot~ntial use or. anti-
idiotypic ·antibodies as ·probes to study. hormone-recepto~ interaction (Sege and 
' " I • • 
Peterson, IQ78; Schreiber, et al., ·igs(); Homey; et. a1.1 1082; Wasserman, et al., . 
. .. 
1 OS2; Dwyer, et al., 1083); ·opened new· ·and · interesting per~pectives for a better 
unders~a.nding or some anti-rec~ptor antibody media.wd disea.s.es. 
- .-- -
.. . I. . . \ . 
· Graves' d~~~.e r~presents ·a · un.ique system, m'ainly' because its e~iolo~cal agent, 
. ·i.he·. thyroid .. st.i~ulating antibody (TSAb) is thought to· be an ~nti~TSH r~ceptO.r 
.antihodi (Mc.Ke~zi~ ~~d Zakarija; ·1Q7~~· Kldd, et · ~l., u)so) Despite th~ fact~tliat 
• • ' • • .. • ' . ' • • • j • • • .. • ' ~ • • • • • 
TSAb bas been found ·to produce biological responses similar· to those ·or-TSH., at .· 
the time' 'that .'th~· studyw~ initiated: there was:still .. no 'agreem~nt .as .to ~h~th~t ~ 
• ' 1 • I ' 
:> .. : qrav~' · diseaSe . ~n~ibody · is'· a . true an~~-r~cepu;r.,. ~ntibody . or ' is relat~~· to 
,: ·: . · . ine.~br~ne .. · e.onipone~ts .. elose· to it. ·. · . · . · ·· · · '' 
. . ·; l'. . ·' '. . . . ~· ~ .· .. 
';~ • • ' ' ,1" , ~ • , ! . r , 
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;\··:'/ .. _ ·: · ·. ·. · .. .. ·.· . Itl ·wa5 ·c~aJie~gillg to apply the b~ic concepts o~ the network theory a~d-
;:(.: : : •. ' I ; , ' ' : ' • • ; . , • , ' ~ ' ' ,' ·.. ' ' , . , ' i ' • ; <:P,; 
}~~:;: ... : ·.· _: .. . :. . . . ·.. . . ' . .~ . . .. :··· ... . ' ~ ~ 
16'" f • • • · - • • ' • ' • • • ' • • • '{: ~¢~,{.f.:;; ;, ··-:i>'· .. ;D:;;,;,:,).:_:. : .>:.' :-.~.:: ... ·.·,,.:'<.: ; •::; .. · · . ·:. ·; .. ··.··· ·····.•; , ••• .: : ·,. : ·: .. · ·.:: : .. :.: .: .:.,;·~ ~~,:~~;;:·~-~~,. ··::~\ :;~&ti4\~~*P~t~\!i~~~~~;1~~:t;;i~:,: '\~&~:~i~fJ::,~:.;!·~;d\~~4td{~ ,S';~~~·~·,{.;'t, ~· ~· .-i):.:;;;.~i;- :: :~ .. ~~.·~.~~ ~~~:~f~.(.~~J~-~~:i:<~;1J~~ 
· .il-l~ t'r, t'4l'"'"~~.tf.JG. ~~0~\tJ~.t-a ~S''i\o-i."!.l'-1i.~Ykf\ .t~~~.~~"":ffl.t:!u·~ :M. . ~ ,1_b_..;--,r. :-w .J,:&> ~:s.fh .•• _:::t;~,. \:!1 ... It ! \r 
.r~7~t~~~r{';-r:[~;"";k. -::.-.. :,:; -.~:;•',:-;.;,.~:;::~;:;,,~.-:,··:,:~·~:··.;~~:t~;'\'.') :·-~·-; ::-~;r; ·~/'<.:.~·:·~L;!l':· !,':';'F'··· .. ;;:.:•;·:: ·""."t; ("'~~-· .~ :..:~ ,· ::Fl' ();'j,i- •:~'1:,:,~·!\'k"·.:l:., -- ·~- I ~HI\.1-'!"·~...-.:-.~·;\<;'.,;~;;~,:..-, · ~,. ~ i' ·r··~"" r~ f; ·.:.·,>I , . "· .: ;• .' ,. '. ~ · ::• • c.: ~ '. ·•· ~ ' ·. ·:· • ; '<.'•' >~; • ·:, .. ' .:· : ' ; •·~· ' ', . ' 0 ? ;• ; '>! . ··, :;::; :•: "·<\;"'~::•'~". ·~: 
r:·. . . . ; 
.:·~:. attempt .to raise an'ti-TSH anti·idiotypic antibodies, one t~ of which. might be .··:? 
. ;1-~·· *·. 
... , ~ . 
,.•: •I 
.· . 
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•internal image• anti-idiotypic antibodies, represe.nting •artifically raised• anti-;. 
. - . .. 
.· TSH receptor antibodies. These a~tibodies could then, have the same properties 
as the naturally occuring antibodies found in ·Graves' disease. 
. . 
This challenge was taken up by members of the Thyroid Research Laboratory at 
M.emorial U~iversity of Newroundland who· began this study by raising 'suitable 
. • n 
antibodies around De·c·ember of 1Q7Q (Islam, Pepper, ~ri~nes-Urbina; and ·Farid, 
1Q83). I became pattrcularly ipterested in this field of researc~ and started. testing' 
the bioactivity of the available anti-TSH ·anti-idiotypic ··antibodi~s . . ln starting-this 
' . . . 
work it was dirticult to .foresee if such antibodies would recognize . the TSH· 
' . 
receptor and, if they di~ so, to predict what type of errect would thef have at this 
' . • • • -;;.;! • (' • • 
level,- stimulatory or inhibitory. ·The first objective- of this. stuoy, then, was to 
: I • • • I • ' 
' 
·investigat~ if these antibodies could recognize-the TSH rec~r. I( ~this testing · (.. ~ . 
. ~.. '· .. 
. ; . 
..... . 
~ .. . 
I •' 
. 
. . , 
•": .. . . 
I ' ' 
was successful the next objective· was to charactEjfiz~ the type of interaction that 
occurred and its con~equences. . 
. - ~ 
If, after careful study, it was concluded that anti-TSH anti-idiotypic antibodies 
were indeed ~ap~~le o~e~~gnizing the receptor and also or activating _receptor 
mediated biological responses, it would be_ considered appropriate to use' this 
/ . . . 
approach m mvest1gatmg ditrerent characteristics of the hormone-r_eceptor• 
interaotion: 
~ 
TSH subunits are biologically inac'tive when dissociated (Pierce and Parsons, 
1981 ). 1hu~as been difflcult to study their role in receptor rec~gnition and 
cell activation. 'A novel experime~tal. approach was considered ,theoretically 
. -
possible .~o circumven·t this problem. Internal image anti-idiotypic antibodies 
raised against ~ntibodies specific Cor · the 'a and p ' stib~mits of TSH should be 
0·: '. · · capable of re-cognizing the TSH receptor either alone or in- combination. The 
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7-~ ~ ·. objective or tbis set of 'e~periments .~as to obtain. new inr~rmation as to the rote or ' . : .. 
.... ·. ' •.. . "> 
•:,:.:. each of tlie ~ndividual TSH subunits in interaction with their -receptor. . :·, f~---~ . -~ 
~~t~:··~·· .. ~ . . ::\: 
(1·~ · . · r , ... , t::.~ ~8: :.\:· ) · .. ' .. . . •' .. . . . . . ' ' : . :._;j 
~~;i~:·l-,~:·f~,:;.,.,,,;.,:.;;;~i~: ,: ;• ~: '''· ; ,: ; '. . • ; ; ,; \ ~ : · .. : . : ~ .  :. .· ; :. ' ; '~ ' .. · .··•  .· ....  ··. . . . . . . ;; '' . . ' : .· ' J:,.:. :!~ ~· ;,.Jjl~\!!Jt~b~;,..:,...,(..~~~ jj,~~l·~-,.·~·e;q;}:~\( .. '?r(,..;_",, /.i·...,t = t;~ .• / -.,, , .. i ~~~·,\;.:~! ; · 1.: Y .. ,,. ,• '"' •\ f.~ \. i•f. ~: . .:• ·:-.' .;\ .: J· ~· -\·."l ' J • • • •• : ......._ ~ :~ . l_,·~· ' · ; l •,•• . . . .... · .. ~··· -, , ,,-,t.~ .. ,._, ., ..:.:.-.... u.l!J~ 
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Knowledge~ about the receptor structure and involved in the 
regulation of its biosynthesis would allow for a bette understanding of the 
interaction ol TSH and TSAb with the TSH recepto . The availability of 
' 
·antibodies capable of identifying the TSH receptor wo ld permit the study of 
. some of. the factors involved in the cont~ the bio~ynt~~is anid turnover of the 
TSH rcept;_:· I I ,. 
The aims of this study can, then, be summarized as follows: 
I 
I 
. I· . 
1· To investigate if ~n.ti-TS.Ji anti-idiotypic antibodies ar~ capable of interacting 
with the TSH" receptor. , \ 
\ 
I 
2·~ .Jf t~ is intera~tion occu.: to study its natur~ i.e. inhibit~ry or stimulatory. 
. . :~ . - ' \ 
- . ·~S:· . . I . 
3- It possible, to compare th~'·.biological respons.es produc.ed by anti-TSH anti-
\ 
idiotypic antibodies with those produced by TSH and , the naturally pccurring 
TSAb or Graves' disease . 
4- To investigate the possibility of r~ising anti-TSH subunit sp·ecific anti-
idiotypic antibodies capable or recognizing' the TSH receptor. 4 
5- To explore the possibility of using this antibody model'~ in st~dying the 
• . I 
participation or the subunits or TSH in the hormone-receptor int~raction. 
. . . . I - . 
6- And finally; il these antibodies are .demonstrated to be speqific Cor the TSH 
rec~~tor, . t!> benefit fr?ni thir~haracteristi~ to d~si·gn · a ~odel~~hat permits the · 
. study- or the influence or TSH on the synthesis and turnover of it own receptor. . 
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MATERIALS AND METHODS 
. . 
~~~.1. PREPARATION OF ANTI.;TSH ANTI .. IDIOTYPIC 
ANTmogms 
-/ . ' 
An.ti-'PSH 1anti-idiotypic Abs ·were prepared . as described by Islam', Pepper, 
-Briones-U~bina and Farid (1Q83 b). · Briefiy ,. three 6 \veek old m~l~ Spra.gue-
Dawley rats were immunized with 50 micrograms (pg) or purified hTSH(Union 
. . . . 
_Chimique~ Belgique, Brussels, ,Belgium) in complete Freund's adjuynnt ' 
(CFA)(Gran·d Isla~d~Biological Co., Grand Island, N.Y.). The ~nimals ,e'cei~ed a 
. . 
booster·injection~ a· weeks later, of 20 ~'g of hTSH in complete Freund's adjuvant 
. --
. (Gibco, Grand Island, N.Y.). Bleeai.ng :was car~ied out three weeks after the " 
second injection._lmm'!noglobulins were isolated from sert}m and tested Cor their 
capacity to precipitate radiolabeled bTSH. - Anti-TSH antibodies were purified fin . 
' J. I • 
;t-TSH aff.tnity column, (TSH-ACCi-gel IO)(Bio-Rad, Richmo~d, California) 
0 
Three New Zeal~nd white male rabbits were immuniz~d with SO pg or the lgG 
eluted from the TSH affinity column in CF A. Th~ animals were boosted with 30 
pg ~r lgG ari~r 3 ~eeks and hied ~ weeks .after the sec~nd injection. IgG was 
prepared from, these sera and . extensively. absorbed with glutaraldehyde-
. . ' 
' immobilize~ pooled Sprague-Dawley rat lgG (Fuchs and ~ela, ·lg7a) to·remove 
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' 
2.2. P.REPAIJ.ATIO.N OF ANTI-TSH ·sUBUNIT-SP~CIFIC ·· 
c . . 
ANTI-IDIOTYPIC ANTmODIES · 
Mooocfonal antibodies TS28, an lgM specific for the hTSH a subunit and GC73 
' I o ,o: o • ' 
an lgG specific Cor, the bTSH P subunit were kindly provided by Dr. Jurag Ivanyf 
• (\Vellcome Research Laboratories, Beckenham, Kent, England). Briefly, these two 
monoclonal antibodies were prepare~ as described by Galfre, Milstein and Wright 
(197Q) ·and Ivanyi and Davis (1980) by fusin·g spleen cells from Lou species rats .....,. 
. . 
immu·~i~ed with hTSH with th~ Y3.Ag1.2.3. rat myeloma cell line. 
In the present study_four .New ~e~land.White male ·rabbits were immunized with 
> • 
those antibodies. Two received 100 pg of lgM _ (TS28) and the other t~o 100 · pg of 
'._ - JgG (GC73) in CFA. (Gi~co), injected in ~ultiple subcutaneous sites. After one 
· month, the rab_bits wer~ boosted every .second week _for 10. weeks with· 50 
.; .. micrograms of the. specific monoclonal antibody in incomplete Freunds adjuvant 
(Gibcp). 'Two weeks after th·e .. last injection the animals were exsa~guinaied. It is 
. ..... t ~ ..... . • . . ~ • . 
· stressed that the d~fferenc·e in the immunization .schedules in pro_d.ucing. anti~ TSH 
an.ti-id~o.~ypic o.~ibodies and in ·p~p~ring a~t.i-T.SH subunit speclfic a.nti-idiotypic 
. . . . . . . . . . · l' ;·· . . . • . ' . 
·antibodies is oue to the fact that the screening :test that was being utilized' Cor 
• • • • • • • • • • • • .. y .. 
dete~ting the pos~ible prese_!l~e of antl-idiotypic antibodies (2.12) was· negative 
·, I - . . . 
~ . -
when performed every two weeks. With _every negative ·result a .new 'booster 
. . ·. . • -..... 
injection was given. At the end_ oC the· @~h _ boo~t, depite·: the fact that our 
screening test · w~ stiU negative, the anim\ls were -sacrificed · and their serum 
. proc~ssed for l~r.ther -~t~ting. Immtinogl~l!!lilis~o~ preim~une serum as well as . 
from immu'ntzed and control animals were obtained _l:)y precJpitat_ion at. 0°0 with '· 
half saturated ··ammonium sulphate (Heide and Schwick, 19.;3). ·The product wa.S· 
" extensiv~IY. dialysed agai~st a buffer containing·2oo ~ TRIS HOI; 25-~ ~aCl, · 
. . ' 
pH. 7.4; and p~ed th11ough ·a-r~t immunoglobu_iin· affinity column (Rat-lg/Reacti- -. 
. . . 
gei}(BioRia. .Laboratories, Montreal, Canada) -Jo remove allotypic and isotypic 
• ... • • • t • 
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2.3. SELE.CTION OF SUBJECTS 
Ten patients with · Graves' d~ease; seven patients with Hashit!loto's thyroiditis ' 
and . ten health.y contf<.?}S • were chosen to study the interaction of 'their Jg's with 
thyroid plasma membrane protein blots. 
The criteria for the selection or Graves• disease patients inch.•de~ the presence of 
florid clinical features. a diffuse goiter,the absence or thyroid nodularity as 
verified by rectilinear scanning after the administration or· 99Tc, high 24h 
radioactive iodine uptake and elevated thyroid hormone levels .as determined by 
radioimmunoassay. TSAb ievels were not determined. . 
In the case of Hashimoto•s thyroiditis~ five of the seven patients had goiters. All 
of the seven patients also had high titers or anti·microsomal antibodies (1:1600 or 
. . 
~igher) b~t were negative for anti·thyroglobulin antibodies in: the standard 
haemagglutination test. All t.hese pa:tients were currently rec~iving oral thyroxine 
. . 
I ' • I 
therapy ·ao:d were euthyroid. · o 
. ~- PREPAiATION·OF THYROID PLASMA MEMBRANES . 
~ordne tbyroid tissu'e (approximately 40 g) Obtained frO~ the local abattoir was 
-~omogenized in 10 volumes of ·a buffer containing .10 mM TRIS HCI, 250 mM 
sucr6se, 1 mM MgCI2 and 1 mM EGTA, pH 7.4 (STEM) at ~°C with a Polytroq 
Tissue)Iom?geneizer (Polytron Inst~uments Inc.) Cor a period or~ min to cause 
tissue disruption. ·The homogenate was centrifuged at 4500 x g at 4°C for 5 min 
and the supernatant discarded. · .The pellet was resuspended in ST~!vi and 
homogenization repeated for a period or 1 min. The _product, was Ciltered through 
·a. nylon mesh.:· The filtrate, mainlr a single cell · suspension o,n microscopic 
examination~ was place~ for 20 ·min' in a. 'n'itrogen cell disruption born~ . (Parr 
· · Instrum~nt Co., Moline, Ill.). under constant stfh:t_ng. and at a· pres5ure or g()O psi. 
At the end. ~r the stabilization period rap.id dl!comp~ession resulted in cell ruptu~ 
• 0 ' • • ./' • 
~itb ~efficiency or go.gs%. The suspension was then succe~ively c~ntrifuged at 
' . . .. 
1000 ·x · g and · 4500 x g at 4°0 for 10·. minutes each titne; the pellet was discarded 
~ · 
. . 
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in. both . cases. The membrane fraction was rec'!vered by centrifugipg the above 
supernatant at 32000 x g. for 30 minutes at 4°C. 
Peliets containi~g the· crude membrane fraction w:re r~uspended in 21 ml or a ) 
buf~er co~taining 55% .sucrose in 10 mM Tris ~Cl, 1 mM ··MgCI2 and 1 mM 
EGTA, pH 7.4 (TEM) by gentle homog~nization with a glass, teflon pestle tissue 
. . 
grinder. The product wa8 transferred in equal volumes into six 4 inch diameter, 
' , 
cellulose nitrate tubes ·(Beckman, Palo Alto, California). Sucrose soluti.ons ·or 
: 45%, 40%, 35% and 3.0% in TEM (approximately J ml each) ·were caref~y 
layered on top of the membrane suspension. Ce~trifugation was ·carried out in a 
. ~ 
Beckman SW27 swinging rotor at 113,000 x g for 90 minutes at 4°C. Membrane 
. 
bands at the interface between 30% and 35% and 35%. and 40% were coilected 
.. 
by aspiration with a ~a.steur pipett~ and pooled. . The r~covered . material was . . 
• • 
diluted with TEM to achieve a sucrose concentration ·or 250 mM and product was 
' . . 
c~ntrjfuged at 113,000· x g for 30 minutes at ·4°C. The fin~] pellet containing -the 
. -. . ~ . . . . 
purified m·embranes was resuspended in STEM. · Protein . concentration was 
' ~ . . 
:· · determin.ed by the Fplin phen~l method (Lo'Yry .et ~1. 1951) .. Aliquots or 100 ul 
' . 1 . ' . I • . 
with protein· content~ between 400.:500 vg were stored in '.liquid nitrogen. The 
. . . . ' 
plasma membrane preparatio~s were- as~ay~d for 5'nucleotidase and NADPH 
. . 
cytochrome C reductase and examined under electron mic'roscopy to assess their 
(degree of purity. These procedures wer~ kindly performed by Dr.' N.M . . Islam and 
the De.part~~t or Electron ... Microscopy, respectively, at the Health ~nces 
Centre, MUN, Newfoundland. Where human -thyroid, pla.Sma membranes were 
utilized the preparation procedure was identical. Human thyroid tissue was 
obtained . at surgery. .. 
2.5. DETERMINATION OF ADENYL:ATE CYCLASE 
~CTM~Y . 
Aliquots equivalent to forty .mic~~grams of sucrose gradient purified · thyroid 
• . t' 
., 
.' l 
' • ,. 







.. . ' " 
., 
' . 
antib?dies (200 and 250 pg/ml), monoclonal antibodies (25Q pg/ml) or control 
immunoglobulins {200 and 250 pg/ml); A. C. was assayed in ii. final volume of 200 
11l in 50 mM TRIS HCI pH 7.5 in the presence or ~bsence or 10 uM . 
guanosine-5~-{P'-r-imido} triphosphate (Gp-p(NH)p)(Sigma Chern. Co., St. Louis, 
Missouri): Tlie. reaction ' was initiated by adding to the prei'\ubated me_mbran~s 
equal volumes of an adenosine ttipbosphate (ATP) regenerating system containing 
. - . .. 
4 tnM MgCI2, 5 mM theophyllin, 4 mM ATP, -IS mM creatine ~hosphate (~igma 
Chern. Co.) and 25 pg of rabbit muscle creatine phosphokinase (Sigma Chern. 
Co.)(Zor, Kaneko, Lowe, Bloom and Field, 1Q60). Incubation was carried out for 
30 minutes at 37°C. After the incubation period was over, assay' tubes were 
centrifuged at 32,000 x g for 15 minutes at 4~C. The supernatants were recovere 
and kept at 4°~ f?r immediate cAMP determinations. 
cAMP. -¥ras· measured using a protein b~nding assay· (Gilman, 1Q70) . . Briefly, iO 
11l of the above supernatant containing unknown am.ounts of cAMP were placed in 
12 X 75 mm plastic culture tubes (Faicon p~~tics,· Oxnard, Caiia.d'a)· with 4Q #Sg or 
. . 
equine muscle cAMP dependent protein kinase (Sigma Chemical Co.) and 10 pM 
3H cAMP (,...,40,000. cpm)(New England Nuclear,· NEN, Boston, · Ma8s.) The final .... 
. . .' ~ . ..... " . 
assay vol~~e or · 200 pl was achi.eved by ·addition ·or · a 50 mM sodium ace fate 
• I I . 
buffer pH 4.0. Incubation was car-ried out for 2 bo1,1rs at 4° C.' At the end or this 
. . .•, 
period 1 ml or 200 mM potassium phosphate· pH 6.0 was added to each assay tube 
-· 
to stop tpe reaction. Bound and Cree. cAMP were separated by coliecting bound 
· complexes on HATF 0.45 11m ni.trocellulose ' rilters (Millipore·, B~dford, Mass.)."~ 
• Assay tubes and individual filter holders were washed three times with. 10 ml each 
. ... . 
of cold 20 mM ·potas~ium phosphate pH 6.0 to re~ove uob9und radioactivity. 
Filters were ai~ dryed. at room temper~ture and, placed in -s~intilla~ion vials with 1 
- . . . 
. ml or scintillation grade· 2-ethoxyethanol (J.T. Baker · Cbemlcal Co., Phillipsbing, · 
. ' 
N~J.). Arter the · filters · were · dissolved, 10 mls·· of Scinti-verse, a · scintillation 
. ' ' . . . 
counting ·cocktail, (BDH Chemicals ttd., Toronto, Canada) were added and the 
radio~ctive. con.tent.~a8 detet~i~e~ · in a. Beck~an Li-330 c~unter . (B~ckman ·. 
in.dusiries). Efficiency calclJlate'd for 3H was 64%. Countin.g errors.be'tween J .. s%. 
. ' . 
' 1 
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\ cAMP values were .obtained by comparing experimental data with a 
.contemp~r* st~ndard curve .prepared Collowin~- similar methodology. A sa~ple 
of a typical standard curve is included i~ figure 2.1. Known concent-:ations of 
.. ' 
cAMP (Sigm~ Chern. Co.) from 1 to ·10 pM were included .. Linearity of the 
etanda.r~ plot was obtained ~it~in the ranges or 2 to 8 pM. It is 'important to 
mea~ion. that, when 10 ul of th~ sup_ernatant con'tained higher amoun~ or cAMP 
than those appropriate to compare with the linear part ·ot. the standard curve the 
,, ' 
sample was adequately diluted to achieve an adequate level and final value was 






When tb~ . effect or TSH subunit specific monoclonal antibodies or 
immqnog)obulins from patients. with Hashimoto's thyroiditis on TSH-driven A. C. 
. . . 
WS:S in~'es'tigated, · these antibodies (250 ~tg/ml) or normal rab· or human 
~ - : I 1 f/ . ' 
l:;~~~::~:::~:::i::~;h~a:::::~·o;;::::i:::b:::Pr: ::P::i:::.~i;: ·.~ 
\:othe~ experim-ents. test . i·m_mu'il~globulins ~~ere ~_dded sim~Jtaneously_ 'Yitli TSH . .,.:~ .. 
The rest or the procedure continued as described above. 
• l • ••• 
. t . . . . . . . . 
• 
·' . . . .. . 
2.8. PREPARATION _OF DISPERSED THYROID CELLS 
P~·rclne thyroid. tlssu~ ~!18- obtai~ed from t~e local abattoir ·_and transporte,d on 
ice. Fat and fibrous· matedal were· carefully -removed, (hyroid tissue was then 
I ' • • ,. • • ' • 
slic~a with a scalp~ int~ -~pproximately 0.5. -~m fragment~ and washed twice ·hi 
Hanks ba)~ced saft solution (HBSS) (Flow Labs, McLean,· Virginia). Five grams 
.-. . 
or tissue were .transferred into a i25 ml capa~ity siliconize.d Erlenmeyer Fi~k and 
- in~ubated .. with. 2~5 U or c6llagen~e .(Worthington .Diagnostic Systems·, D~blin, .. 
Va} dissolved· i~ IO inls. o(HBBS . . I~cub~tion was carried out for .ao minutes at . ... 
• • ill :' .' 0 • • • • • • • • • ' , • 
~7°C ,in · a. sh~king water bath at 120 str~kes/min. if:l an atmospher.e_ of 95% 0~ . 
a~d ·. 5%. ·cQ~: . All' subsequent incub~ttou steps were carried 0~ ~~~er'' similar . , 
conditions. · . : 
' . 
At the tnd or. the. lint digestion ste~ the super~atant w~ d~canted and the 
. I 
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S8mple of· a typical cAMP standard curve. · 
Xcpm: corrected fo~ _background 
" . 














I ~ I 
'· :.:· 
··: .. ; 
... 









' ·) ; 
.-· /~ 
' ··~ 
:. -:. ... 













tissue wuhed twice,· with. 50 ml HB~S. ,-he partially digested material was 
·· further trimmed or· 106s~ fibrous material and s~cond ~igestion -step was ''Started. 
. .. . . . ~ . 
Tissue ·was incubated lor one hour with 3915 U or collagenase dJ,ssolved in 10 mls 
ol JmSS. At the e~d ol this p~riod 10 nils of HBSS were added to termi~ate · 
. ·. ' . . 
digestion by dilution. The produ-Ct wa8 filte~ed through . a. nyl~n .mesh and the 
liltr-ate centrifuged at 200 X g for 10 minut~ at room temperature. The cell pellet. 
was washed twice by resuspending. in 40 ml with HBSS and further centrifugation. · 
. • f . • 
The cell~ were. resuspended with 40 ml HBSS containing , 0~005% W /V 
. . 
· deoxyribonuclease (Sigma Chemical Co.)and .left .tor .10 min· at room temperature. 
Incubation was termi~ated by centrifugation at _200 :X .g for 5 minutes .. The .cells 
. . . . ' 
were then· washed with 40 ml of HBS~ ~hd p~t resuspended in Ea~Jes'. modified 
Minimum Essential . Medium (MEM)(Flow Laoo.ratOries) containing 0.2% . Na 
· bicarbonate,· · 15% - ·fetal ca1f . serum (Flo~ .Lab~ratorie~) . . · .and 1% 
. . . 
antibioti~/a'n~imycotic/kananiycin (GibcoL (~¥/~CS). Cell .viability was · · 
· . . determined at .. this -stag~ with . the J . ~rypan . blue .exclusion t'est an~ . w._as 
demonstr-Bted . to. h~ :gre.ater·· th~n go%. Cell yield· wa.s appr~~imately 2-~ ·x 107 cells .. 
. . . . ... . . , . 
per ~ra~ of tliyroid -tissue 'used: · •. 
. ' . ' . 
Several ·experiments were :·carried out usmg a similar· method but different 
balan.ced salt solutions. Krebs Ringer· bicar~onate ~as used instead of IQ3SS but 
as th.e. cell viability ob'tailied. with thE! l.atter proved to be s~perior, this proc~dure 
. .. . ' . . ' ' 
. was adopted r~r further ex·perime~tation. 
. . . 
2.7. RADIO-IODINE UPT~E· BY DISPERSED THYROID 
CELLS 
' . 
Radio-iodin~ upta~e by . dispersed"·thyrocytes ·was car~ied out us~ng tWo . 
methodologies. In. ~b~· ex.peri_menis .that test.ed th'e biolo.gical ac_iivity of ·the·TSH-
. · · ~ti·id,· 2.~ ~ 196/inl cells in ~ :volume ·~r 1 ml in Krebs . ~inger Bicarbonat~ 





.•. . &O!ution .were· pla~ed in: 12 X 7s mm . plastic tubes' ' (F~lcon . Plastic.s, · Oxnard, .. ;-:· 
~·.. • tr• r • . ; · • . . · · · . • · · • . . . , . . . ~ 
t· . ,.. . Cali~~r_n;~r~ d lnc~bate~ .. wit~ bTSH·(5: 10 an~ 50 mU/ml)! TSH-;a~t~-id (125-25~. . . : 
~~-::: . . . . . · ,.gjmlj or. NR-Jg · ( ltl>-2SO: I'K/ ml). 'the 1ncubat10n was carried· out for per~ods ·of ·· · . '. 
" · . ' \..· . - .' ( 
~i> . ' ; . . . ·.· .~. 
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•'• added per tube in the 'incubation cad1ed out ror 10 ~ore minutes at room 
.. temperature. The tu~es were then centrif~ged at 200 X g for 10 . minutes,' the 
supernatant. was removed' and the cells _were· ihen washed twice with the -Krebs , 
Ringer ~icarbonate solution. The radioactive content or the pellet was t~,cn 
determin~d. 
On later experiments a different methodology w~ used. This choice- was made 
. ' 
because it· was obser~ed that allowing ~b~ cells to plate and recover Cr~m the 
isolation procedures improv~d their Viability. ·This method was used in testing the 
. . . ' · 
a-anti-id and p-anti-id antibodies. Dispersed thyroid ceflS, prepared~· previously 
described, were allowed to plat-e at a concentration or 2 X 106/ml in ME os in 
. ~ ' ' 
6 well. tissu~ culture dishes (C~star, '·Ca~bridge, Ma.Ss) _in a volume_ o·r 5 mis . p.er 
well. Culture was carried out .at 37°9 in a. .humiaified atmosph~r~ ·or Q5% air. and 
5% C<,-2. Arter 
1
a 24 hour recoveiy p~eri~d, p~~t~d ~ells were incubated ror 4 hour~ 
· wJt~ either bovine .TSH (100 or .200 ~U/~1), ·anti-idiotypic antibodies {2.50 or 500 
. . , . . . . . . . . . . ' . ' 
llg/~1), NR-Ig {250 or 500 llg/nil) or control medium. At •the end or _this · 
. . 
incubation period cells were carefully harvested by ·scraping. with a rubber 
policeman. Cell number was determined with the use or a haemocytometer and 
the· concentration adjusted to 1 x 106/ml in HBSS, all these were viable cells. 
One ml or . ce~l ~uspension was allowed . to react for 30 minutes at 37°C with 1 X 
105 cpm ·or , 1311 (~N) in plastic 5 ml culture tubes (Fisher Scientific · Co., 
Pittsburg, P A.). Cells were then chilled to 46C and washed twic.e with one m~ of · 
cold HBSS by centrifuging at 200 xg for 10 ·min and later .resuspend in~ by. 'gentle 
. . . : -
agitation. T,be radioio~ine content of· tb~ pellet was determi.ned and percent 
uptake calculated. ·Counting errors were between 1. . 5% Cor the counts ad~ed and 
the time ~ounted.' Typ.ical uptake v~lues _were o_r the order or'- 6-6 % per pellet. 
Control values were eonsidered those obtained when th_e cells were i.ncubated in 
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2.8. FOLLICULAR ORGANIZATION OF CULTURED· 
THYROID CELLS 
Thyroid cells were prepared ~ previously described, and resus'pend!¥1 m 
MEM/FCS at a concentration of 1 x 1~ /mi. a ' 
Culture was ~artied out for seven days, in Lab-Tek 8 · chamber tissue culture 
slides (Lab-tek Division, Miles ·Lab., Naperville, Ill). A volume of 0.4 .ml .of cell 
suspension containing 4 x 105 -cells was delivered per .well. DiUerent final ·· .• 
. c~nce~trati~ns or either ·b-TSH (100. and 200 mU/ml), Jlnti-idiotyptt'~ntibodies 
. . 
~250 and 500 .·pg p~o.teins/ml) .or control h:nmunoglobulin~ (250 and 500 pg 
protein/ml) ···were inc.lu_ded . in .8 weils e~ch tb .~tudy the influence of "these 
substances upon organ-ization Qf the cultured cells. . The. medium was replaced 
. ~ . . .. ' "' ... . 
once· atday 4. At· day 7 the Lab-T.ek' chamber cover and its plastic support base 
we~e C,!l~~rully re~o':ed t~ av9id distu~bance. of. the sl~d~ C~D tent. Slid~· were. 
,• ' ' • I • ' ' ' ' 
· , c!lrefu~iy ~~bed ~·Y 'ge~tle .im~er~io~·. in phosphate buffered sal~ne pii1.2 and a .. 
cover slip w~ placed on top or plated cells'; ·, • 
... . . . 
Cultures were e;camin.ed und~r . a Zeiss Pbo~i II light microscope. Pictures were-
. . ~ . 
taken using a phase contrast 50x lens with pr without 'a green filter and a 35 mm 
. . " . ... . . 
MPS55 (Wild) camera attachq1ent. 
~ . · · For PAS stained specimens, ~ell monol~yer~ were rinsed as· before and fixed for 
. . . . . . . . ... 
18-20 h . {lt 4° . C .in . glutardraldebyde.picric-acid-_acetic acid (GPA:. gg% of a 
· inixture .or. 1 .. par.t· 25% 'glutarydyaldehyde ..(Merck L!lbo~atories, · Dat:~tadt, 
. G~rmany) . a~d 3 par~ · saturated pic~ic ·acid (BDH Chen:.icals . Ltd~ , Toronto, . 
. ' Can~da{ mixed with· 1% .. ~f .gladal_: ~~~d · (~ish~r Sci~nH(ic ·Li~ited~ ·r ·a:Ir Lawn; 
. N.i) ... Cells• .wer~ . 'then washed 'su~c~iv~ly . in so%, 70% ethanol and dtstilled 
water an·d s~bsequ~ntJy si~i~ed ; with a : PAS staining kit. (PAS; .Harleco: EM 
r ' ,. / • • ' ' • ' ' ~ 
: : . 
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· lnd~shie9, Inc., G~town, ·N~J.): . Other . samples were staine-d with both PAS ~ 
;.:, ' ' 9 . • , .. • , • . , • • a , ""' ' , _. 
: . · and: haem.alurri tO obtain ~ better visualization or the nuclei. . . _, ~ · · ~t~ 
~.-r,l , . , .···-~~ 
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Ten micrograms of highly purified bovine thyrotropin (gift of Dr. John Pierce, 
' -
UCLA)('"':' 30 IU/mg)(Table 2.1) or 25 pgjprotein of different- immunoglobutins 
\ . 
(Anti-idiotypic antibodies, TSH subu~t specific monoclonal antibodies and control 
• I - ,. 
rat or _ _ rabbit i~~unoglobulins) iere radio-iodinate'd~ ... w~h 1251 usin_g the 
lactoperoxidase rn~tho~ (Thorell and\ Joha~sson. 107~). 1 Labelled proteins were 
s_eparat~d from free iodine on Ultrog~l A~A54 columns (Reactifs ~F., L~ Labs, 
France) by eluting "with a buffer ~ontaining 20 mM Tris HCI, 25. mM NaCI and 
_- · 0.1% bovine serum· albumin (BSA), pH 7.4. 1251 human TSH was purchased from 
. ' . . ' 
Nuclear Medical Labo~atories (Irving, Texas), spec~Cic activity was 50 pCi/mg . 
2.10. 1251-bTSH BINDING TO DISPERSED THYROCYTES 
·. Isolated_ th~rocytes ·were· cultured· · for 24 hours after .,_preparation 11t a 
concentration of 2 x Irl jml i~ MEM/.FSC; · Arter th~ recovery pe~iod was ~ver b-· 
.. ,. . .. . ' ..... 
TSH (USV Lab)(lOO inU/ml} was added to the culture medium of two different 
groups of cells. Group 1 was incubated· in the presence of TSH for a period of 3 
hours· and grqup 2 for ·a period of 15 hours. A third group did not receive TSH 
and ~as kept as control. 
At the end of these in·cubations ~ells were gently collected with a rubber ,· 
. , policeman and subsequently centrifuged at 200 x g for ·5 minutes at room 
. temperature. Cell pellet~ were resuspended in HBSS at a. concentration o~ lx .107 
cells/~1. 
. 
Thre~ hundred-pi of the ab~ve cel,l suspension . (3 x io~ cells) were allowed to · 
react with ."' lOO,OOo cpm. (~ 2.5 pM) of 1~51-bTSH in the absepce or in · the 
presen~e qf5o to.soo· rnU/ml of nati~~ bl'SH (USV Labs) for 30 mi~~tes at 37°0 
' . ~ . 
in. a 'total final volume of 500 ,.i in HBSS ·in l.S ~I polypropylene conica~ bottOm 
. : . . . .. 
micro test tubes_ (Brinkma_nn . Inst~uments, Inc., Westbury; N.Y .. ) At the end or 
' . 
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'Thble 2~1: Equivalences of the different TSH preparations used. 
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• Intem~tional Unit: ActiVity' compared to the inteniatlonal Standard: 
. ·... . ~ - . 
• · . Iritemational Laboratory ·or: Biological Standards, 
Holly Hill;· London, England . 
• • Thyrotropin activity tested using the method of chick thyroid iOdine depletion assay 
of Piotrowsky ,'Steehnan and ~och (1953) and compared to the iritemational standard. 1 . • 
• • • Biopotency c9mpared to th~ Wodd Health Orgaillzation h~ TSH standard 68/38 
). 
. ' 
from the International Laborat.Ory·of Biological St.andariis, Holly Hill, London, 
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England. 
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the incubation, samples were centrifuged for 1 minute in a Beckman Microfuge · 
(IJeckman I~stru~ents) at room temperature the supernatant was aspirat()d, and 
th\ radioactive content of the pellet determined in a Beckman Gamma-300 
\ 
coupt'er,.(Beckman Instruments). Calculated efficiency for the counter for 1251 was 
74%. Counting errors were between 1-5% for the number of cpm's added and the 
time counted. 
. - . . 
2.11. INTERACTION OF 1251-ANTI-IDIOT)'PIC ANTmODIES 
WIT!! TJQ'ROID PLASMA MEMBRANES ., 
For the ex~erimen.ts testing TSH-anti-id one hundred; jllicrograms of sucrose 
gradient purified porcine thyroid plasma membrane· in 50 pl ~r 25 'mM N~Cl, 20 
. . ' . .. . . . 
rnM TRIS-HCI. pH 7.4: binding buffer ·(BJJ) were incubated for. 30 minutes at 37°0 · 
with ....... 20,000 cpn{ (""'5 ng/protein) ·of radiolab~led anti-idiotypi~ ·antibodies or 
, . .· . . . 
radiolabeled control. rabbit immunoglobulins in the absence. or in the . presence of .. 
. , 
either bTSH at ~oncentratio~ of 40 to 200 mU/ml, native anti-idi.otypic 
antibodies (50-200 .pgfml) ,ntrol immunoglobu~ins (50-200 pgfml). 
For the exp~riments testing-the-·-binding of r11diolabeled a-ap'ti-id and 
radiolabeled ~an~i-id to porcine ·thyroid plasma membrane' ......,50,000 epm ( ....... Jo 
ng/pro'tein) or labeled antibodies were reacted with 100 #lg or purified membrane, 
• 
in similar volume of BB as above, in the absence ,or in the presence of '250, 500 or 
+-.. 1000 mU /ml of unlabeled TSH or 500 or 1000 pgfml of ,unlabeled a-antt-td or 
.~ ~anti-id. The final assay -volume was 200 #Jl. . Arter incubatio~, I tubes were 
centrifuged a:t 32,000 x g for 10 minutes at 4°0. · The supernatant WaS aspirated 
. . 
and th·e radioactive c~ntent of the pellet determined. Counting errors between \ 
. . -
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·2.12. EFFECT OF ANTI-IDIOTYPIC ANTffiODIES. ON THE 
. . 
·BINDING OF RADIOLABELED TSH TO THYROID 
· PLAS'MA MEMBRANE 
One hundred micrograms or purified porcine thyroid plasma membrane in 50 11l 
. -
or BB wer~ incubated with "'0.5 pM or 1251-bTSH (--20,000 cpm) in . the ~bsence 
or in the presence of different . concentrations of either native bTSH ( 50-250 
m~/ml), ~nti-idiotypic antibodies (?~' .soo and 10~0 pg/ml) or control 
immunoglobulins (500, 1000 pgfml) Cor ~0 minutes at ~7 °C. The assay· was 
. ·'' . . ' 
carried' out in BB in a: final V<?lume of 200 pl. . At the end or the incubation period 
' ' 
the sample5 were centrifuged at.32,9()0 x g for 10 ]11inutes a.t 4°C .. The supernatant .-
• , • I , 
~as .aspirated ~nd the. radio~Ctive content. or the peliet ·determined. Co~nting 
- -. ------- .. ' " 
errors. were between 1~5% .. ~. :.·, . . _ . 
2.13. -BINDING OF. RinloLABELED TltYROTROPIN TO 
~H~SUBU~T SPE-c~IC_ ~ONOCLON~ ANT~ODIES . 
On~ b\lndred micrograms per mililiter. of each monoclonal antibody (TS28 or 
. . 
GC73) we~e prefncubated Cor 14 4o~rs·~at '4 °C or 30 minutes at 37 °0 in the 
.absence or in the presence of either 50-200 mU/ml of bTSH or 12-5, 250 or 5~0 
'11g/ml . •of .· the respective anti·t.?iotypic · antibodies. · 1251-TSH (bovine 
(bTSH)(,..,..20,000 (:p~0.5 pM per tube)(""100,000 cpm/ml ......, 2.5 pM/ml)) or 
··human (hTSH) ("-'20,0~ cpm, "' 0.48 pM per \iube)("'IOO,OOO cpm/ml ,...,.. 2.4 
pM/mlf ~a.s · added to samples and incubated at 37 °C for ao· minut~s. · The final 
. . 
assay ··volume ·.was -200 .. pl . and· the conc~ntrations expreSjed represent those 
obtained -in the final volume. In another grqup ·or experiments identical quantities 
ot · mono~l~nal ~~tib~dies·, w~re incubat~·d for 30 inin~tes at .37 •c with 
radioi~eled hTSH in the ~res~n~e . or absence · of. ~ative human TSH (1.5 
' • • • • • • • ... • 0 • 
IU/mg)(kindly donated by · ~DK, Balt_lmor~,Maryland) _(Ta~le /2.1} at 
. conc~ntrati~ns vary'ing from 250. pUfml to ·25. mU/ml. All ~says were car~ied out 
• ' ,. I 
· in BB in :a ·rinal voluine 9r 290 pl. At :the end of the incupation.J?eriods bound and 
.. fr~e TSH were s~parated _by ·adding 1 mg .of bovine gamma. globuli~ . in· 50 -pi of 1 
... 
'· ' .. 
....... 
! · , 
I I .. ~ 
. ·. :· 
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M NaCl and 250 ,1 or polyethylene glycol 6000 to obtain a final concentration or 
~ . . 
12 %, followed J:>y centrifugation at 32,000 x g for 10 minutes at 4°C. The 
supernatant was aspirated and the rad~oactive content of the pellet determined. 
Counting errors for these experiments were also between 1 to 5 %. 
Titration experiments were carried out to search for the ideal concentrations for 
, 
polyethylene glycol to obtain an adequate precipitation or the T~H-antibody 
complex vs. increasing the background counts._ The concentration or 12% was 
. . 
chosen after careful comparison between these two pina.metc~s. At higher 
c-;mcentrations no better precipitation ~as obtained but the bac,kgrouild counts 
were-highly increased, hence the 12% concentration was used. 
• 
2.14. INTERACTION 'OF RADIOLABELED MONOCLONAL· 
. ... ... . 
ANTmODIES WITH ANTI-IDIOTYPIC ANTmonms 
Radiolabeled .. ~onoclonal ~ntibodies ( ""50,000 cpm, "'-'lq ng) in 100 ·,.,1 ) or 
. . . ..... -
1 • 
radiolabeled control rat immunoglobulins containing mostly lgG but also lgM (N 
rat lg}( ,..._,~0,000 cp~, '""'15qg) in 100 ~tl were incubated in the p~esence or specific 
anti~idiotypic antibodies (100-1000 ~tg/ml) in 100 ~I or similar concentrations of 
control rabbit. immunoglobulins (NR lg) also in a volume of 100 pl 't~r 6~ minutes 
at 37°C. The reactiQn _was carried out in a. total final volume or 200 ,I. At the end 
of· the incubation p~riod bound and free antibodies were separated by adding 1 
,; ' . 1 . 
mg of bovine gamma globulin in 60 pl of 1 M NaCl and 250 pl of polyethylene 
- . . ' . .. ~ . 
glyco.l 6000 to obtain a final concentration of 12 %. This was followed by 
. 
centrifugation , at ,32,0QO x g for ~0 minut~s at 4°C. The · supernatant. was then 
, . . 
. . . 
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2.1&. PORCINE THYROID PLAS~ MEMB~N~ PROTEI~ 
. FRACTIONATION BY.SODrtiM :DODECYL SULFATE-. 
·,. "PO:tY ~flliAMfi>E GEL ELECTROPHORESIS '· . "\. 
(SDS .. P.AGE) 
· ·Polyacrylamide gel electrophoresis was carried out using the discot?A~uos buffer 
. . ' 
gystem described by Laemmli (1Q70). Briefly, stock solutions containing 30% wfv 
acrylami'de (Bio-Rad Labs., Ric)lmond, Califorpia) and ·0.8% wfv N-N'.bis-
methylene ac~ylamide (Bio-Rad Labs) in deionized water were prepared. 
. . 
Acrylamide solutions at concentrations or 7.5% and 15% (used in experiments 
descri~ed in ·a.I.'7, 3.2.1 and, ~'t2.2) or 5% a.nd 15% (used in all experiments in 
·section 3.4).' wer~ made using the stock solution and a ·buffer containing 0.375 M 
Tris-HCI pH 8.8 with· 0.1% sodium dodecyl sulphate (SDS). To a~hieve 
polymerization· 0.05%' or 0.025% v/v respectively or tetramethylethylenediamine 
. . . 
(Eastman· Kodak Co., Rochester, New York) and .0.25%· wfv or ammonium 
persulCate (BDH Cbemic~ls, Toronto, Canada) were adde(i.*l3 x .14 x 0.3 em slab 
... . ' . 
linear gradient gels were prepared by using a· gel grad!cn.t mixer (Hoefer Sci~ntiric 
. . . 
Iost.ruments , San ·Francisco, · California). : The . sta~king gels 5% and · 4% 
' . ' . .. •. ' ' .. 
respectively, contained· 0.125 M Tris HCI, pH 6.8 andil% SQS. ·The ~lectrode 
. . . 
. .. 
burrer contained o:o25 M Tris base and 0.102 M glycine, pH 8.3 ,·with 0.1% SD~. · 
_ · Protein sampl~s ·containing 100 pg "in 100 pi or sucrose gradient pu~ified thyroid 
~c .. mbra.nes in a. buffer. ~.ith ~.0~25 M Tris-H~l, . pH 6.S,. a% SDS, ~~% 
glycerol ·in the presenc~ o.r absence. or 5% ,8-mercaptoethanol were thoroughly 
' . . 
~ixed ahd pla~ed in boiling wa~er for ~ minutes .. Alter the •s'ampl~s had cool~d orr, 
· 0.01% bromophen~l blue was. added.-as tracer .dye:· The samples were placed in 
• • 1 ' • . 
individual slots in th~ stacking g~l and electrophoresis carried out at 200 ·volts 
' . . 
until the tracer dye· reached approximately 0~5 em from the bottom of the gel, 
around 5 to 6 ·hours at 4°C. To d~termine the molecular. weight ot the r~~lved 
- . • . . ' . 'II' 
'proteins. the follC)~ing ·standards were included: myosin· (Mr=205,0oo}(Sigma·.' .. :· 
.-. '•' I . , • , . - , 
Chem. Co.Y, ferritin. monomer (Mr.~220,000), phosphorylase-B. (Mr::::Q4,00Q)', . ·' . 
bovine sertl~ albumin (Mr-:-67,000), carboni~ · anny~ras~ _(Mr=30,Q()()), so~ bean · · . · . ~ 
. . .. 
;' 
q • • 
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trypsin inhibitor (Mr= 20,000) and a- lactalbumin (Mr=14,000) (Pharmacia Fine 
I • 
Chemicals, Piscataway, New Jer(ey). . · · . 
2.18. ELECTROPHORETIC TRANSFER OF PROTEINS 
FROM SDS-PAGE ON TO NITROCELLULOSE PAPER 
' ' (PROTEIN BLOTS) 
The· protein bl~tting procedure was slightly modified from that prcvi'lsty 
descf.bed (Tow bin, Staehalin and G'ordon, 197Qi Burnette, 1981). A •sa!Mwich • 
- was prepared using the following successive layers: the lower side or a transfer 
plastic cassette (Hoefer Scieltificf, an electrotransfer porous polyethylene sheet, 3 
mm thick (Hoefer Scientific), one sheet of blotting filter paper (BioRad Lab), a 13 
X 14 em sheet or BA-85 0.45 pm nitrocellulose paper (Schleicher and Schuell, 
' 








.. ' ·1 
' ' 
side of the transfer casette was· r~placed ~nd secured. This .. procedure was carried 
. - ' . . 
out with the layer,s submer-ged in a buf(er .containing 20 mM Tris base, 150 mM 
- I 
glycine and 20% v /v methanol (transfer buffer) at room temperature . 
. ·. 
The . •sandwich • . was then placed m the chamber of · a TE 42 .Transfor 
. electrophoretic qnit ·(Hoefer. Scientific In~tr\ul!.ents) previously filled wi·~~ ·irB;nsfer . 
buffer, .. to ·r~n at 400 inA for a period oC 14 hours at 4°0; Tran~rer of polypeptide , 
bands ~as .more .;han 80% erricle~t as measu~ed by com~aring the.intensi'ty of the 
~ ... 
staining or the protein bands in ,the poly!J.cry)amide gels prior to transfer ,and post 
transfer witli ~e use of a densitometer. 
. . 
2.l7. IN.TERAQTION OF TSH, H~N AND RABBIT 
IMMUNOGLOBtlLINS WITH THYROID PLASMA, 
i . • 
·MEMBRANE PROTEIN BLOTS 
..; .... ~ ''· · ... .. ~ - . . · . . . . . .. . ~ . 
To test TSij b~ding, thyroid pl~ma membrane protein bl<?ts were prepa)'ed as 
. de5·cribed pre~iously (2.16). The paper . wa.S fi~t .. 'fa.Shed twice ~ith burr~r: 
~<:>ntaining 20 mM tris H!Jl; pH 7:4, at . room·. temperatu.re. Blocking ,of unreacte_d 
I 
' • 
' · • ' f ' • ~~ ~i~:~ ·--~~·~-.:; _ . l .~:- · :~~~:~:~~~ ;~ : .. : ·~~ ... ~.~ ,.: . .-:i ~.::::.< .. ::. -•. :· .. _.;:, ;: ; ... ····:·< .·.: :.' .:··.··.·,· ... _ .. : ..... -~' · ,, ··: .. .- .: .. _' :.:... -:. ::-·-.· .... · · ' ' · ', 
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sites was carrie~ out with 3 %_ bovine ~serum albu~in (BSA) in 20 ~ Tris HCI, 
pH 7.4 (BSA-blocking). Blocked papers were incubated with b'i'SH '(USV• \ 
. . . 
labo~atori~s) at a concentrati~~ of 1 U/ml diluted in B~A·blocking .for 4 hours at 
4°C in a total volume or 5 ml. ~the end or this incubation, ~apers were briefly 
washed and anti-h'l;'SH antibody 'raised in rabbit)(Bio-RIA Laboratories} at -a 
dilution o( 1:30,000 in a final volume or·s ml was ad~ed and maintained for 14 
hours at 4°C. X9nreacted. antibody was then removed by washing with several 
changes of 40mM Tris HCI, 200mM .NaCl, pH 7.4 (TBS). A second blocking 
I 
procedJre was carried out using 10 % horse serum, 3 % BSA in 5 mJ 7of TBS 
(Blocking reagent). Peroxiilase conjuga._ted anti-rabbit lgG (Kirkegaard and Perry 
Laboratories Inc., Gaithersburg, ~~la~d) at a dilution or 1:500 in 5 mJ of 
blocking. reagent was added· and niamtained for 4 hours at room temperature. 
. . • I . 
Alter this period unbound 'eroxi_dase labeled antibody was removed by repeatedly 
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; • 
naphthol ·(Aldrich Chemical Co., Milwaukee, \Vi~) and 0.33% hydrogen peroxide 
(BDH chemicabj in. ·s ml. or TBS. This s~lution was applied and mai~~ained for 15 
m 'nutes at tbom temperature. 
. -\. : 
I ,' 
To t~st antibody bi~ding to pr~teip _ blot~, papers ·:w.er.e bri~fly1washed ~ith T~s· . 
Un ~acted sites ~ere blocked . using bloe~ing reag~nt. Test · immunoglobulins; 
... , - ~ \ . 
human from patients with Hashimoto's thyroiditis or Gra~es' d~ease or 
rabbi (anti·idiotypi~ antfbodies), and c.ontr~l i~~~~globulins (nor_~ai human 'or 
. . . . .. 
·rabbi } were diluted .to concentrations of 1 and 2 mg/llll 'in blocking reagent a.nd 
. ·. .. \ . ·. . . ' . . . -
incu a ted ·with blotted nitroceUulose papers for ·14 hours at , 4°C in a total volume 
of· ml. Apart from· the fact that peroxidase conjugated anti-immunoglobulins 
. . ·. ... . . ~ 
sed ~ere species-specific, all further steps . were as descr.ibed a hover. . 
' . . . . : ~ . . 
. ' . . " . . ·..l . 
Whe~ dispiacelnent or anti.body ·binding by. TSH was investigated, nitrocellulose. 
entioned above and" after 
briefiy washiDf, · test · immunoglobulins (Hashimoto~s, Graves·,: or an_ti-idiotypic . · ~ · . 
. . . . .. . . :. ' . . ,/ . 
paper . bands·. were reacted in . pre9ence of. bTSH ·as 
. ~ ' . ' . 
. . 
pr~viously_ described . . AJr · im~unoglobulinsfwere incubated for 14 hours .. at.' 4°~ · 
. · ·: . ·_- ~ther steps_ were id~~tic.al ·~ t~ose descr.ibed a:bove. 
. / · . 
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2.18. BIOSYNTHETIC LABELING._OF DISPERSED 
THYROCYTES 
,. . 
Thyrocytes, prepared as pteviously described (2.6), were adjusted to a 
' . 
concentration of 2X'l06 /ml in MEM/FCS (all viable cells) and delivered into 6 
well tissue culture dishes (Costar Laboratories) in a volume of & ml per well, and 
c:ultured for 24 hours in a humidified atmosphere or gs % air and 5 % co, at 
. . ' - . 
37°C (conditions that were 'maintained throughout) to allow recovery. from 
dispersion proc~dures. "To study the rate of synthesis of the T$H receptor and the 
. . 
influe~ce qf TSH_ upon it, ~T,SH was added to the culture medium or ~test• wells 
at different c~ncentrations (50-500 mU/ml) .Cor 12 hours. Control wells ·received no · 
• 
· TSH. To study the bioiynthetic labeling, culture medium was first removed from 
stimulated and control cells avoiding disturbance of the cell monolayer. The 
, monoJayer was then . carefully· washed with leucine· free medium (~low . · 
. Laboratories.), cont~ing 5 % FCS! 0.2 % sdtiium bicar~onate and 1 % 
. . . 
' 
antibiotic/ antimycotic/ kanamycin (Gibco) (labeling medium). Subsequently ·40 
· pCi of 3H .leucine (NE~) in 2 mls ·or labeling medium were deliver.ed per weli ~nd 
. . . . . .. . 
mainiain~d tor periods ra~ging from .15 . minutes to 8 ·bou_r~. Aft~r ·J_abeiing ~ells 
were. chilled .at 4°C, carefully scraped off with a rubber policeman and -washed 
I ' , , • 
:~itli cold HBSS for tqree times. ~y resuspendin-g "and pelleting. Four samp-les or 
c~ns were ~nalyzed _r<>r each l>eric;>d or time an'd ror each one or the· different 
conditions investigated. The final cell pellets were stored frozen at ·70°C until 
analyzed. 1 
.; 
To inv.estigate the turnover rate of the receptor; four groups,pf.tbyrocytes were 
\ " . . ' 
cultured under .siinilar ~onditions ~ · th.ose described above. ·Groups 1 and 2 
received TSH enriched medium (100 mU/ml) for 12 ·hours prior tO labeliilg, the · 
other t~o . wer~ incubated In control medium. Biosynthetic l11beling was carried 
out ' as b~fore,·_ with _ ~0 -~ci or. 3H - leucine :in labeling _medium lor a peri~d ol 3 
hours, recognized from previous experiments. to be .. the . optimal labeling time~ 
. : Gro~ps _'2 ':hd 3 ~er~ l~beled in the 'presene_e or b_:sH (ioo mU/ml); wb~le ~~up-. 
1 a~d 4 were labe~d i~ the ab.sence or TSI~:~rt~r _3 hou~s tb~ r~~~ac~_ive medi_um 
- ' 
. . . ' ::, 
,. . . 
. .. 











was removed. The monolayers were carefully washed with. 5 mls of MEM/FCS at 
r~m-· te~perature. Five .n:tl ·of l(!uci~e · c~ntainin.g ME~/FCS· 'warmed at ~~°C 
were then. dispensed per well to start the cold ch~e which ·was continued for · . 
. ' . 
different peri~~s of time (from 15 min\tes ·to Q6 hours). Group 4 received TSH 
(100 mU/ml) during ·the cold chase while the other groups: were chased·ip absence 
of TSH~ At the enil of .the cold chase· periods the cells were cbilJed to 4°C, 
scraped, wasped three times with chilled HBSS by resuspending and pelleting and 
the final pellet was stored frozen at - 7o °C until anaiy·zed. 
_ 2.1V. ~ENTIFICATION OF RADIOLABELED RECEPTJR 
BANDS ~· · . 
• Pell~ts of previously biosynthetically labele<l thyrocytes {2.1~) wete lysed with 
• 4 - t 
· ~00 Ill oC 1.5 % SDS in 62.5 .ffiM Tris HCI, pH 6.8 and ·to % ·glyceroL Samples 
\- were vigo~ou~ly 4vortexed and placed·· in bpiling water for & minuteS' fc;>llowed by · 
cen~r.ifuga.tion .at 32,000 ·X g for 10 minutes at room temperatu,re to remove any . 
non• dissolved .material. ·Protein co~ tent was. determined "Using a ~i~hioro ·~cetic . 
acid (TCA) . precipitation method, wit~ which SDS ii known not to interfere 
· (Schaffn~r ~nd ... Weissm~1973). :pne h~n.dred pl of the ·cell ly~a.t~~ ~onta.ining. 
approximately 200 pg piJofein, were resolved on 5-15 %slab linear gradient gel, ·. 
·using th~ disc~ntinuous b~ffer system ·~t Laemmli pretously · . d~~ribed (2.15). · . . 
~ . . . . . ' .. . . ' . 
Protein~ on SDS-P AGE were electrotransferred . ont? ni~rocell~lo.se paper as 
described above (2.16). t 
' ' 
Using the enzyme-linked imm_!lno-binding assay .described before, protein blots 
were incubated w'ith anti-idiotypic antibo.d' .s known to be capabl~ or rec<;>gniziiig 
.. . . . . . : ~ . . 
;; · the· T~H hol~receptor prote' ba as w ·as several breakdown products.· rhe· 
>: · ·.· ·polypeptide ban~corres ndin~ to .the TSH h~lor~c1eptor and ot)er unrelat~d 
;{· · bands were carefully. cut Nitroce lulo pie·ces w·ere pla~ed . iil · scintillation vials 
' t 
• • 
·~':.~ ..... ·· and 1 .ml or scintillation .gr e 2· ethox.rethanJI .(T.i Bak~r Chemica! co¥ . ~;:: .·; .. . , . \ . ,·added: Wh~n · the -pap~rs wer~ dissolved, .. 1_0 ref of··· ScbitiVerse ~niversal . · ~ ___ __ .





~ ; . • \ ' • • • . .. • : I • • ~\-:' :\ the r~dioi.ctive l:ontent 11f the samples dete~mined. ,. . • ' · , 
~·:·:,: . . ' . · ~' 
,. ., • '\ •• !· · .. 
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· . . · \· 
. . , 
., 
• ' . 
2.20. DETERMINATION OF T~E 3H-LEUCINE PO.OL IN 
. BIOSYNTHETICALLY LABELED THYROCYTES ·· ·· 
; . .. . 
' Dispersed thyroid cells at a concentration of 2 x 1~6 /ml were aUowed to plate 
in 6 we11 'tissue culture d~h·~ (Costar Labs.~ for _24 hours in a volu~e or 5 mls/ 
well in MEM/FCS. Subsequently they were incubated for 12 hours ~n ~~ther ·bTSH 
• • • / r • • 
(100 mU/ml) containing medium (group 1), or in control m~dium (groups 2 and 
3).'At the end of this period medium was removed from all three groups and ·the 
' ' 
cell monolayers were carefully washed with labeling medium. · Subsequently .the 
cells ~ere incubated with 40 ~-tCi or 3H leucine in :2 mls· or labeling medium per 
well for a period of 3 .hours. Groups 1 and 2 were labeled in the presenc~ ot .bTS~ 
. (100 mU/ml). and group. 3 was labeled in control medium. Four r.eplicates were 
studied in each group. 
·' 
Wlien labelli~g was over, celi; were chilled at 4°C, carefully scraped from "the' • · 
o dishes and was~ed 'with 5 mis. ~f chilled phosphate buffered saline (PBS)(Gibco)-. / 
' ' .. / ' ., . . 
three times by resuspending and pelleting. The _final pellet was resuspended in 0. f . 
. ' - ' . , • ' ' 
ml .of PBS and .0.4 ml or '1 N NaOH . was added, the samples were mixed -by 
..... . . .- ' 
vortexing and.· then ·heated · at .56°C for. 10 minutes. Subs,equ.ently 0.1 mi ·or a ·: 
_solution containing 2.5 m~/ml of bovine serum ~lb_umin (BSA) in :water and. 2 mls .. 
' ' . 
of 10 % TCA ·"{ere added .to each sample, the ~~lutions mixed _by ~ortexing and 
incubat~~L(9f IS minutes ~t 4°C. When incubatio~ was over the. sampl~ were-
' . ' 
centrifu~~d at 2000 xtl for ~0 minutes ~t room temperature and the su~ernatants, 
containing the free ~mu1o a,cids,,sliYed. The pH of. the supernatant~ 'was adjuste~ 
to _2_.2_ ~sl~g 3 N LiOH. One ml or each or the samples ~~ dispensed into a 5 'ml 
. . . ,. . . 




~t~bilize tb·~ -pH. The leucine ~ontent·w"as determined using. ~ Beckman l21 Ami.no ... .. 
. ' 
-acid analyzer (Beckman Co.). '. Th~ C?l~~D e'ua~e w_as ·c~llect~d .e~!.ry 2 minutes -· '' 
· (2.5 ml fractions) and l~ter ·c~unt~d u; ·determine the, radioactivity or the. leucine 
p~ak. The radioactive _leucine· contents or the . 3 p-oups. or c.el~ inves'tigated ·were. 
: ' :~1 
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~aleulated and comp~r~d .. The analysis ·was kindly . perf9r~ed : by Mr. D. H~ll of· . . . ._ 
' "' • I • ' • • ' ' 
_ . the Bio~hemistry Department at Memorial University or Newfoundland. · .. ·· · ',; 
;.: . . .· . . /. . . . ' . ' . . (( 
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'· • : . ~ ·· . 
rrotein blots -were prepared by •first resolying 15 pg ot -commerciaiJy a.~.ailable 
porcine thyroglobulin (Sigma. Chemical Co.) by polyacrylami~e gel electrophoresis 
under non:red~~~d conditions as previo·usly described .(2.15). The .protein bands 
were later transferred on to nitrocellulose paper under similar conditions as those 
used to prepare prot_ein blots of thyroid plasma membranes (2.16). 
, 
2.22. ANALYSIS OF THE DATA 
. . 
Wb~re statistical comparisons were ma~e, the nonparametric Mann-Whitney -r1 . 
""' > ... ~ , I o 
test was applied (Sie-gel, 1Q56). The p value was considered significant at vajues 
. ~ 
equal to ·or .less than 0.05. Binding affinities were detemined by Scatchard 
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Chapter 3. ( : .. ·· 
RESULTS AND 'DISCUSSION 
. . 
3.1. ANTI-TSH ANTI-IDIOTYPIC ANTmODms 
\ ~ 
' . 3.1.1. Displacement of binding of 1251-bTSH ·to thyroid plasma 
...... 
membranes by ~~tl-TSH antl-ldlotyplc antibodies 
• . , I 
Anti-TSH anti•ids raised·· as pre~iou~ des~r~_bed (2.1) ~er·e te~ted for their 
capacity to inhibi~ 1251-bTSH fr~m bindi~g to thyroi~ plasma membranes.· · The~e 
tests'_were used as an initial screen to detect .any ~ompetitive activity that -these " .• . ·.·: 
1 
an tib.6d.ies may h~ve with TSH at the T$H· ~eceptor· level. . · .: .· ·. 
: ' 1 . 
PrOiimi~ary experi~~nts studied the interaction of ditre~~nt ..,onc~ntrations of .· f7 \:;,'; ~he· porcine -thyroid plasma membrane (50-1000 pgfml) with increasing 1amo1lnls ~ .. :', 
. radiolabeled TSH {50,000- 5'000,000 cpm/ml). At 500 pg/ml with _the addition or · ·.··:. 




·.• . ._ 
. ~ . 
;. 
·. :·: . . . . 
);.' .· ·. ~ 
·. · . 
~ ' • D • 
100,000. cpmjml. approximately 11% of the radioactivity was bound ... A dose· ·. 
. . .· " . . ' . . .. 
response in~reasipg .in .the a~poun~ bound was obtained up to' ·250,000 cpm wi~h'·a 
maximal -binding or ·approximately · 14%. Higher · cpms· pnly increased the· 
. . ,· . . . . . ...,. 
background ·counts. Hig~er a~ounts or membran~ prpduced a r~lative incre~e in 
th~ ~ti~be\ ~r · c~unts i. bouiid_ ·.bu·t · .~he _o~er~ll per~_en_;a~e of. bin~Ji~g did not 
\ increase (Bako ·et al. personal communication). · · · ·. 
. , . 
-
·Sera from 2 out or 3 ~aJ;>bits. i~munized_ with anti-:TSH antibodie$ (ld·lgG) w_ere 
· · found to be able to .inhibit ~~61-bTSH · from binding''{()6oth porcine and human ·•;. 
~thyrQid':plasma ~e~b-ran'es ~nder si~ilar' experimental co~'ditions. (2.12}_: p~~cin~ 
thyroid membrane bound 11~ or the 12~-bTSH added, w~ile buman._memb~~ne · .. 
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. ,. 
' 
bound · _~4% ~r · the l~~bTSH. · a<Jde~ .. TSH-anti·id· _ca~sed ~ ·d~e de~enda.nt · 
inhibition ~r this bin-ding. At a· ~ose of 200 JJg/rnl, 38% .or the r~dioactivity bound 
tO human . thyroid pl_as~a membranes was displaced, 52% of the . r~ioactivity 
b~und 'to porcine ~embranes was ·displaced, NRig at the same dose o~ly ·displaced 
... 0 • • • • 
17% ~of the r~dioactivity bou~d to porcine thyroid membranes. It·. was therefore ~ 
obs·erved, that: there w~ adequate dose dependent inhibition of- l2~·bTSH .. binding 
· by. TSH-anti~d i~ both porcine and· human·_ thy·roid plasma membranes. ··Being as 
porcine membranes were more readily available this system was utilized ror 
further experiment,. (Fig 3.1 ). 
----
Scatchard analysis or the8e interactions yiel. ·a curvilinear plot (Islam .et al., 
• t • • ... • • .. • 
IQ83_ b). This _appears to suggest either that there is more .than one binding site 
· ; 
Sj' 
' ,_ ' ' • ' I ., ' f • 
occupied by the •Internal ~Image• ·antibodies or that th_ere are _nntibo~ies ·t~ 
:- . bjnd t? \~~receptor .:with diffe_rent degrees ~r affinity.Jt is ~i~oimportant tO point _··. : ·.-
out· that tbeJ amount or antibody preparation . ·req~ired to· produce up to 52%. 
. -.. . . . 
displacerJ?~Dt. or the radioa{-Jive. label . bound ~,the porcin'e ~byro~d plasp1a _:: 
. - . . · . .. • ·. • • , ' .i : 
nierilb.rane ~s ra~her -~arge~ _This is most likely -indicatiye ·or ~he ·small num,~er- of .. , 
molec~le~ · that truly -repres~nt . the •hi~e~nal . Image• type antibodi~ with the 
capability of··~i~ding ~-t~e receptor :and displacing -its nS:tur~i ·ligand. :As the ·~ 
.• . an~ibody preparationt w.ere p91yclonal in origin, it' was expected that 'there should . . 
.· . 
. - J . ' 
: . 
be an'tibod~ ~olec~ies directed· to' other ~ntigeni~_ epitopes on the TSH ~olecule 
~rr,;~e~t fr~ny th~ bin~ing site ~pecific for- rsH.- .-Other _·~xperi~ental_~st~~ies u~ing_ 
. antl-1d1oty~rl ant1bod1es have · also en~~':ln~ere~ _that ~nlr a ~all ·percentage or ~ ·r:. . . . /-. 
antibody molecules in. th~. preparation .-were found to be, •internal · image• .-... •._,:-· ··: .··-.·.;-· 
• . . t ' . ,. . . . ' . .... ~\.: • ... 
·.an ibodies_ (Strosbei'g, Cour:aud and Sehreib~i',· 1081): .. 
~~ : . . . . .~ . . ~ : . ·- : 
' . ·' ~ 
~ . . ' 
. . . 
~; . . .l he Kn or the high a!lini'ty site to w'lli~h rsH:~li:id binds Wa:s _ ... ~gne~f 8 value. • ' 
~::. ·. : _ ·. ... ' fr 7.0 X 10~~.- .This .yahie is . similar to '_that or 1251-bTSH (i.a X _lo·1<M) . :·~ ·:·;_-·;. 
[~\: _. _· ('{ sug~~tin~ t~at th~ fract~on ~~r immunoglobulin .bound to the ~emb~~ne is ljkely <:-· 
(t):,:·:· .. . \: · '-.... attaeh~d to t~e T$H-R. .. . . .·. , ·, . . . ..; 
u:· ·, . . · · ·, ! 
!:t~· ._ \ ' • -, ': -.-' ;![ ;t'; ( , 1 ' ' • • . • -~: ~j . • . '\· . " .,.. ,· .. . ' ~-... . : . . ·. .. . . .• · .. ;-_ ~~~~'; 
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~>:: i~: · -1-bTSH ootint8.'oound to thyroid membrane at. a given dose of TSH-anti-Jd, . :·;i:rl 
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The 2 ~efa ca~sing . inhibition ~~ 12!1-bTSH binding io thyroid plasma 
· membran\ wOre 'P?"led and used for further experiments . .. . . 
8.1.2. Inter_aetlona between ldlotyplc and an*l-ldlotyplc antibodies 
I • • 
Next; it w imperative to establish the antigen specificity of the competition ~I . t ' ' between the rst antibody an a~ti-TSH (Id_-IgG) with the second antibody an_ anti-
anti-TSH (TSH-anti-id). 
The interaction ·or Id-lgG with radiolabeled TSH-anti-id was investigated. 
--- --~ 
Approximately 30-35 pg or ld-IgG were able to precipitate more than QO% (Mean: 
' . ' 
Q4%, SD 2.1) or the ra"diolabeled a.nti-id_ (,000 CPM ........ s pg). Subsequently_ the 
· ''., influence or TSH-anti-id on the interactF ~r Id-lgG with TSH were tested, 1~-
. .: \. · · IgG at a dose' of ~o 11g bou~d 5~6.5% of the 1251-bTSH. ( 10,000 CPin) added to the 
systkm. It -was rather ~urpri.sing ·that' up .to 30 pg, of ;ld-I~G were required ·to 
. prec.ipita~e approxi~ately 50-6 .. 5% or t~e i 25I-bi'slf, T~e preliminary elperiments . 
had demonstrated that 5 pg pr~cipitated approximately 17%, 10 pg ~23%, 20 IJg 
. . . .... , . . 
. ap~roximately - 36% whiie 4o pg only~ p~ecipitated 71% - -~f the tadiolabeled TSH 
. (lsi~, M.N,, pers~nal . eommunie~ •. Li~~arit:Y in the dose response _e~rve was 
. observed. up to 30 pg. Several .exvifn~tlons can be thought or for requumg these 
. I . . , . , · . : 
. big~ doses of antibodies.' It could represent. incomplete precipitation of · antib9dy 
complexes . ~ith the method . used, low affinity. of the Id-IgG for TSH or low 
numbers of actual a':lti-TSH molecules in ·the _preparations used. As these -
e~periments . were .more designed to observe the behavi9r of . these different 
, preparations in ~ompetitive -~rotein binding .assays that t~ ·establish·. a. mol" _to mol 
interaction. ·or the antibodies . this in~t-ter. was . not pursued' furiher. For: further · . 
~~mments· .30 . p.g or ·Id-lgG. :\Ye~e . used, this·. _a~o_unt ·precipit~ted 50% ~(the • 
. . . . .· . . . . . 
. radiolabeied ma.teri.al, range that is acceptable to compare displacement curves in 
' ~ , 0 ,< 0 ' ' ' ' r f • , 0 • ' , " , ' • • ' ., 
. co.inpetiiiv·e protein binding' &$Says (Work . and Work, 1978). . ·. · 
... . . ~ . ' . . . . 
· Varying amounts· of TSH-anti~id .. inhibited_ th~ binding 'in a dose dependant . 
4 • • • - • • ' ' 
. . .- . . . . ' " . I . , , . 
· . ma.nmi~ . . A.t ~0. ·,¢ 23% (SD 1.5) .o.r the r~~iolabeled TSH boun,g_ to. Id-IgG was 
. . . ' . . . . ~ ' ' : .. ,. . . 
: .· . .. 
.. 








. , . J; ' 
. . 
.tf.t ' . . } . . J ·l~r."' t ·. . ~ · . 65 . ' . . . . . <,1{! 
~.:· . ---:displaced. At a dose of 2l! ,g· 55% (SD 2.8), at SO. pg 75% (SD· a~s) an.d at 100 pg · · .. : \\ 
::::~ .· . 88% (SD 4.1) of the. bou~.d radiolabeled TSH h~, displaced by TSH-anil-ld. . .:_:;~ 
·.. On the . cdntrary NR-Ig at similar_ doses ·displaced a. maxi~un of 10% of the . . , .: 
·- ' 
· . . 
-. ' 
' . ,, 
l-
' .. 
·' .. . 
, ' 
radioactivity bound. , ) 
, 
-To exclude the possibility that some bf .the effects pr<?duced by TSH anti-id on . 
the binding· of' ~ 251-bTSH to Id-lgG were due to its capacity to bind TSH (ariti- • 
TSH antibody 1nstea.d of anti-idiotypic antibody), th~ binding of TSH·anti-id to 
• · radiolabeled'irSH was studied. TSH-anti-id was u_nable to bind 1251-bTSH or 
,. 
. . 
1251-hTSH to any 'lignificant degree over a wide range of. concentrations. Up to 
1000 ~g/mi or TSH anti-id were tested. This concentration resulted - in . the 
. precipitation or only 11% (SD 3) of the 1251-bTSH (20,900 CfM .......,o:s pM) .add~d. 
Blank tubes in which radiolabeled hormone and buffer alone were .added counted 
' . ' -- -- --
. ~% (SO 4) or the. radioactivity added, representin-g the _background counts. NR·lg · 
preCipitated similar percentage of counts as TSH-anti-id .. 
. . . ' 
. . 
. 
These experim~nt~ demonstrate that TSH~anti-id and Id-lgG · JiL~a to form 
. co~plexes that are precipi.tat~d by P~G. TSH-an ti-id is capabl~ or inh)bit _ing_ the 
. . ' . . ' . . ~-" 
. binding . of· radio labeled TSH to the ld-lgG but the binding or this antiboay, to 
~ 
radiolabeled TSH is mini~al a'nd not more _significan~ than that qbtained with 
. . . 
NR-Ig or -simple baekgroun.d countt, Fro111 t~ese results one· can conclude that the 
. . 
effects. of TSH-anti-id qn 'the oiridi~g of radiolabeled TSH. to the ld-lgG are most 
likely due to the presence of anti-.TSH aclivity but to the presence of true 
• internal .imag~ • , anti-idiotypic antibodie~. 
3.1.3. Binding of T~-J!Ultl-id to' thyroid plasma ~e~branes 
. . . . / ' 
. . . ' . .. . ' . .. 
The direct bindi~g or ra~iolal:)eled TSH~anti·id (20,000 ·cpm ""5- "g) with 100 ,g 
. ' ' . ' . .. "" . ' . . 
.. or crude thyroid plasma ·membranes was studie_d as · described -~ above '(2.11) . 
. ' ' . . ' . ' ' . 
'Preliminary ~_xpefim·ents tes~ed the binding· of iricre~ing arnou~is of radiola~elled 
TSH-anti-id wid~ 100 ~g. of thyroid plas~a· me~bra~, ·a~ounts of 30,~ cpm or 
' . . . .. 
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not increase past 50% (Bako, G., personal communication). An averige or 4% 
(SD 0.7)of the radioactive 1261-TSH-anti· id added; w~ found bound to the crude 
thyroid membrane preparation. This low binding w~not surprising considering 
that" only a small percentage of the· antibody prep(uation used likely ·represented 
. •.internal image• aoti·idiotypic antibodies capable of re~ognizing the TSH 
\ 
receptor in the memjrane preparatio~. Unlabeled bTSH in do'ses of 40...200 mU /ml 
were added to th'i·system described abo,e. The hormone caused a ~OS~ dependent 
inhibition or this bi~ding. At 160 mU/ml64% (Sri 5.3) or the radioactiv'e TSH-
anti-id was displaced. 
~ ~ . ' . 
.Unlabelled TSH anti-id -in doses of 50-200 ·1Jg/ml and NR-Ig in similar. doses were 
. ' 
used to investigate sa:turability of binding. Up t070% (Mean: 65.8, SO 3.2) of the, 
. . . 
. 
1251-TSH·anti-id · b~u~d to•thy~~id plasma membr~nes w~ displaced by u·nlabeled 
TSH-~nti·id at ~'dos~· or 2QO pgfrril.. ·B; contr~~ o~ly ts%· (SD 2) .of.' the .counts 
• • #' ' · ~e~e· displaced . wb~n 200 .pgfrnl .or imla~e~ed NR·Ig- were ·added to·the system. Q 
'The .d·iCC~~e~c~ ·betwe~n t~ese .two. ~~tu·~~ w~ : ste.tis~ic~lly. s~ific~n~ (p<. ·0.05)~. 
:rhese results . ~uggest ·.specificity and s_aturabiiity ·or ~he bin!\ng of. TSH-anti-id to 
thyroid plasma membranl. . . 
3.1 ••• Eft'ects ot T~H antl.:ld on adenylate cyclase activation 
t 
Th.e next gr~up ·of experiments WS$. designed to estabiish the biological errects of 
. . . 
these -antibodies art~r their interaction ~itb the. TSH recept~r· (TSH-R). It is w~il 
. . . 
·d·o~ume~ted tb~t: TSH media.tes many of its. a~tions through the activation of AC 
' . ~ . ·. . - . . 
with the subsequent genera~ion of cAMP fr~m ATP ( · Zor et al, HJ69; Saltiel et al, 
: • 'I . . . • , . 
~981). 
•' ~. . . ,..., 
:~~-:.. . ;' . . . .. . . -
.. _.· The effect or. TSH-antHd <?D AC activatio.n was measured a.nd compared.· to tha.t · 
~ •' . . . 
. .. 
. .. 
. .. · 
' . - .. 
. ' 
-
. - . 
.. . 
~ ;~~.~ ' I • ' • f' • • • ' ' ' 
~;-:. · · · · · of .TSJJ.: The _liniJt~d capacity or bTSH ~Q s~untill\.t_g AC on ~he por~ine 'thyroid. · · 
;:.: ... :: .,. pl~ma ~~mbr~ne has. been p~e~iobsl~ d~~.c~(V~r~i~r, Plan.eils and.Lisstzky, .. 
t{.: . .'· .. : .- \. : 1077). I~·~as ro-~nd; how~ve~,- that in th~ ~~~~aJor GTP· ~r .its non hydrolyz~ble ... 
~f~ii~·.· . . .: \·: : · -. .' .~ii~o~e :,~·~o9i~e 5'(_~.-rl~d~). t~iph·osph~te . (Gpp[NH)p) the ac·~.i~~tio~ .or_ ~c·· · · · · · · -~ 
~:·f -.. · ··was·. quit~· signific~t . (s~ltiei. et ~~~~ los!); . : .. · · · · . · ... ,. . : . · ·~ 
~"""-,"\ · .. · : • , , ~ a · : ·, •l .. , ' l .. . : , • , • • • • . . ". 
~~~\~:~,~1;;:~:~~:\{~~i· /':~;·. ~ ~ .. L . f.· .. ,:,,· ·:· .. • .·.:.; .......... : ..• :  .: : .~, ~ ·~·• ,,~:~· · ~ · .·: · ·.•·~ .: :-·:-, .. •• ...• ,: .. ·• :... ;. .i~ . . . • . ~:~ .. :;:,1; 
• ~'ti, :- -~O.:kt.;,~~ .~:J.l~r·.' ~c.'!i.t trl~,;~·L . ... ~1r ,.~ ... i:.~~;·:: :-~- ~A~Ln.·~~: . ..,: -·~ ~r;c\. ::" ~~~~~~..;··.::,.":.;;.~ ~1~!\ ·f')o.f_!:t .. t.'~ -~;,.h!~ ~r..~~ _J\ ~1,-;:\;,;~\·.- ,:..._ .~·:t~~~~1'~: t.j......t: ... tA:' · t :~:ttt ·i · · • ;; ... ~·.t.~.i-..:.~~~~1 
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" The activity ~f bTSH ·on the stimulation of AC WQ.S~ ~easured in the pr.esence of 
. ' I 
GTP and Gpp[NH)p at 37°C.' The ·~ddition or 10 .pM GTP or 10 11M Gpp(NH]p .. to 
the cAMP generation ~;_stem (2.6) produ~e<l . a .0% stimulation from: th~ basal 
activity or the porcine thyroid plasma m~mbrane bound AC~ . The addition or· 25 
mU /rpl or. bTSH ~increased this·stimulation to 20~, .at SO mU /ml 40% and a.t 100, 
mU /ml the maximal stimulation was obtained witb 45% from the basal activity. 
For these experiments the basal activity•.varied between 134-185 pM. cAMP/mg 
. 
protein/minut~. Some or the variations in the. basal activities ·appeared to be 
. . * 
rela~d to·the use ~r different batches o~ porcine thyroid plasma membrane. The -
differer:i'results were always reproduceable within the same batcli~or membrane 
and tb~ l;en.ds l?stimulatio: o~ inhi,on were constant·on repeat~d,exp~:i:en~s. 
The,inCluence or TSH-ao·ti-id upon porcine . thyroid plasma .merrtbrane bound AC 
was.st~died at dirterent. te.~pe,ratu~e~ in the presen.ce or GVJ>{NHJp (2.5). At 30~00 . 
' ... ..1.- • 
TSH-anti-id (20<lpgjml) ca.usea'.a"tl% ~timulatio~ of the AC basal . a~tivity. 0~ the 
. . . . 
., . . . . 
'contrliry NR~~~ (200pg/m~) c~u~ed a .12% inhibition_· of th,e basal 'cti~ity. ~Y. 
comparison TSH (100 mU/ml) produced a. ,60% stimulation (p< 0.05) (Fig 3:2). 
. . ' . 
At 37°0, 200 ·pgfml of., TSH-_anti-icf produced a 2~% stimulation from the basal , 
activity (p< 0.05)._NR-Ig (200 ,gfml) ~auseda IO% ·inhibition. As mentioned 
' • . 'i- . . . 
above 100· mU /tnl of bTSH ,produted a maximal stimulation of 45% from ba.sa.l -
- . \ . . . . 
(p< 0.05}(Fig_ 312). 
Stu~lies .on AC activation. d~tnonstr,ate tb.a.t' TSH-anti-id like TSH is. capable of 
' . 
stimulating porcine m~mbrane boupd AC: !fhese findings suggest tbat .. this TSH-
. , .~ I . . ' • I 
;lnti-id ·not ,only re~ogn;izes and intera'cts with the TSH-R but also initiates •TSH-
• I . ' • 
like• ~lgnals, · indic.ating tha.t . t~e~e aptibo~ies_ ar_e agonist& a! ~he recep~_r level. 
~ • .... . "t,. , ., ... • • • ' 
ijecause of th~ rnod:¢8~ incteases')n AC generated tt . w~ considered necess~ry to 
' . . ' . . .. . •. study'1h~~ effect· 6r· TSH-an~i-id. on: two physiolo-gical rundions thought tO be. -
~ . . .. . 
• , I . . . • 
mediated by .. c,A.MP. The.!irst se~o! experillli!nts explored the effect 9! TSH-anti- · 
: .. ~: :.~ 
,• ~ . : 
.. .. ,: . 
. . . 
' 
. . ·: 
1\t. · ·' 
... 
' . ..
· -: .. 
. \ 
·. -.· .. 
. ' .: .. .-
I · . , '. · 
:..' · 
··-
' . •"':, 
' o f ' • I ~ • f • > ' 
.... : • , · ~d u~~~ io~ide u~,t~ke . by ~dispers~d thy~ocY,t~ ~n~ the seco~d tested tlie infi~enc~ . .. 'j 
::,:> . . ~ · ~r t~.S•. : anl.ibodies.,<?n the orgatiizatlon or Cul~ured thyroid epitbelial .eells iDto . . , ·.~.~i 
~;~. : ~· . . · · . · ' . follic~~ar 'str~c~reJ . . · \ . · . 1 } ~ : ., ... ~. i. ;• - . . ,..... . . - ' .. . .,, 
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·. ~ NR loG (200 ug/ml) 
• TSH- a·nti-ld {200 ~0 / ml) 
. " . 
.. 
H (IOOmU/ ml·) J 
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Effects ofTSJ( ~H-anti-id and NR-Ig on· ~e guanyl nucleotide dependent 
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3.1.6. EITecta or TSB-alitl-ld on the lodlde uptake by thyjoold epithelial . · 
. . f 
cells 
Iodide uptake by dispersed thyroeytes was studied at different time intervals. . '--· 
Thljocyt.es ~~re incubated wi\h. 131Na.I {lx 10.5 cpm/ml) i~ ~he presence of TSH-
, 
. . • 
anti-id, bTSH, ~~Ig and eontrol medium for 10 minut.es and 4·hours {2:7). ·When 
. incubated in· the. P.resence of·~ither TSH (S, 1~ or SO mU/ml) or TSH~.ant~·id {'125 
. or 2·so l'g/~1) Cor. 'to ~inutes the percentage or. 1311 tahn up ·by thyr.old cells_.wa5 · 
lower .than ihat obtained . in t~e presence ci NR-Ig or i'n . co~trol medium. 
. . I . . . 
·Incubation for 4 hours o~ t e other 'band stimulated the ·uptake of 131rin both . 
'tS~ apd TS~·anti-id i~~ub~ted. 'ce to'· a slgniricantly.· high~r degree. than tha~· 
caused by NR-Ig. . · · . · 
' . . ~ ' 
TSH in concentr::itions of 5, 10 and so mU/ml were used to investigate dose 
·erre~t o~ 131.1 llptak~ by thyrocytes. At 10 mU/ml 131I upta~e was ,increased ·rrom. 
. . ' . 
the control value of 4.2% to 7.1%. At 50 mU/ml the up~ake was of 6.8%. TSH-
lJ . . . . • • . • 0 
anti-id a.t a dose of 125 pg/ml produced an uptake or 6.5%, while at a 'dose· or 250 
pg/nil the uptake was ·5.3~. NR~Ig (125 pg/ml) produc-~d - a.n uptake ·o(3.9% and 
: . at 250 pg/ml 4.3%. Both or these I~ iter yalues ~ere within the levels or uptake 
• t 
round in cells incubated only in contrql medium ('fable 3.1)~. , 
'"" "' I I 
. . '> • , I 
I ~ . ' o O 
It is noticeable that a lower concentration . or TSH~anti~id ( 12,5 pg/ml) proquced 
. • . . .· • . ! . ' . .. "+> 
a· ~igher s~imulation ~n ' ~pta~e than ~ h~gher c~n~ent.ration ~250 ,Pg/~.~~-~er 
conce.otrat1ons, however,·were_ not t-ested. No obvaous explanatiOn for these-results 
l \ . -
.can be. orr ere~ r~o~ t~~ ex~~riment~~~for_m_e~. , .. 
The effect or· TSH on iodide uptake by th~ thyroid gland has Been sbpwn to be 
. ' . .. . 
·. ·• biph.asic, with ·an iiJiti~l increase jO. tb~ .e;rn~x rate .. ~qllo~ed b~ a~ ac_celeu.tion . in 
· the 1nfiux rate· (-Ha,ma; e~ al., 1060; W1lhams and·Malayan1 197~). LOw.er 1~1 Nal 
• · . . : • ' "' . \ • . . . • . . •'1 " 
. .. uptake at ·to min in cells ~tu<Jied in tbe presence ol TSH· and TSH·a·nti·id th~n in 
·. _, · ~ells ~iudied in the · ·prese~ce ol.fo~trol med~um appears to h(dicat~ · de~reaaed 
l~Dl;IX on the radioactive material intO the· ,first t~o "groups of .cells, .It couid. be · 
•' 
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Table 3-1: Effect of.TSH, TSH-antHd and ~-Ig on the radio-iodine uptak~ by por- . 







up _ e Stimulation 
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(mUtffil) \10' 7.05 0.03 - 168* ± I 
. l 
50 ., 6.75 ± 0.04 l6P 
NR-Ig 125 
' 
3.88 ± 0.03 92 
{ ugtml) .: 25~ \ to 4.28 ± ·0.02 102 
' ... 
TSH-anti-id 125 · 6.54 ± 0.03 156• 
. 
(ugtmlj .. 250 5.33 ± 0.03 . . 127 
•: p ~.05 ~~m basal: ~alues or co~pared to; those ohta.iried in presence.:vr 
! . . . . I 
NR·Ig._ (Marm Whitney U Test)_. 
· N ~ 6 (2 parallels_ per, e~riment) 
2.5· x lOl' cellsitube in l·ml 
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speculated that this is due to the effiux oltiodine occurring in the TSH ~nd TSH-
anti-id stimulated cells. Studies to ·determine the efilux or iodine lrom the cells, 
however, :were not perfor~ed. · · The results obtained ·hi these exper~ments-· 
therefore suggest that TSH~anti-id appears to induce similar changes · in iodioe- .. · 
. . . 
uptake khietics in the cultured ·thyrocyt'e sys~m studied as does TSH its.elf. . 
... 
... 
. 3.1.8~ EfTertts or TSB-antl-ld on the organliatlon of thyroid ·epithelial 
. - . . . . 
, ' 
·cells hi culture 
. . ; \ ' ' 
: The capacitJ, of cultured thY.roid.cells to organize into fo~licl;llar structurcs .·~hen. 
. , . 
in the presence of TSH has. been previously· d~monstrated by several workers 
. . .. . f . 
(K~rkoff · et al., 1Q64; Fa yet et aJ., 1Q70; Kondo' ei al, 1Q80). Th.is re~ponse . is 
. . .... . " fll 
· thought to be mediated by cAMP (Lissitzkr, Fayet, ·Giraud, Verrier and 
. . \ . 
Torresaqi, 1971; Bourke, .CarselditlEl, Ferris, Huxham and Manley, 1Q81) . 
~ 
Thyrocyte~ cultured ·eithe~ . in .~he presence of TSH-a*·id t~r TSH _(2.8) were · 
·capable .or organizing tnto follicles: By. contrast cells cultured in the presence of 
' . .~ . 
NR-Ig or · in conlrol mediull}-~lo.rm~d a uniform mo'n~layer in which . the _cells 
. . . ............  ~ . ·. . . . 
adopteJ' a' slightly elongated ··shape, s~rnewbJltr·similar toi that exhibited by. 
. ' . . '-.,.·v""!' . . 
fibroblasts. Folli~ular structures started to form at 3 or 4 days of culture .and were 
• • • • ~ t .. ' • 
quite weli orga.niz~d at day 7 in TSH sti~ulated cells. Thyrocytes cultured with ... · 
TSH-anti~id started to organize int~ folli~les between days 4 and 5. A~ day 7 the 
• I .. ' 
s~ructures were· clearly recognizable as follicles but they were. observed to be· 
.noticeably smaller than those obtained with TSH: Day 7 foHicles were comparable 
• to· those obtained at day . 5 .or 6 with TSH by simple~ observation, no specific 
I - - ""' me~ho~ for quantificat~on was utilized (Fig 3.3). · · { 
. .· . . . I 




·. The final set of ex.perime~ts done with ~8H-anti-id investigate! th~ .. interac~ion· 
ot these anUbod_ies with prot in blots of _puriried thyroid plasma membra~e (~.17) . . · 
·. . .. ± . . 
It lias been pre~ious~y d te; i~ed that the T . holoreceptOr is an Mr.-- 200,000 ·. 
glyeoprotei' heter;.,ompt ( I~ . •nd Farid ,. o8s; Bai<O et. al., 1086 ). . • . · , 
~ ' . . . 
'.··' . I 
. · .. / 
~ ' . ' . 















Figure 3-3: Effect of TSH, TSH-anti-id and NR-Ig upon the organization of thyrocytes 
after 7 days in culture 
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Bovine. TSH produc~d a positive reaction in. protein blots of .thyroid plasma 
- . . . 
. me~brane resolved under non-reducing conditions at the level of the Mr ...... 
1g1,000. When reducing conditio:S. ~;ere used this band .was lost and none of the· 
re_duc~d components appeared to .interact with TSH. This suggested. the n·eep for 
the integrity or· the Mr-- 1Q7,oob receptor band for TSH binding (Figure 3.4, lane 
. . . . . . . 
2). . . 
· t. . 
· Using · t~~ same detection method, it was observed that t·he TSH-8.nti-id 
produced a very strong positive reaction at the lev~i or th·e Mr-- 197,000 protein -
. - ' . . . ~ 
band (Fig 3.4, lane 3) .. ' Most of the reaction disappeared when tbe prot~in blots · 
were pi'eincubated with TSH (Fig 3.4, lane 4), whereas when the blots were 
preincubn.ted with ins~lin (Fig 3.4, Jane -5) or human chorionic . gonadotrophin 
(HCG)~~igure 3.4, lane S) i)le intensity or the· band was 11;0t reduced. \r.~ese 
firidi.ngs demonstrated ·t~e specificity of the Mr ....... 1Q7,000 tor TSH and TSH-an~i." 
id. /NR-Ig reacted with several lower Mr bands but ~·as n~~ative for the. 
Mf.......,tQ7,000 band· (Fig.a.4, lane 7). The ~indinf; to these bands was no~ displaced 
by any ~r the _above· men'tioned hormones. These results add more evidence to 
support t6e hypothesis that '.PSH-anti-id recognizes al}d i~teracts _with _the TSH-R. 
. .. ""'...,. 
3~1scusslon or th~ ex~!!rlmen~s l~vestlgatlng antl-TSH 
antl-ldlotyplc antibodies . '\ · · . -. 
. \....._.,; . . 
In these groups of experiments it w~ demonstrated that it i~ possible to produce 
anti-ldiatypic antibodies functionally similar to the hormone used in producing the 
first gnti.body. The TSH-anti-id described here represents a TSH. •internal image• 
I ' • • ' ' 
anU-idioiype. ~urthermore, it actS as an agonist at the TSH-R level and is capable 
0'1 mlmicking several 'or the TSH's physiological acti?DS. It is temptipg' to compare 
ihe . bioactivjty of . TSH-·antt-id·. to .. tb~t of ~be .spontaneously . occurring thyroid 
stimulating aniibody or Grav~s' J?is~ase (TSAb: used ~ere. as ·a generic te~m to 
encompass .antibo~ies detected by receptor modulation as_says as well as the cAM]> 
. ,._ . . . 
generation assays). So f~r, in ~11 the tests performed iJl ili.!Q with TSH-anti-_id the &r 
.. biologi~al actions a~t.rlbuted to the TSAb have he~n reproduced~ • · ·' 






















Figure 3-4: Interaction of TSH and TSH-anti-id with thyroid plasma membrane 
protein blots. 
1: Coomassie blue stained electrotransferred protein bands. 2: bTSH (1 U/ml). 
3: TSH-anti-id (1 mg/ml). 4: TSH-anti-id in TSH pretreated protein blots. 5: TSH-anti-
id in insulin pre-treated protein blots. 6: TSH-anti-id in HCG pretreated protein blots. 
7: NR-Ig (1 mg/ml). Positive bands at the Mr -- 197,000 are seen in lanes 2, 3, 5 and 6. 
1.'/'f-i>.~; .... · ... · .. : ' ·:· :. . • .. : · . .. 
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On the basis of these data we proposed a new hypothesis suggesting the anti· 
idi~typic origin of the TSAb, in at least some. patients t'ith Gr~ves' Disease (Isla~ 
. . • "'· . . I 
· ~t al., J.Q83h; Farid et al., }g83). Most of the evi<lence ·found in the literature 
. \ . 
"\ ,· . . . ' 
sugges\i.ng that . TSAbs are anti-receptor ~ntibodies or directed to · protein 
. moeieties\· close to ·it was· based on indirect \evid~nce (McKenzie ·a~d ZakariJa; 
~ • . . . . • . • . ' . . ,· "" i 
1978). TSH.:anti·i.d being a • mirror image'• ·of TSH would be expected to '\mediate 
. . . . . - -
·.all . of 'its •TSH-like~ actions ~nly · through binding to the receptor . . ·hlt~raction 
"'"' ... . 
' . . . ' . ' . 
· with other . membrane mo·eietie~ !lhould· not occur with. this type or antibodies. 
· Biological response would then be expected to be _highly. specific. \ . 
. . 
. . ;. On .. the contrary, if TSAb is raised · ~gainst the 'l_'SH·R it is Hkely "tbat other 
~e~bra~e compon_ents, close t~ ~nd ·in dependant of the · receptori would be 
expected to · be represented in the . immunological respo.nse. ·The an~ibodies 
. . 
interacting exclusively wit~ the . receptor will be responsible fo.r · the specific . I 
biologi~al respons~. Antibodies raised against other· membra.ne· componenja may 
. .. . . ,· . . , . . . ' . -
account for..: some unexpected experimental r~sults. obtained · ·when testing the. 
activity of i~~uooglobullns of patients with Graves' Dlse~e.lgGs derive.d fr~m- -. 
patients with Graves' Disease .can in some cases produce •TSH~like• activity in . 
. . .. 
assays d,epe~~erit on AC stimulation but not necessarily on .receptor · mo~ulation 
. · .assays or ~ice . vJrsa (Zakarija and McKeilzi~, 1080; J\.tkison, Me Gregor, K~ndal- · 
Taylor , .. Peterson :and ·Rees-Smith, 10a2). Antibodies toAxie.mbr~ne moeieties other 
. . . . . ~ . 
. than tb~ recepto'~ ar~, .however, ·not the only possible explanation for these 
apparJmtly connic'ti_ng results . . The sen,itivity nd spe~ifi~ity . of .. the d.irferen.t 
detection.: systems, ':interaction with oth~r eom onents in the ·sera, like normal 
. ·immun~globulins, and 'the varied uniiormity 0 . the- antibody preparations can all 
I . • . . 
eontribut~ to these sometimes conttadictory esults. It is worthwhile to comment 
ihat all thl expl~n~tions ·offer~d to date remain th~or~ticaJ.·. The fuli_ 
t ' ' '.. ' ' ·~l,..,. 0 ·, 1 or 1 • .. ., ' 1 \ ' 0 , 
understanding of the interaction ·of the differept antibddies ·~j~li the 'fSH-R is_.s.till 
• • .. ~ ' • ... f • • 
• . I • ;t r 
· . la'cktng. . · . .. · ~ . • : . : · 
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cautious in relating 'the pathogenesis of. Graves' Dise~e to the occurence ot anti-
~ # .. ' 
· TSH-anti-idiotypic,antibodies.: ~o further s~rengthen . this hypothesis,"'- it would be· 
important tO directly demonstrate. the natural occur(mce of anti·TSH ·antibodies 
(idiotypes), ·as well as of .anti-TSH·anti:. idiotypic antibodies (anti~idiotypes) ~n ,, 
patieriti/wiib Grav.es' Disease, ~ well as to establish the correlati~n b~t~een anti-
idiotypes and' ~he activity 6( the · du;eas~.- lg fra~tlons which bind -.~·31l:bTS~ with . 1/ 
• ' • I ,, ' , 1' • 
high affinity and: low capaCity wer~ desc·ribed in· 6oth healthy controls and in . .. 
. '• . . . . . ' ~ . 
patients with Graves? Disease (Biro, ·IQ8ll;tft could b~' argued · that th.ese · 
. .. . lr 
_ ~ntibodit;s . repr~sent . natural~y occ!Jring. anti~ TSH antibo~es. Also in oth~r study · 
.Igs tb.at bound· radiolabeled. TSll with high capacity· and lo rrinity were found 
. . 
. . . 
· in 38% of the patients-with Graves' Disease . te~ted . T~ese Igs als<;l inhibited the . 
.TSH driven AC activation hi'~ dose depenaellt maimer (Biro, Jg82). Oth_er groups 
have al.s~ desc~ibed ·the presence of a.utcran_tibo~i.es with high af(inity for_ TSH i(. 
. the sera or thyrotoxic patients (Beall ~nd Kruger, igsa; Akam~zu, Ishii, lshihaka; • 
• !~ekubo and Imura, /gs.4). T~e r~levance . of .. the pre~ence of anti~TSII ~u~ 
· .. ~nt~bodjes in _some pati~~ts with Graves' Diseas~ ~s stilf uncle.ar. .The. ·pres_ence :or. 
·. these TSH binding lgs could be .explained in several"wa s based on the principles 
. . . . I . , 
. of the •network theory• ~f · the immune system. Thus,1jS4h m~ · be an anti.;TSH 
. ' . . 
anti:-idiotypic antibody .. (llb 2); which developed against naturally · occuring anti- · 
. ~ ,. 
. . ,. ' . . . . 
. TSH antibodies (~b 1) found in the sera of these patients. Ab 1 .would bind TSH. 
It is possible that Ab 2. triggers the pro.duction of anti-anti-idiotypes (Ab a) so~e 
---- . ' . ~t which would be able.to bin~ TSH (Farid et al., 1Q83). On the ~ontrary, it can 
. . ' . .. ... . . 
~lso be · argued that. ·ir TSAb is an 'B:Dt~body . rais.ed against the rece~tor, it could 
. . 
ptomote ·the dev.elopmept·of anti-idiotypic ·antibodies.some of which would be able 
.. ·. . '. . . 
·.  to bind. to TSH; 
.· 
.- · . lndirtttt evidence for the· participation of idiotypic/ anti-idiotypic·· neiw~rks in· 
• ' I : , • " ' ' 
·.the regainh}g of immunologiG~-competenc~ hi Graves' Disease can be considered . .• 
. ' : ' ' .... ,, ' ... . . . . . " 
' because or the disappear.ence or circulating immune complexes that follows 
' ~ I · ~ 
.. 
.. ' 
"' ·, ~ 
•.:· ~ : · " effective treatment of the diseas~w.ith ·anti-thyroid drug5 (VanDer }jeide, Daha, 
. . . (C \ ·· • ; , Bo:k~ Be.ssem~Or, De Br~iD,· Gos~in~; Van ':" and <t•rido, 1080). Evicjence for 
~:~~: ::; ~;~· . . . . '
. ~ i 
. . . 
(~-\ · "" . ' t ,:~., I • • • • I ,~·t'i ' .... ,~ ·.; . . ·: . . ) ' ' I • • • • • #' .. I , . • • • • • ' : f I ~ · ' ' 
!!.{\b:i~(;: ~· : :. ~~L;,: .. : :·.~ .. ;rt ,:~:: ,. ;,;~:t,:.~;;.::. :, .. :~ ~ •. ,; .• ;, ; ,.: ::·: ; ~:,,~,;•. :. ;, ··-' "· ..;~; . , · .• ::· .:. ' ; : . :·, : • .:. ,. ., . ,,.. ' .: .·,-· . · . . ~. ,.;· ••· . ·'.: kii 
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~- the dire.ct partidp tion' or idiotypic and an_ti-idiotypic antibodies in the ~ctual 
hnitiatio~. or the !disease proc~, howev~r,- will' remain mor~ . -dirficuit' -t~ 
\ . . . - . . 
laccumuhlte. The possibility t!llat ·JSAb ·is. an anti-TSH anti·idiotypic .antibody-
~eeljls ·valid. Furt~~r ·· ~tudies to ·demonstrate the presenc~ ~r · sp~ntaneous.ly . · 
~c~rrri~g idiotypes:· and a.ntt-idio~ypes in ~a-tie~ts with Graves~i.:~ise·ase,_ -~ well as _· . 
th~ me~ui-e.~pent l' r tbe~r fiuctuati~ns with dise_ase :re~ission ~lid . r~lapse. will be 
nebessary to subst ntiate or. disprove this hypothesis. , ·. . 
J • • • .., ' · , • • • 
• tportim~ obseLiion~ that deserve ~ be riientioOed i~ the. di~cussion~r \hese. 
rirst _ gi~u; ·or expe;i~ents d~~. witb the production. or the antib~dies. us~d; -'rhe 
Jresentation, or a~tige~s i~ thought to be or .ex.tre~e ir:porta;. in the re~poil.se 
~bat the laborato~y' ~ni~al wili produce to both the initial ,an~igen -as -~ell as the 
~bl. Wi?zell, Binz; ~rischknecht, ~eterson and Seg~ (lQ78) tested· a great nu~bcr_ 
jbr adj~va~ts and con~lu~ed that F~eund's complete adjuvant. was ~he a_djuvant. or . _,., 
;choice to raise anti-idiotypic .antibodies. Hence; the use or tbis agent in this work. · 
,. ~ . . . ·. , ~ . . 
I 
The _cho_i~e of ... the J~bor~tor1 aiiimal(is also o~ _g~eat impo~tance. ~alb(_~ mic_; Cor 
example, have ~b~en found to be. bTSH non-responders {J. lvanyt, . personal 
./ c~mmun'ication). Rats, ·on the · contrary, were fom~d to be good r~sponders to· 
·I 1;-sH. In. this .work the choic; or Sprague--Dawl~y rats to raise the. antibodies _was, . 
. . . . . ~ 
however, for~uitous: The.' time of sample. collection was also o! extremec 
importanc~.· 1 The difference betwee~- h:vi~g . _an agonisti<t or an·. a?tagci~istic 
antibody . resided ..oiL-the choice1_ or an appropriate time to collect t,be· sample · 
ma:terial. . Ma~y -~nti-idiotypic resRPnse~ ~ppear to . be transient likely due to the 
i • • s- ' r~cip_roca.l_ ii1~rease· ·or Ab3 (Ke~oe and Cerni~, 1Q7Q; Couraud, ~u and Stro~be~g, 
· 1gg~(. This problem was circumvented by multiple. sampling aroun~ tlie ·2·3 week · . 
, I . , . . . . . -
.period _arter the last booster injections when the maximal response of Ab2 
· appeared to b~ presen_t. 
In summary it was possib.le to~ produce anti·TSH·an~i-idiotypi'c antib.odies with 
· agonisti~ activity· at_ the TSH·R. · T,he product~on _ ~ these an~ib~dies requi;ed · 
careful choice or adjuvants, laboratory animals . and, multiple sam_ple testing to 
' . ·.. ... ' . . . . ·' .· . . '· ' . 
determine optimal time Cor specimen collectio_ns. · · ( · 
-. 
;;:, . ~. - . . . .. 
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a.2 .. INTERACTION OF. SPONTANEOUSLY OCCURRING 
· ANTI-TiiYRori> AuTo·-ANTmonms WITH TmRom· 
PLASMA MEMBRANE PROTEiN BLOTS ·. " . 
.. 
~ ., 
. . . ' ~ 
I ' ,.. - a • t> \.• ' ' ' 
·a.2.1. lnter~tlon of IgG from patients . w.lth Graves'_ ·Dise&Se on . prote_in . 
... . . . . ... . ·• 
~· I 
. ,· . . . , · blots ~r. th7roM. plaa"'C membr,ane . N 
. . . . . . , . 
· As described. above, both· TSII'.and TSH-anti-id interaci with the Mr"-'197,000 
·on protein ·b\ots or'= tby~oid -.>I~ma membrane (3.1:7)._ This protein band . is . 
·believed to. cor~espond ta the TSH holore~eptor' (Islam, Briones-Urbina, Bako and 
rar!d, 1~83c; Islam and _Fari~, 1Q~5). It was thus ·or interest to investigate whether 
'\. immu~oglobulins. from p~tients with activ~ Grave~' Disease w9tl'td react in similar 
' . ~,~. 
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fashion under si~ilar experimental conditions . 
• 
lgs r~o~ 10 patients with active. Graves~ Disease were obtained by precipitation 
·.·at 0°C with· ~air saturated a~~onium sulphate (Heide-a'n.d Schwick, 1073). These 
were tested ... at a concentration .or 1 .mg/nil "'f .prot_~in. All 10 ~amples pro~ueed 
. , .. . ... . -
· positive teaetioris in the enzyme-linked immunobinding assay used .. {2.17) at the 
' ... • , .. , • • J • 
.level or the M~"" 10.7f000 protein ~and (Fig 3.5, lanes 3 and 4).'1n_t~raction or the-
antibody was observed .with prqtein blot~ or human (Fig ·3.5,. lane 4} and porcine ~ 
: . . . . . 
(Fig 3~5, lane 5) thyroid plasma membranes ~nder ~on-reducing conditions. 'the 
. . " . . . 
. reaction Was, however, consistentjy .. .stronger with htUJ!an . than. with porci~e ' 
. . . ... 
· thyroid plasma membranes. Thi~ finding indicates a degree of a~tibody specificity 
' . -
for the . human_ TSH receptor, and implies that the human TSH . recepto.r 1s 
"" 
organized in ~ siD)ilar (asbian to that or the por~ine rec.ep~r. 
.. 
·:.The biiuiin~ c>r the antibodie~ ·to thi~ ban~ ~ _disappe~r~d wbeh· prote.in. b1dts ~ere 
• • I 1 '(, 
. ~retreato~ . with bTS~ (~ig 3.~, · ~an~ 5); .Unde'r r~·du.chig co~d~~.io~s .the .M~_-;--_ 
· 107,000 was no longer ·visuaijz~d with Graves' lg noJ; were either or tb"e ts-eceptor 
I . , . ,., • 
componehts, suggesting'again tpat the 'inte~ity or th~ recep'to~ is nec~ary . both 
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Figure 3-5: Interaction of TSH, Graves' Ig and Hashimoto's Ig with thyroid plasma 
membrane protein blots under non-reduced conditions. 
1: Coomassie blue stained electrotransferred protein bands_ 2: TSH (1 U/ml). 
3: Graves' Ig (1 mg/ml) in porcine thyroid membrane blots. 4: Graves' Ig in htunan 
thyroid membrane protein blots. 5: Graves' Ig in blots pretreated with TSH. 
6: Hashimoto's Ig from sera with anti-microsomal antigen titre of l/25,GOO (1 mg/ml). 
7: Normal human Ig (1 mg/ml). 8: Normal human Ig (1 mglml). Positive bm1d ·at th 
M - 197,000 holoreceptor band are seen in lanes: 2, 3, 4 and 'l faint positive in 8. 
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. Nine out of 10 control lgs tested w~re negative for this band in . both human and 
.porcin~ .thyr~id- me~braile protein: hiots _(Fig_ 3.5, ·l~ne "r).How~ver. ·1 of _·them 
.exhibited a"' faintly ;oiitive ·b~nd (Fig 3.5,.1aile.S). The.thyr~jd. tuncti~n .. ol~the . . 
. · ·~ont~ol 'iridividual positiv~ Cor this $SSay.was n~tmaffor' up ·to·is ·m.on~hs ·arter th;e ., 
. iime or··i~~ing~ ·.What. wa8 ' inte~~ting ~ .. ·that th~ per8on· ~as invoived hi work · · ·· 
- . . ·. . . . . . . . . 
·. . dealing .with the isolation.or the TSH-R. This incidental fin~ing suggests thilt- the .·_; .. 
. ··. . · . . . . . . .. . . 
presence. O( aut~antibodies Alone is not ~nougb -to c~use autoimmune · dise~e; 
de'iangement at oth·e·r .. levels .or th.e im~une control systems app~~~ to .be required 
-~ · 
(. ·. 
. . . . . ... . . . . 
for ".this. to occur. · · 
... 
! . , 
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• : . 
of TSAb's. TSH:-like activities (McKe1nzie and Zakarija; 1Q78;. Kiqd et at, ~-980; 
Onaya et al., ,,1 Q73; · JRees-Smith and Halt 1Q7 4;' En do et · 81.-, lg78). The 
' , t • .. ' " 
demonstration that th~· ·TSAb bii;ids ·the Mr....., }.Q7 ,000 ·T~~, bolo receptor pr~i~ 
~ - 'I ~ 
band in . the assay syste~ investigated, provides the. first evide1ice to sppport the 
noti6n that. TSAb is" a true anti-rec:_epior. ~ntibodY.. .· . . !.. • ~- • .. •. ' . , .. . ' 
' • • .,. • • • f,. • • # , , I 
. , . ' . 
. ' 
3.2 .• 2. Interaction or lgs trooi p'atlents with ilashl~oto,'s Th)"fOldltls on 
~ ' ' • • 0 • 
' .. 
.. 
. . ~teln . b~ots or .thyroid_ 'plasma m_em±r :e ' . -. . . " 
. .It was also of i~tOrest to delefmine hOw I~ fry, patientS with IJ'f rea~ted with 
the M~~I07,000 bolorecepf.or protein. A firs ttu of sO:Iri~les. corr\!Spondingto 3 
p~tients was tested u~ing lg at ~ ~~ncentra,on of l~g/!fli alJ th-e·,r~actions were -~_:'. 
· neg~tiv~· (Fig 3.S, lane 6 shows ·a typical. reaction of a s~fum with anti-microsom~l ~; · 
1 
. antibody :tit.~~ ~rr 1/25,~00) The .·Ig concentrMio!l. WaS then i~cre~e·d to 1.~5 and 2_ . . . ' 
mg/mi. At . 2. mg/inl bands or various degre·es of intensity ·were observed at tbe . 
. . . ' ' . . ' ( . 
•. Mr.....,IO'i,OOO l~vel in all 7 ... patH!nts teste~ (Fig· 3.6, lanes 1,. 3, s·, ~ and · 0)." In , 
' ' .. .. . . . ~ . ' \ 
contrast , to what was observed with ,Graves' ·.Igs, however, "Wbeh the. blots were 
.. 
. .. 








~~~~~~ .. . . . . . . : . . . ~ .. I ~ ·: . . 
;:;_~ ·. . . pretreated with ~SH the bands persisted (Fig 3.6, lan~s 2, ,4, ,6, 8. ~nd ~0). It \ .• , . 1 •• 
10: ' -"&~?P·~·· i.heD; that ib~ dom~r to whi~h.Hash~~~; •. Jg binds in the TSH-~.; not. c) . ' 
~;:,;··: .. ~. : · very closel{ ~ciated with the TSH binding site. · · · · · · · 
1,,.: · · , , · · .· · L:-;:-. ,-.· r · · · · ·-\·, 
~ · ~: , · \ ' I • • • .. . • I • . ~ I 
't~J; J . ! 
,. · ' ,., ' ' H l t ' ' t ;, 
;~K.~,.~ ,_: ·:>."'" c ! : . . ·:· , . . . ; .: -:,' '·.' > ~ ; :' . • ; . : :· , •• , . ,.)J: .. ·., , · .. • .I .· .· ;_. . · .•. .•. ·:. : I .. , ,,;) 14th.~~ \;.\! ~~~\\ ·~ .. "'~,~~:v;'t~~JYt~ .,._._.,.1.*); t~ ~:J . ~~- ·'L .~.~ ~ '>-:~ \~l· t~~ 1 ' ... ,· • ._ .; \ ;. t \Ji.~~ h t"J :.\:~ 1\:~;\ ·\~~~.:'•l. ;\' ~7.i ·.'.~.~ ;:t,;. ~\ ·S· ·,.~".:. ~· i., · •. ;<~·. ,-, .~>/·,~~ t ;\ .~ : 5- ~.,• .. ~ ·-.~·~ ·u ~·- ~ · ~ ;\1. :- ; ;. :7 .. ~~ ot ' J.{!: 
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1 5 6 7 8 10 
Figure 3-6: Interaction of Igs from 5 patients with Hashimoto's thyroiditis (2 mg/ml) 
with thyroid plasma membrance protein blots under non-reduced 
conditions. 
(-): no pretreatment of the blots with TSH. (+):blots pretrated with TSH. Positive bands 
are seen in all lanes at the M -- 197,000. The arrows in lanes 7 and 8 indicate the 
r 
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region._·This band co_r~:esponds to· the·. ~210-,000 .. {~ig 3.6\ ~lanes .7 ~'d S). . . , · ·' 
. Another patient ~ted·~ very ~ro~ln.ent b~iia··&tf:h~ · Mr,......20,e00 l,~el (Fig · , . ..·. ~-
. . 3.6: :lanes g. and. -1~): The nature_.o( .the~;~ ~o-,ooo pepti~e is c~rrentl~/~nknown. . .. 
The characteristics of 'the.·Mr-" 210,000. was further -e~plor~d ana· will be · -. 
-_ • . •. • I 
~xplained later. ·.seven ~ontrol 
:co~ce~t~atio~·(Fi~ al-7). "\ 
lgs · ~.!.~~ ~~egative ·for · ~oth ban4s at · s1milar 1' . , ' . ·~ 
'-...... ,~ 
. . 
·Under reducing condition~ the Mr,...,_, lg7,0 0 was no longer visible as in previous. 
.. . . . . . . '-...:. , 
··: experiments when TSH (3.1'.7), T_SH-,anti-i (3.l.7)' and TSAb (3.2.1)' were tested. 
' '\ . . . ~... . . . .. .· . •' . . 
· This sugge5ts that for -tlie binding of HT -lgs · the integrity of the recept~ also 
-r~q~'tre_d. -~n:.:der re~ud~g conditio~s the. M:t:,;.;.2to;ooo .migr~t:d with a m~bnity'. 
consistent--with an_ ~-r,...:_ 180,000.· · 








...... .. . . ~-
A nu.mber. ;f _ repo~t~- in i._the , lite~atur; _ r.~ised the possibility that sera from. r" . · .. >_. -. -~ 
· · p~tien~t ~ith ·. Hashimoto'~ . -Thyroiditis ·(HT) ~ay -~ontain · an~ibodies . dir-~tcd -.. · ·: ·:{ 
. . 
. • . .s 
; . 
· . ... . .- against ,th·e rsH-it or .p~~~a metn~ran~ determinan~s clo~·el;. ~oci.ated ~ith the' . 
.'- . . . -~~c~ptor (En do et. al.~· lg7s).' · s~rn~ ~~( th~e -i~- have . aii..arra~-~f - activitie~ :on AC.:. _ · __ :~-- ~~~~ 
• ' · ' # • • • • ·-- ~ ,_ .. . " . ·• ~ : . • : .. • • • • . - • • : •• ' " ' ~ .,, 
· · C,_ ··some:workers-haye fotind·thep1 to ·lie-$timulatory; others _inhibitory; while_ others -.. - --~~ 








. .. . 
nave · found them to have. nq ~ctivity wh.t\t ·so ever (Blidd~l, · Bech, Feldt-
Ras~ussen, Tb'om$el.!, Ry~er, Han~en, _ Sier~bac·k and Fri_i's, ·i~82).._ .Endo, Borges,· 
. . • . . . . . . . I . . 
~ir and lngbar (1gs2)· ~ompared. a method of -preparing receptor . purlrte( ·. / 
. . . " . __ _____ _, ___ __ _ _ - -. . . 
-~ 
Grav,es' Dis~ase · ~~cific immunoglobulins_ .using gu~nea_ pig adipocyte membranes 
• ' " I • ' ' I 
with. the method using hunian thyroid. membranes._ They round ·that their puHfie'd 
··!~ ~·~~ ~bl; to. hind to b.oth hu~n ~n\guinea pig_ thyr~id nie~b~an~s ~~~ th~ · - , ~ ; 
th1s bmd~_exch,J_sJvely d1splac~d ~y ~raves'. D1sease lgG but. :DC?t by _. ;- . ·--~ H~~imoto's Tii'yrQidit1s -~gq. __ Th.e bi~ding"?r, the. receptor purified lgs pr_epared~ . · ,::· ~ ."--_:-..: . 
witn the· rnethods . ushig hum;~ --tliyroid .membranes, . however, were in~ibited by··. · -........:...._ · 
both Graves' and· Hashimbto's.IgG. Thb --lead ~the authors to believe that human • -? 
' I ~ r · : j • .... ......._ ..._, . ~,...._ ~ • ~~ 
thyroid meJpbranes appear · to eo)ltain ·antigens compleiJlentary to -b~tbw Gr~ves' .. . '_; 
... •. • t ".... ~ • • • 
and . H~himoto's' dise~e ·antibodies, while guinea pig adipocyJe ·cells co !afn · · 
. • _: ' , , ' ~ , ' I 
- . 
. . 
_  , ·.',: 
_, :.. 
.. ·. 
::: ·. . ' .. ,_, 
' ..; : ·~ ·I 
. -.. •• J 
. . ' '' '·.-s:::: ·.: . -~ . \ - .. ',,' ~ -. \ .. ~iiJ~}j?;: ;:: .;~:.:· ~ i ~~~: ;,(C .. ·:· -i _':,:·::.:; :": _ _- : .. :.::.:,·;;. ~~:·-~:;~;·-~;._ ~; __ ·:··,. :~: :;_ .:; .. ;-;;:. ~.:'~.;}._.·. .· .. > :' -·-: ~~ -~ - . : -.i: : :;;,. ,:u:·.~:.:: .. ~::.:~\:. L: ~ .. : ~- -~/:.·: . < ... ~_ . .- :.:-.: · .. ,i >~· :< ~ ·_.'_ .. :·.:· .., ._ .. _·.-~_. .. _.·-_ - -~_.:(f:ij 
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197K-
Figure 3-7: Interaction of Igs from 7 norn1al human controls (2 mg/ml) with thyroid 
plasma membrance protein blots, under non-reducing conditions. 
TheM "' 197,000 and theM -- 210,000 are negative. 
r r 
~";;r.:.:{•'·:/ /, ~~· •·s!~; . ~/,""t ' :.,:rt'~~-;,;: 'i~ ' ( ... •, '·t~~> r,::sr-;o:-1~·,~~1l'..,.,"<(~,·. -.:-'};~·l;e;.. ;\;o4'$i~· Y;.r....-l't v-·~rr''')r:.,·~ ·~"~" .. ·j-i("; .;'i.;!'["!l~"t~~""·1'-di'.(.~\~'J~~"!fi"':'-:..~~~~~.r(~'.fJ/ ~}~~-l"V'.~~o. "l"'J,'lr',·~·l:~~ or.>- t,,_..~l" :·f~l\:jiJ~\ ·"~)11·•;.· ~t'''' :''C . . . ::_:, ,,_ . . ; ~\:"'· '- >, -, .. .: -.:, -~-~ •• ·. : J:': '22:~~ 7: ,,: -~--:~:' . -~ ·;', . -·<::~ ,.,,, ,,, ;r:'· '";-':';-'{'' '0~ #f;~;~ 
-· antigen~ compl~mentary only to Graves'· c;IIsease :antibodies. J1~~ver, unlabeled · · · ~ .-< :·; 
; .. · ' . ' . .. .. . '. . ' . . .... . . . ' .· .... . '~' . :...· •:, .. 




·. th.yroid :emb_~~es suggesting tluit at.le~t par.t of· the bhidi~g of .t~e;e ~~· is: at .· _. · ;···, 
the. level or the-Tsli~R. ~t ~ein~in~d unclear, however, if the thyroid me~brane" '. ·~-. - ~ 
a~tigen~ comple~entary . for Qashiinoto's Thyrojdi~is antibodies ~e~e · part ~r the. · · · 
TSH~R or not. Oth~r authors (T~o and- Kriss, _1gs2) .ha~e· ·suggest~d~ ~that · ~thfe· 
. . .. ' . .. 
.antibodie$ found in Ha:shimoto's· Thyroiditis may be' part or. ·a. group or 
..... • t \. 
h~terogeneous· antibodies that are able· to._ bind antigens in thyroid! ,!nembran~ · 
- . . . .... . 
preparations ,containing TSH rec·eptors. 'The .binding sites, however, were thought .. 
. . . . ! . . .-.- -- · . . ~ . .. . ~ ' 
·'to. represent antigenic ar~as separate from the TSH-R ... This mostly because of. the 
• ' • • • • • • • • 0 •• 
ina;bility of TSH-.to interfere with the.bin.ding of these ·antibodi~s. " -· .. 







' , // //With tbis b~kgrou~d'tbe e~p;~iinents pOr!~rmed ~a.me -~~ ~ajor' i~ter~st.,. : ·• ;,:j 
<.. -~--------: : The .re~ulis · ha~e· demonstrat·ed sev~ral f11cts:: ·The · first ·: es.iabli~Jl~s · that · .~il .. 7' · · · · . . 
~ . . . . , . . ' . . . . ~ . ' - --- ' . . · . ' . "". . ·, 
. . ' . . " 'pa.tieilt~ with··~HT - tested- .hav~:-'anti~'Fsij.:.':R,. ~ntibodies. Th~~ antibodies· .. howevcr, . . ' ,,· . .: 
. " );- . ;. - . . .' . .. . .. • . . . • • . . . . . " : - . . ' • . .'·. .. .. : ', .:>1. ' _. . , .. 
. _.. "" · appear to -l:fe • weaker• :than .those found .in · cases or Grav:es' · Disea8e. ·It appears.': :.. .. · · ·. : .• <' 
. ···, 
.. :· .. · 
. . , 
• 
.... ~ .. 
\ I , ' 
. - - - . - :. ' . . . ~ '~ ~ ; . ' ·. ·.. ~ ' . ·•. . . •. . . . ' .... .... ' . . . . .. . . .. ' . . . . 
~e~on.able · to suggest 'that the ~nti~TSH~~ a~tibo'di~ found .. in : HT ~n~ those. · · · · 
. . . ' . -. . . . ' - ' ' . ' . . .. . . . . · ~ ' . 
found in Grav~s'. Dis.ease are directed ts> different epitopes in. "the TSH;,R. This :. 
. . .... . . ' .. . . . . . 
:. cont~~tion is su,;'tained _on the grounds that· ~ontr.ary to Grav~s' lgS".tie .. p~~tivity . . 
obtain~d wi'th HT. lgs .. w~ not; inhibited with th~ pretreaiinent of the prolein blots :, 
' . . . . . . ' . ' 
with bTSH . . , 
. ~ , . 
-3.2.3. Characterlzatlo.n 6r the Mr....., .210,000 protetn__ band 
. . ·.. . . . . . .. . . . ;.. . .... ' ~ ----~ - · -..\ _ \ . 
As m.entione~ above . (3.2 .. 2~ · 2 ·out. of_ the· 7 lgs from patie~ts with HT-t~sted., 
.. 'showed ~ positi~~ 'band _.on t~y_roid ._pliuima r,Dem~ra~e ·protei~ :blo~s· .~t~the " l~.v~l or . 
:· ·. ~~ ~~,_, .2IO,.ooo .. ~Sine~· ~~e ~o~J)osii~o~ ,,o~ i~~~nd ~~ ~n~~own th~ p~~ibility ~ 





·· ~ ·-· 
' · " 
. ' ~: 
.. that"· t~ may const1tute a -thyroglobulin breakdown product was .constde_red .. The · 
• '-. : • • • ... • • • • • • .. - - ... ' ' • • • ' ' 0 •• • ~ ' ... " . ~ -
odds · against' this possibility ·Were that . all the . patients' with·· Hr chosen for this ' •' •, ·. ·.·: 
. "':. ~ . . . ' . . . - . . ,. . . . . .. ... ~.· ' ' '· . 
. . :study. were. nega~iye for'. anti-thyroglob.ulin an~ibodies .in. 'co~v·entional clinical .tests . . . • ' ' 
~·' _ · : .'. ·. · . · and.: ih·a~·_': ~ll · th~> ~~~~~a~; pre~aratio.ns. ,us~( had . be~n . · sepa~a~~d : o~ s~cros~ . .· ·. \ .· · ~ · f 
~ .- . · _: . ~adie~~ · exp~~ting· to obt~!~ ~ ~urified ~~~ddct: D~?i~e ~liis, .. it .w~ ~~Jt~ll d.ce~e~ .· ,· ... . . : . . ·::·:i'.l 
; ,, : ~- :· neCessary .to test ,this p~ibOi~Y  \ / · , . _ ' ' '.:: 
~~~~;D,.;, • _,,; f, ,;; :: ~-\ ;~~;;(. ; .,; ; '~:,, ': ~ :.· •. /.: \ i --~- ·, .. \ ~·::~: :: ~;,;: ·· :.~~ l~'<,;:,. ,h: .L: ~,~ ~-. , . .', i · .~-: .. : ,~c.: i, ,f,-.· ' •' :;;,~ : ,·_ .::~,)~;l~ 
~i!?' :~:; :•: .· • .~ ~· : :f-:7'' ' : ,·.:-.·: ''~"'" ;' : "'.: :: , ·: 2 . ~ : ·~{};~:~ , ,,, ~·' !·s~, :s· . ' ':'' ':'- W'·' :;'r,· :~:·:s:ce:';';~:'." . ?',\;71(.'>('-':':'i':c ,, '~~~t7•~ 















. ' • 
:' .' 
. · .. · . 
.... .. 
;~: . 
: , ~ . . ·. 
. , ~ . 
::-~ . 
.. . .. • ":. ' . : . . . ' . ,·:. ·, . . . .·• ··.: . • ' . . • ·. 7 .. . • ·•. ~· ~ • . . • ·';' 
·· .. . . ... Por\iD~ thyroglobul~n pro~'ein blOts were prepar_ed under ~0~-r~duc¢ co~cJ:i~ions . . -·- ;. · ·:.·· .~:__: 
• • f • ...... . • • • -- • • ~ 
('2.2JfA,_.high· titer rabbii polyclonal anti':'human thyroglobuliil antib6dy {kindly 
d~~ated bj.Df?~;-s~~~i_ail, F~cult);' .o_(_M~d!~in~, :MuN,· Nfid. ): was. ~sed 'as pos!.ti~e 
. . . . . . . . . . . . ,~ ') . . . 
conft~l in ·tlie- e-nzyme-linked immurio:-b,in~i_ng 8s8ar .d·~ser~bed-: elsewhere:.(2.17). 
. .. 
• 
'" ... , 
. . ,· 
. . 'Anti~·thyrb_gl~bulin anti~ody . a.i. ~ concentr~tion ·of 75b ._,gi~r intera~ted .. with - . . . . . .. -::: 
. . . , ~ . ' . ... ·: . ·. . . -~ . . ' . . . ':' . 
· bands at the lev·el or' the Mr""' 210,000 a~d the Mr.....: 180,000 . as .well as other· · 
-~ . . lower'mol~c~l~r· ~~i'gh~ bre~kdown prod~~~': in p-rotein blots or both ·ihy.roglob~lip 
... ~ . . ' . -- - . :-~-- --. · -· . . . . . . -, . . '-
(Fig-3;8, lane ' !) and plasma membr~ne- (Fig.•3;8,- lane. 2) ... The_ jnten~_ity 9f the 
.. . . . . - - ~--
reactioq ·:was lower · wit~ p:rotein ·bl~ts of ·plasma membr~~e: The ,Ig5 .from th.~ two 
. ·paiients. that :;~re. ·p~sit'ive. for . the_ Mf""' 210,QOO ~and were··allowed to\'int.er~ct 
• • . .. • - . Alot. • ; • • ' • • • 
with · thyro-globulin prptefn·. blots. Tliese I~s. at a~ concentration of . ~ . rrig/ml-- . · 
··· exhibited a positive'~eaction with proteins .of Mr~. 2i.o,ooo and Mr~ ·180,000 (Fig · .-. 
~.8,_· l~_n·e a).)~~ pro~~ilbJots ~r lne~b.ra~~ th~ _Mr--- ~to,·o.o~ ~ -~~11 as· n~~ band ~ . . 
. . . · ~ -1 . . . . ; . . • . . I • . . 
.. · at the leyel of tbe ·Mr.....,l97,000 ~ere seen ·(Fig 3.'8, Ian~ 4). lgs from· patients with . 
.. : ~ . 
. . - .... 
. .... 
. . .. , 
. 
. .. :· ·.·· . 
' • • • •• • , •/ . , : • •I ' ' ' ' ' \ , • • , ' 
: . : . ~~~~~~' . Dis~ase . ;t bo~~- 1. ·m~/~l_.a~:~ _2-~g(m~ .w~r~_. ~e·gat~n \~h~ t~_Y~~glob_u·l~~ · . . . . _. _:· .. 
----- ·; .... . . . 
· . , protem . blots (F1g 3.81 Jane 5). -In- protem blots of thyr01Cl plasma. membr_ane l · - · , : . ~· . 
·: .. · . . 
.· : 
.·. ' . . 
· .. 
~ · .. ,• .. 






, ·;.· .. 
\. 
• •• • ' • , • . • • • • . • " • !. • • - • • • • • ' •\ • ' • • ~ • • : ~~ 
mg/mf ofGrav~s'· Ig was enough tO produc~ ·a positive reaction at the. level of the . ·,. .. :, 
· :_ Mr~: IQT,OOO. No ·si~ific~n~ - <tir~e~e~~e ~as· observed ~ith _·. ·G~.~ve~' · lg ._at ~ 
. ,-· ~ . ·. , . ·. . . . .. . . I . . . . • . \ 
. -': ·. 
concentr.a~ion or 2'mg/r:nl:(Fig ~.8, larie 6). ··· ." ·. · ' · · · 
• These · results, :~ggeste~ in • the firSt .place 1 that sera. . from ~a~ts . With: · . . . · • .. ·• 
.llasbiirio~o's . thyroidiiis -~hi_ch ··.were n_eg~tive f~r :~_nti-thyrc:>glob~lill'\ ant~bodies in : .' ·.: ' 
. c~nv~ntion~i heim1agghitlnation -tests ~ can gi~e: .positive response~ i~' the enzym~ 
:-_ linked im.mu~_~bhidin.g' ~ay; d_ttmo~~t~ati~g . the ~ea~r- sensitivity .or. ~he. method. · 
.• ' . . . .. .. . . .. 
. ...l _ . ' Seconqly, -it .'Y~ ·sho~n that the porcine ihyroid plasma ~e-inbrane prep~~ations 
" . prod~ced in · : ~ur · labo~ato~y · ·b~~ :su~~ose · ~a~lie~t ·purificatio~ .: contain ~-~everai·. ,_. 
tby~ogiob~iin : bre~kdo_wn ·pr~d~c~~- When. ~~olved· by line~~ -giadie~t ·snS.PAOE 
. . . . ' . . . . . .· . . 
. : . . at conceii~ratioils of ·.5 . to 1_5 % . )n1_de~ . non ~educing . condit~(ms the . rpajor· 
. ~ th)'r~gl~b.ulin ' bands. appear at .the Mr....;;' .2l.O,o00 a;nd. Mr~ 180,000~ Th.es~ bands .· 
.. . · . . . . .· , . _· . . . .... ·· _ __ .·.·· . ·. 
. .... . 
: I ~ 
.. ·. . .. 
. . · i . 
' ·. ·,. 
•. · . 
. ' ... ~: 
• . . 1 
. . . .~ 
·, c·, 
·. , were easily . de~ected Wtth anti-~hyroglo~ulin . anti~odies: It .is· important to met;tt\on . 
, • ' • I 
0 
' ' • ..... -.. , ' - - • ' ' • ' • • ' f , ' I 
that th:e native molecul~ . of Mr....:.660,000. ·a~d ItS Mr~330,000 subunits. wiil not · · . . - :·: :} 
~.:)_.·~~ ··:·· .. . . enter· the polyae~iamjd~ · gei -~t th~ c~*c~~t;ation~ _·u~ed . . · . , . . - ·· · ..... ·.·:.': \:.: 
~'•, ' ,, •:\ o I • 0 ' • o • I ' '• ' ' ' . ' ' o ~ o :: - ' .... ·~ 
·:.::: ' . ·.: . . . . . . . .... , : ·. ' ·. ... . ·•. . .· . .. ·-'.: . . ·.·_' ... \ 
:1 '' . ' ' ., , . . . ' ' .... . . \: ~ ; , ' ' t ' ' ' • I ' ' ' : • ~, . t ' ' ' ' ' • ' ' 'I ..,. ' ~.\..· ~ • •• ,... .. .. ~ : • ·: ' f • • • • • • ... ' • • • • • • • ' ' • • ·.;· 








Figure 3-8: Examples of interaction of anti-thyroglobulin antibodies, Hashimoto's Ig 
and Graves' Ig on porcine thyroglobulin and thyroid plasma membrane 
protein blots. 
1: Anti-thyroglobulin antibody (750 ug/ml) on thyroglobulin blot. 2: Anti-thyroglobulin 
antibody (750 ug/ml) on plasma membrane blot. 3: Hashimoto's Ig (2 mg/ml) on 
thyroglobulin blot. 4: Hashimoto's Ig (2 mg/1nl) on plasma membrane blot. 5: Graves' 
Ig (1 mg/ml) on thyroglobulin blot. 6: Graves' Ig (1 mg/ml) on plasma membrane blot. 
Graves' IgG 2 mg/ml has similar effects as those observed with 1 mg/ml. 
tr::·;;: -,~ ': '!~ ::~'·': 1 :l\' :-r·t ::'·".~~\f.'·:' '.' ••• ,.-:, ·:: ''·'?:_· ;:·• .. , :·' \ ;:·. ::~· ;_. '~:· .. ' '"'·~· "t'?'" ·.·y.:·f '?' :•:~;::;.:' r·::  ~~ :: ':~''" f>~{ ' :r:_~'.:~ 
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' I .. • I' ' ... • . . .... ' • • .. • . • . . ·. ... • .. .: .. _ - · " . · . • . • :~, 
.~>··., ·. ~ · ~: -~ _, The :e_~p)erim.~nts to . b_e_ ·d_~~ribed· _next _ ~nvol~e .·:the p_r~·~uct~~~ o_~ -~~-~.:su~u,nif . ~i -; : .. ' 
'- · .. '.. . ·.· .--. specific 'anti·iCI'iotypic antibodies wi~h th~ objectiy_e of- ~nvestigating the .rcile-9£ th~ . - -~ ·.' ·. 
I . . ·. . ... . . . • l. .. • ' • : - ....... __ .., • •• • ' I • • • • .. ':"' • . - ' • ~:·. 
· · subunits or. TSH in the hormone-receptor int-eraction: Th~ first part ·will describe .. · 
- • • • • • : . • : • ..... •• • • •• ' ;# •• • • .. • .. . • • • • • • ! 
·· · . · the characteristics• of ·.tbe subunit ·specific monoclonal antibodi~s used in. raising \ ·: 
' ' ' ' • "' ' ' • ',' ~ • 0 .... ' • '-' ' . ' • ' ' .. o l •' I ' , ' ' ' 
, . · · ~ anti-idiotypic ··antibodies. The second. part will deli~eate ~be . characteristics of the · .. . . 
. ' , .·. .- · , idic;t~~icj.anti~idi~t;pic int~~a~ti~~s. Th.e las~ ·s~ion wiil d·~al ~itb t~~ biologic~i ··· ~ - · · 
·.activity· ~i .. the : ~riti-idiqtype~. ·; . . , 
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. Th~ monoclt>nal·antibo'dies ·TS2$. and ·GC73 were received rrPtn.· the ,~W-e)l.come·· . .. .. · _-: ~ · 
. ).f. R_ese;.,ch ,iii~o~~ti.ri~~ (p;;,le, Engl~?d); Tb~y we.~e f"~dtice~ .~ d~~crib~d ·~'th~,. .• . . . . 
. · . refer~nce quotelabo~e (~.2). ". ..._ .. - ~ ~ ··: . · · . ~ · .-·.;· ·. : · · . ·. ·, _··: ~ . · . 
j'.,. ~- · : .. --.- ~ ·~~-_ .. -• : : -~ ·-:·~· - · ·> :. ~· :" ·.· - .· .. . · . ... · .. ' .. . ·· .. . ' 
~, ..... . · : The next section :will descnbe the. mvest1gat10ns done m our .laboratory ·'to · . , -' 
. '·-......... >-·- .; ~haracterize· th.e oi~t~r~ct~~n :~r· th~se ··a~tibodies -~ith .1-:SH and:its actions. ~n TSH- . . . . 
': ~ ~~·, ' . ' ..... • • ' . • . .... . ! """' 
'-._ . medi~*e4 receptor events:. . .. ·-. . . ' • ' 
' .. . . .. 
. ~ . . . ' 
•• 
. .... 
. . ·· 
' ' '-........ __ - . .. . . ·. ' . ' . ... 
. . ... •' ~ 
. . a.3.t~l._Bl~dlng or. T.sll:.&ubunlt. ~peclnc 'moiuiclon~l a-n-· t,....,l ...... b_o_d--:=-Je-'-~--:t:-o-----+------'--'-
... ' ., . . . . ' . · .. "' . . . .· . . . . . 
.· · · · . human &ncJ .bo~iile TSB . · . ·· . ... . -
. "' .... . ; ' 
.- .·. ·._· .. -.and _G,(?73··.was. te~ted; Dose ~esp~>Iise curv~ p,erformed r~r these experim{mts_ti.sed ' . : . .. . 
. ~ -. · · initi~]]y:incre~ing ~mo~nts cl. antibody 'with' ~o~starl.t a~~unts or. r~diolabeiie{ . . . . : . 
't ' ' ' · ' . " · , A , •f · ~ . · • · , ~ 
· ·· /~.':.: bTSH (l_OQ,OOO opmjml ...... 2.5 pMfmir or hTSH (100,000 cp~/ml . ......, 2.4 pM/ml). 
· ' .. · · -Up · i~ · 2oo · ,.gfml · were rea~ ted with bTSH with n~ ap·pleciabl9-·binding . b"eing .. 
• ' I , ._ ' ' 41 .. ' I , ~ 4 'o ' ' 
obtahied .. With hTSH TS28 botJ.!l~ ~ maximun of 58%- (SD 7) ·and .. GC73 _.47% (SD.· 
. , . . • . . • · • . r ' • • . , . ; . , . • . 
5). or the radiolabel added. Next, 100 p.g/ml of. each antibody were reacted with . 
.. . '- . . 7.in~re~i~g amounts or radiol~beled _.:maier~al (S~,o00-_.1'~,~ _cpm/m9·: 't~~ .. . ~ .... · ·> :· . _.-. ·· 
·-~·· ·. .. ~axiinal binding; was obtained with 2oo,ooo·cpm, ·being 73% (S 7) for TS28 and : : .· . · . · 
:·. . . .· ..._ .• (!.• . . .. . ' ·:.'. ;\ ·:. ~ . ... . .. .. 1 ,_t· . 
! , ~ . -~ ~ 
1> · .· 1 ·., ,. 
~'""/:(~, ;;;};,;,~;.,~~·~ · .• ,;':: \)~~~:~,;;;:.i:;:;. ,;;,,' .. ' lj ·.·  \ ,;:;; ,., · ;~; ' \: ; :~. ": .:;: ,, ,: ;.: \ , ; \ •.•0. :; ,:,,:; .;,;\ 'i' : i." ~· ' ';; .,:;.', \ , ·  ·.: , ' j , ~J;;ji 
·.Bindin~ ot 'both r~diolabeled .bTSH ·a~d hTSH ~0 - ~oboclonal antib~dies TS28 





' ·. :' :. \ .. 
~(.F~\:t ~1t,~;~\S\J'~~i\i:;i•.?(':'~··,;ft;;'.:'':;;r.:;:·~~;.~{~'-tt~;~~l'l?~\~'\'t~l.<,;~,~ifjr~''· ,j·f\~~~·~d~.t,~. · . ~-~1!,:~~1>'>\~''tf~.·-·'jJ'[:~.-l"';tf' " ' ' !}r'l't".'-' ,,, '~~~~~. ~11!''•6\1,';•'!1 -.':{",'1<\1.:: t ' 'J\Irc7 . .f.l~"''j?!i"':':-<.~< 
:·::: :·.- · ··. ; · .. _-·._ag~ : (s~ ~,~~ .ro~:.~?!~:~~ -·_t~~r~~ihg 49ses)u~t' caus~~ }Jl<:te~e ·in·-~~~ .. b_ae_k'_g~o~·n·~ ~ .· .. ':· ~ .. ··:_,: ~$ 
, • \ • ' ,Q ~ •' ' ·... ' ' • • ' ' , • ' • •• • • , ' ' • • • r • , ~ ' < 1 • ' ,. ~ ~ ~ ~-_,.-.. . .. : Q · a~tiVi~r :Wi~~ · .minlma.I.incr~ase i~ th~ pe\"~e~tag~ot birl~ing.- .It is .· ag~in: P.o~ible· .,, .. - . :~~ : ·-~ · . .:·~ 
. ·.: :... . __. . " - th~t ·t~e : ia~~e· .' .. bonc~~~raUo~·s ot~~tib~dy:: · r~quir~.d·,:. clepend:· ~~:·: .in~orri~1~i~ . ·. :· · .. ~ ·.: .'.;:,;~ 
·\\~ · · ···_ ,, ~ -. · .. . ~r~f~~i~ati?~,:~~: ·~f~~ .. .ri~no~ibh-~l: ... ,~~~~~?di~~~ -:~sH. ·~o~ple~e~ .. ·h~t :this. w~· ~- ot . , . ·.: ·-.. /~} 
~ ~ , ' jJ .,, ,, (~ ea· n • .,,l , ' "' • • ,; ' • t" · 1 ' • ' ' •• . • • • ' • • • ' ' ' 
· ~'- · " ~· ' . fur~~er ~exp~ored as .the results <lemons~ra:t~d ·reproducea}?ility. ·.T~e. userulncs~·: or .. : ~ 
. .. ;~ · •• :>., >- ··/';. p~~.x~th.y~~~~. gly~oi""in~~~-~~~f~in~- -~re~.'tro~-~~ntibod(boun~ poiypeptides h&S lo:ng· · .. . . . : . 
. -.. ..' · > \. . ~--~~n-'r,e~~~~~-ed . (~e~~?qu?is an~ A~rbad~,· _ig7_1) .. It co.uld ·b~ argued. t~at ·th-e . · .. 
_ .... :.:,; ~ '· : .~ . ~-: ~oncentra,ti9ns·: used' 'i~ t-~~se ¢xp~riments' 'mi_ght hav~ · ~een~ ioo low_, .aS ~he' sn{alt',cr . : .. . 
c;· · :·<;?' :·: ·: · ; ';·· the ~o~pi·e~ ~-h~ '. · high~r · the:_ concentration . r~quired .'to produce an adequa~~ __ 
:~·''·.: ~~.,0 . . . J-·~~"~.:~. ·: .... se;ar~ti~~--:or\l}·e -,..fr~e ·, fro~ th_e an~ibo.dy-~ciund ·radiola~eled 'fSH;· The ~ort . . · . . -~ ·· ... 
J · ~~:"} ,;>-: · · ·~ :-~ .··:· quoted . -'rigu;~-~·:_'~ ·- .15% . .In. the· P.reli~inary : ~xper-~m~rits\ perCor~~d, . lio~«S~~r, . · ; '·:·; 
;·::::•,P .~< ;~ ·~ '', ,,'_COD~e~·tr~tiOD~ . or . 1~% . prod·u~ed . ~ efflci,~nt~ ~ _ ·pre~fp_i~a~iO~ . Of. the -~~~~~CXCS. ~ .. . . ~ ~ ... '··._<".~~ 
·:: ·~~:~:'··. ": . . #:~ .Ir/% .. ~_- IS% . conc~n-~ration .. ~rfth~_ . c~ntr~ry .. cau~ed . a . ~a\k~ ·inc~e~e iq_ -~h_.:,e _ · .,· ._ ... _ ..,··.<·< 
-: ' • ) .. ' • ( . . . . i ~ '· 
·.: ' .. 
... : • 
,. 
,, 
4 .~ •. 
; ' ' ~ 
,• .. · . 
. ' 
.. . ,.· _.-. , hackg_ro~1,1d.c~un~.: .. · · _. "' > .. • :. : ._, · ... · . · .\ . ·'-'· . i . ·· : .... 




. - • ~ • - f' . ' : , ... .• ·~ . . • . • .. ' • . • ~ • " ; ' . : · ~ • \ . • : : ,. ' ,1 • • 
·· · Both_· . mo~oClonals. exhib.ited high ~pecificity for hTSH . . . Unlabeled ~ hTSH was . · .- .: 
: . used·io ~ry to' c'ompe.titi~ely .. displac~: the hi~ ding or the ~on.ocion~ls· to ' :th~ iabeled .. :'. : • , , T' ! 
~ f · . . · '. ' ' . · • . ..- · ·1 : • • I · . . ·. 
. ·· ~.TSH. One.h'uridred pgfn:tl'of. eacq antibody, we_re reacted ··wi_th !oo,ooa. ~P-~ . .---2.4 - . . - ·:~ 
· . . , -.;· 'i>M/ml. ~r .125I:hTSH.· The · co~nts .bou~d ~9 'J'S2S in ·the ~bsenc~ or cold :·:Ts~ . .. · _ _;_. <.:; 
. . - - . ., . ' . . . . . ,. - . . . . . . ! ' . . .· -~ ... 
r . constituted. 50% · of those: a<Uf.~4't- and. for GC73 46.%4""Cold TSH-displaced this . · · · .. ·. ; -
' ~ < ' : ' • .. ' -~ • 0 • I •1 ' ~]~ • • • ' • I o ' • ' • • o p t • •': ' ~ 0 ' :....,.... ' ' 
. radioactivity~ .in · a ... dose . . ~epeJ)dant ·manner.. With: 'f-S28 t~e : maximum .. -_._; 
. . .. . . - . . ~ •A· . I , . ! 
dispiacement was obtained at a· ~on.ceiltratio~ or 2.5 mU/ml o'f hTSH. At this·_ dose . . -~ 
. . · ~ore than . Q5%: o~ the~ ~adi~acti~ity ·bound __ ·w~ .displac_ed. With _ GC73 ~ d~o~ . of · ~- .. ~. 
-.. :· 
.TSH appro~fmately 10 tim~~ higher · w.~ required to cause displacement or· th~ : _:;:.:: 
·. radioa.cti;ity. Maxiritum. displac~m~nt ~~ · obt-~h1~d at . ao. mU /ml :. wher~ · · · 
. .· . ,.. -- . . \ ·. ~ · . · ... ·~ 
approximately 'DO% ·or ~he· ra~ioactivity w'as ~isplace4. (Table·3.2). : . \ · • ·. ·<~ 
,; " . . . . . . . : . . . : ·.' 
• I . . ' 
· • I ' • ... 
-- -~;· ·. ' .. . .. -~ . ~~ ' l . . '·. . . . 
I • ' 
• ~ • I 
. . 
-- . 
. ~ . 
• • 1. 
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. ·: ' · ~ · 
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+. TS2S.(l00 ugtml) 
. . ' . 
+ TS28 .(100 .ug/ml) + 
JlTsH (O.f): rnU/ml} . ; .. · 
.· + ... rffi~g cfoo :;~~1)· + ,. 
.. . · . . hTSH (2.5.mU/ml)· 
: . . . · . ... ( : . . ·.: . . . 
:~ :· ~ +··.rcl28 .. <Hio· ·: gt~nl) . + · 
.. . ·hTSii.'(5:~U/nu) 
. \.. . . ' ; . . · . . . : 
. .. ' \ . . ~ ; 
... . 
!l 
· ~~-5~~hrsii' (Tb)• _. 
./ .Gb1; cioo ~S'mJ> 
.... 
:+ Gcia (l_OO .ugimi) ·+ 
hTSH' (l.~.~ mU/ml) 
- ~· . 
+ .. GC7a·.uoo: ugtml) + 
. hTSH (20~0 rriU/ml). .. 
. . ~ . · 
+ GC73:(100 ugtffil) +· 
hTSH (30~0 rnUil1\1) : \. • "" . 
r 
... 
19;000 ' . 
9381 
· ~ 
49'.4 ± 1 
... 
·r-- ~· 
5455 28.7-± 3 
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·.· 
- , • -
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~~r:·""~7''' :·~~,j~;·'f::~~·v;~tr·;~. ·)·T~·.';:·~ ~.~~1-~?w·(:::;::J,·"~?~;?~T?i;~~~::r'i"'\:;~~~}.~:~:·N~f~ 
;.' ~- :.: bih~.i~g~of·r~~iol~~el~d hT~H·~··~s~s .. ~~~~~~~~:-6 b; jl¢"~ - ~ri ~~~se-. d~p~~~e'i~: .·r < <)_~,~ 
'J ... : . · ·' · • • ~nner~_'At ·-~~ W/~~ ~ s% 'o(t~~ radio~eiivity -bo~~d was.'.<t~p.Jac~d: By -'eoritr.asi , .. · ... . . ···:· <:;; 
: .:'<:: · ,· · HCG'·l!P .to ·a d<?s~\~ ;so . U/~1 h~~ n~ ··eff~ct .-9~ 'the))i~ding 9r _GC1:!Jo·· -tb~ ·- · .~ ·· · ~ · · ·:· o ~: 
:r I • . .. .:' ·. -~ :-..-, 125j_h~SH. (T~ble a:a) ~ Th~- stu4y or' ~he . effe~ts or hLH' a~~ . hrsH ··on . the .. bindi~-~ . . ' "•' 
' .· . . ' :· - .. . or· 'hTS~ t~~ TS~8 and b'c73 ~e;e noi rep~ated -in. our l~borato;y, .fhe infdr~ati~n' - · . . ... . \,:~ 
: .·.·· r~~e~ve.~ ffo'!!~~i&bd;atojy that prod~\d th~e ffionO~IoD'ai a~tibodies indi~ated • . · · . ·.: 
:.· . _ ., . that_ hF~~ ·~nd\htH J ~ave · :no_. effec~.t?ll~~~e ~indi~g: ~f ~:r"SH t~ . ~C7a; _.~o_t~---: ~- ._· :_ 
· · -"- hoqnones; however, .,.Ye~e capable ·oftdisJll:c_iq_g tb~. binding o( bT~H io TS28 (J. t ._ 
~; ;. : ·. Ivanyi, .per":'n~l cOffit~ni~&tiOfinsuJin hacr-lt~ ~ffee~ .on t~k!nding Qf eithe;:-;;1 . , ' : 
.:.~ :~~- :· .. . ~. th~'antJbqdies at_.the conc~ntratlonsnsed. , . ... .. ..... ·• . . r ... 
•, . . . . ~ . .·- . . . . ·. . . ' l..:.. . . . . . . 6- . •• \ . , • ;:~-- : 
1 • • •• • • • • • .. •• \ • • ' • • • " ' • ,.. .,...,.. .. • .. • 




·: \ . 
J :. 
t •• - • • • I i ' • .. \. • • • • • • I 
. _lt is known ·that all- glycoprotein hormones,~ TS LH, FSH and. HCG share a· .·'. ··-• . ·- ;:.~ 
. . ' slr~~tu~ally ,.similar jAI~~~ s~bu~i\, , ~bile thei~, Sp"e ifi~ity resid~s; on tb'~ .bel<> ,· , :; 
.• . subunit' -(Pt:erc~ .11nCI. :P~rsdns, IQ81).: Af~~r aiialy#ng he ·. results .obt~io~d ·it W!lS . ·. :, ._,_,. <·· 
; • o ', • • ~ ' ' '....:... - ' • • • ~ ·: ' I ' • • , ' ' ' ' •• • ' '", • ' ' o ' • • ', • :1 ! , •' , · • . , ', 
.-.: . . ;_.. ' ·.. . . · consi_der.~~ that: the disyl~cement ~r radioactive TS .: binding ·to TS28 . by all . : .: . :·::· 
. . - . ' ·. gJyeoprotein:: hormo,~s-· rna;\ . imply that tlt~ .. bi~d_ing ;site f~r !,'-this . !Ln\i~ody . is __ :_ . :.·. <·: 
.-... ·--::,i· . :- ·:·lri~a,ized : i~ tb~ a~pba s~~nit'or th<?se hor~o~~s. ~-251-hTRH_binding to ·Gc;a :Was - .·: >:: 
·. 
· . , •/ eiccl~~iyely displaCe~ by; h:r~Ii ~ \wo.?Id .j,~ -~~~cted for !-\no~.,;,)QDJllantii>Jdy' . :~ 
· ~ s.pec1f1c .for the betm. ~ubumt of TS~. - · · . · - :.- · . · . .'- _<. 
. . : . ·~ .. - . I· - . -·: "'~ - . . . . . : _~ •... :: . . , ·. 
\ , . . ' . - . ·. ' . . . ' . { . ; 
· 3.~.1 •. 2. E~ect Qf TS28 _and G973 ~~n the blndl~g· ~r 11'61-bTSH, to . .. . . . 
. . .' . . . .·· .. .. \ . .. ' .. . 
, •• 1' · • 1 thyroid pi m~. membranes . 0 • • : 
. . ,' ·. .. . ,• ' . ··-. . ·;· . --, . · -
fu an· attempt . to tablish the TI3H-site to which these motiodonal antibodies.:_ · . 
· ; • .,i · ' ::. :. . . •{-' ditt<!ted, . their: ejt~~~ on th~ hindi; g of r&4iola~eled b TSu ~ ~ tb;roid pl"'!in a 
~embranes was. stu ied . • lt is. import~nt to pqint out th'llt .bTSH ·and not ·hTSH . 
.. . . ·" _. j~-~~.~dfor. th_~~-:e .pe~~m~~ts.;:'D~pi~e>~Jtia~-~~p,ect~tion!l that t~~: ~~~ or ~TS~- -._ 
·. ; , ' +gbt ~· i!Jdi!p'elisa~le, ·_ initial ~cree~i?~ ~~-~di;s -produc~~ . ~ro~ising :.result~ ~i~h . _ 
.. · · ·· · . . the use· of bTSH. C nsidering ·that bTSH ·:was ea.Sier to' obtain commercially ftiis. · 
: ·. . . . . .. . . \ . . . ·~ . 
;·. . . p~odqct was. usea Cor further "ix·p_e~iments. \126r-b1SH-(~20,000 cp~ ·--o.s .. ~M). 
. -· 
: ' . ,: .. ' 
.. 
. . ~· 





' .' . ' : ....J I . ·, . .\ • , , ' . . . ' .. 
_..  .. -. · was· reac~ed .w~t~ -~f il~_ .:'of. su~~~~~- · gra~i~~\ ~~rilied : P?rc~n~ ~hyroid · pl~~a : ,.- · .. >· 
:: membn:e~ . Four~-r per~en~: or the-!~•oael,•v•.ty added waS ~ound. 1828 ~t , . : .·. : : 
•
;_ .. _.· .. ..· • : ' : ; • • . > • :\. -••• i.: . -. . .• .~·. ·. : • . • • .. . • • ·, < 
- . -. . . . ·· .··::\' 
::;: ·.:. . .. •. . ·. . . .... . .. .:· . : . , • . ' · .• . . . ··:·.-~· .. : 
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Table 3-3: · Eff~ of ·HCG ~on ~~· binding ~f 1211-hTSH to 1'828 and ·GC73 
·. .' . 
...~ . 
··~----------------------------~------~------------~------------~ 
.......... l .. 
... 
•, ., ... 
~ . . - . . \ ... 
+ TS28 (1()() .. uglrill) 
+· TS28 .(10Q uglriil) + _ _ 
.. · HCG. (2."5 U/ml)t 
·. . . . . \. 
. . + :rs2s.T10o ·uglmi) + .. 
. . :· · ·,- HCG (5.o·-t~/ml) · .. · . 
·. ·. ·. ·:· · -~~\~2s ·noo, ~~:nit+· · 
· HCG (12:~ l.!lml) · 
·.+· T82s (100 ~gtinl) + • .. '~ 
HCG (25.0 Ulml) . 
--. 
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. dofs ~f 2~o 'JiiJml _and .5oo· pg/mi ier~ added, and t~e percent .or '-i25I~bTSir . · . ~?; 
·_ -:"-· , · , ..- - binding.w~_ I2.2% (SD ~~- an~ -~2:~~- (S~ 1_.8) resp~~t!v~ly. G<(73 at· simi~ar. d~cs · , >~:~ 
(250 attd 500 pg/ml) we-je .alse ~est~d. When ·250 pgfml or GC73_ were added the · . ··:; · 
; .. , • . 
. " . 
. , 
•, 
' . . 
~ --: -t . 
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. . 
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. . . .. . I . , . . . . • . 
. p~rcent ?t ~125I!b_l'SH bin~~~g ~~/8.8 % (SD 1.5) and at 500~£g/ml 6.~% (SD. d~),..; _· 
Thus, the tfion~clona.l Gd73 was· .able to displace 50 % of the rati'ioaetivity bo~nd - -
• _· , '!o • • T . 
to thy.mid plasma membranes while TS28 had no eUect on this assay. 
. ' 
. ' 
. ' . . ' 
3.3.1.3 •. EIT~et or Tf2s .D·d GC13 ~li ~he 'T~B in~dlate-d tli)'rol~ .piasma 
-- ' . ' .. . ' . . . 
. , . ~em~~~ne bo~~d ~C~~on .. . . . : 
' Cont~UiJ!g ~'ith the .. ~~~c_h f()r the 'TSH. site-to which the monodonal·antibodles I 
.. . ~.- · TS2S ~ttlGC73.bind, .'tlie'ir effect on· the TSH m'e"diated AC activation o~-· p. orciD:e · 
' "-t . r-~ I I thyroid".;Ja.S~;~embt~ne w~ studied. rfhis ~as investlgate_d .. using bT~H ~t 3·7°·C 
• • , .,. I . • ~ • ' .. ' .. ' • 
~ - ·.. i~ · the presenc~ · or _tjr ~M .Gpp(Mftp as ~sc;ibed ~b~ve (·2.5}: TSH~ (200-ml))mi). ·._. . 
.. .. ·: < .- res~·lte.d i~ a ·82%}t_im~l~~i~~ ?r the thyr~id;pl~ma ~~mbrane b~u~d A'? - ~~.ti~1ty . 




. ·produced· a to% stimulati?n, _pC73 an ~% stimulation and norma_I..!!Lt lg (N-tat- . · 
. · lg) a 15.6% imulation abov~ basal. ,' • . · · ' _ . . . • , . 
r • , • • i1 • 
-; When T •. 28 or GC7a we~e add~d !.or ~- preincJbation period.· or 10 minutes prior 
""' . . . .. 
-t~ tlie dd:ition ·oC.-bTSH,· th~se antibodies ~au~.ed inhibition o·r the CJW>ccted; 
activa 1on 1pedia~ed ·by bTSH: TS.28 produced; a to% inhibition of the. stimulated 
/ . .. ~ ' .. ~ ~ . . . 
TS a-ctivation. Gq1~. 51~ inhibition. N,-r.at~~~ by c~ntrast caused only a,n 18%· 
.. . . . ' . .. 
·- in ibit~o~ of:stimulated ·AC activity ·(Table 3.4 .a) . .._.. . _, -
• • ... . • 0 • ' • • • • .. 
- • • • • • • t • ,.1 • ' • ~ 0 
.. -·surprisingly w~en either TS28- 0~ GC7-3. ·were. ad~ed .siin.uit~~'eus]y with TSH, 
. . . 
· .· tlie TSH · mediate.d AC activation was · further enhanced. TSH produc~d- a SQ% 
.. I , . , 1 I • • 
. 'stiinuiation. of AG activity ~ . compared . to bual. TS28 (2~0pgfm1 arid . TSR.' 
- . . . . .... . - . . . 
(200mU/ml) ·caused a _. 128% s~ii:nulation and GC73 (250 11g/ml) and· TSH 
. ~ I . . ' - . . . • 
-420?m~/tnl) ail~% stimulati~n (~~bl_e 3.4 - ~)_. T~e results obt.l\ined _with. N~rat-Ig/ 
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Table 3-4: Effect of monoclonal cmtibodi~ Ts28"'luad.oC73 on AC activity stiirrulated 
• • • .. ._ 0 • • •• - - ... • ' • • 
'· 
-...  · . 


























• • ' ' I 
.'100~ 
. .. .. . 
. rsH· c2oo ,ffiu~~l) 
- __. Ts28 (250 ·Ug/ml) 148 ± 30 · 
· ·182:o• 
UQ.o· · ·60~6·· 





-.. ae1a (25o ~g/~) 
.. ·. ~~~_(2~;tlg;~) 
· .. TSH .j/~28 
·. rsH/ + GC73 · 
_._- TsH. + ·N-rat-Ig: · 
. BaSal 
. ·- . " 
TSH·(200 m:U/ml) • 
' ' . . ' 
t ·TS28 ·.(250· U!V,ml) .' 
0073 (2~ usilnl} 
n;H + :TS2S 
" ... -. 
. 'rSH + GC73 
.. TSH + N-rat-Ig 
· · ·145~± 14·. 
1- _155. ·.± ..  9 . . . 
· . . 147±-30 ' ' 
·12J ± 9 
. , 200 ±' 18 
~-· . 
142 ± 7 
225. :f 15 
175 '± 3 
-~ - .. 190 ±' 12 
' ' 
. -325 ± 2 
.. -
' 310 ± 18 " . .. . -
' 
.'154 ± 11. 
N : 6 {a;e~-of 6 pafariels). ··i · 
• 108.0 . 
l 
115.6 
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' . . . . · . . . . -' ' -
. . · ·: • p < 9.05 ·stim~ati~n r~~J>~ ,(M~ Whitney u ·T~): . " . 
. : ·· ~ ~· p <. 0.05.inhibl~rQ~- -~H· stim~~~ value.(Mann ~tney'U .Testl .. '. 
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{";' . . , • · . • 3·.3.1~4~ Dl~euasloli or the ·e~perlmenu bivea*l_gat(na: tb~ elfee~ or~TS28. ·'-'. . ' .A 
,_. • o ' 
0 ~ 1 ° • I I ~ • 0 • ~ ' • I ' • f ' :, 
::;:. ~ · · ~- . apd ·.GC1a· i?n the binding ot~adlolab~led TS.B io·.thytold ·. ·.· .. ·. · :\~ 
. -~ : ~· . . . - . . • . .. . ...~ . . . .. • ... . I . .. • . . ' . ; . ; . -
. :-. : plasma -uiein~r~es ~d on~the TSJ:I-med,l'ate4 AC •etl;..atlqn ,. 
l ' • -~- · -·. -:- • "...... • . • • : • • • . 
· .. :. : Bero\~ int~rpr~tin~ th~ resulti obt~ine<l fr~m the. ~~erime~ts· i.nv.esti:gatilig ·th·e . ... 
.tJit . '· • ,. ,. ... ~ .. . • . • • . ...... • • • . • • . • • .. . • . # ._ 
: ·.·: .. · • . ~ect ·or TS28 . and G07~ · o~ t~e ' binding· .or 1251-bTSJ:I to . thyroid. 'plasma . : - ·'- . ..• 
;:·:·.: · ~~mbra~·e~ ('a.a.'1·:2}'";nd· ~~ 'TS~ -m~~iated_ AC a_cti~~tion (3.3~1$) it is impo~tant· :1 ~~_- ·· • · . -~ 
' . • • • • • • • • • • 0 '. · 
. ·>; to stre~~·-several points. Bo\tine-.TSH and not hTSH w~· used !1ra.es~ \h.: elfec~ of i · · .· · •. 
( ·· .~ :., . .. · the'~m-onoclq~al~ ~~n. i~ese ·z"~exp~r~~~~ta~ !?Y~~ems. Al~~~· ·nei_th~r. 9~ ·{b~ ~two: 1.251: ~-. 
':';" ... : labeled. nionoclo~~lsi·T~28 ·or' GC73, "!'sqowed spe"ci{~c binding to sucrose ·gradient · . :.-:·~· 
... . . .· ... pUrii~d t::..Oid. pti..ma .;.~~br..;. •. -.A . .;...xi~uni Oi ,_:50,Ci0l ~p~ 0!'126[ ·. . ' ' 
:·> · .·.. .. :. : . ·. antib~di · · .. ~.;_<J~~t;? HJO pg ~( p~i!iie1· ti.y~~i~· pj .. ~~ ~~~~r~n •. a~cibj)idmi·. · . ~,: 
~- ~ ·.-~ . · - w-~ less·tliali.~;%. ~If li?t~ . _c~e~:- ·· . • ·· .. ~ · '· -~;· ;~:~.· ' > .• . . . --.: .. ,_ .,,. . ... - .. · .'.·. .., . :. . . . ' ·: ~ .: · .. _;!:? 
.1/.:··· ,· .. y • • • · • AgaJiistthjs· oackgro .. un4_it is :J:e~onab.le,}o .suggest th·a~ upon intera.ctioxf~Ch . :. , ~:: : . <.~ 
. . . . ., .·th:~ . ~ecept~r, _ ~TSH-.~~~e~~o~~ ~on-ror~~ti"o~al· · modification~ ~·uch \~-to ·expose · : · . ··· ,r; ·~ - . ·, • "'l:t. . ' ' ..• # • ·. •· . . . • .. . . : a•l . :_ "j \ 
.·.· ~ -:. epiio~es _whi~~ are· n?w recognize~ .. ·b-y the · mon<><:lo~al . antibodies_ which arc . . ~· 
. :,· . . ·· ·· ., · -~ other-wise highty :spe~iric. r~r.- h'J;~Ii i~ ~ohiti~~- · · / · . · · ·: .. 
·. . .Tbat qC73 added ·~qbe same tin<Bs tlie ligand· can inh:~ii !"bin!ing pf ' . ; 
: .. ~ : ·· "125.1-bTSH, .to thyroid plasma:· me~braties seems to_ indicate .that" -th~ antibody: ·•. ·.·( 
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...... ·· .· 
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Qo1 
·. react~~- ,i~h a~ ~pitope ~robab~y ~ -~-ubupit ·_rel~te~ wh·i.ch be.co~es . expose'd upon ' ... 
·. bind~ng to th~' receptor. q'b_e lae~Of interferenceJn tliis assay ··by TS28 sugg~sts 
• • ~ '• • • • • .. • • • ... ... • • 0 • ~ ., 
, eith~r t~at· bi~di~ d~e~dent ~con~ormation_a~ ·~c~a~ges in .. bTSH does bot l~s~lt in..;,.,.) 
.. a e·pitop_e rec?~izable t>y· TS28. or; else t~"a"t it 1uch a· site. is'_gener~t~d, it js \6ot , · 
. ·. . ·. . . . . ... . . . , . ~ 
relev~nt to th_~ TSH _bin<lJng.__ · · . ~ .. \.. ·. .~ . . " 
/ / - ..... 
• . •. - . f · . .., 
. 'I:~ i~te_rr~rence ~y .bo~~ ~ . anti~~djes JYi~h ~ t:e. T~~~~li~_en AC ~c~i~ati~n . . 
demonstrat~ that both. ep1topes bound may have ·· 1mportant functtons JQ ~ 
• • • • ~ • • .. .. _ • .. • • • • • • • ' • 0 ~ 
activating signal d·elivery.)n~restingly, when TS2S or GC7~·were~reincuba.te~ in:- ·. 
.· . - . . .. · : . . . . . . . . . . . .· / . 
the pre'sence· · or the .11\e.mbrane pr~paratTons before the -~ddition, or .· TSH they . . 
~hiblt~d 'the · TS~-ariv·oo· ·.A.c. ~ctiv·atio~~ ·~~ cont~~t, ·wh~n· . tli~~ ·w~r~ · add;~-· · 
~ · 
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~imu.ltan~usly ~wit~ bTSH they further ~~tanced the hormone's effects. The 
. . • : , . • 7 
. ·auginentatio_n· in _._TSH·dri~en AC a~tiv~ty caused by the ·simultaneous addition ·or 
·.either ~onoclonal -antibody may be interpreted as the occurreiice or a •cross~ 
linking··· by .- th~-m·onoclonaiS or: th~ ·receptor .bound bTSH permitting receptpr 
' . . ·. . . . -- ~ . . -~~). . -
·,aggregation al\4 clustering as has been · sho\Yn lor other receptors (Schechter, .. 
- . 
· ·. He'rnJ~,e_z; Schl~singer and · Cuat.rec~as, 1979; Schlessinger, 1980). 
' .. 
·.· 
· 'l'he · incubation or' the · monoclo'tals -at 37°0 ~efor~ addi~g TSH may h~av~ 
' . 
allowed them to adopt an .• active conformation~' such that"they prqrriptly bind 'to 
.· ·. bTSH .aS. soon·· as· lt binds. to the ~eceptor and exposes .epitopes. recognized ··by these · 
. • ' '"": - . ' • ... ~ . I 
monocloiials. The · fact tpat radiolabeled monoclonals we_re unable to bind porcine 
.. - . . • . i .. . . . 
th.yroi~ · memb~an,es in-any significallt· quantit)•atcompared. to N-ra~Jg· an:o~s-- one 
to ~ex~,ude the p~si.bili.ty . that tlie. monoclona)s \ecosni~e sp~Ciric e~it~pe~ at· ~he . 
,. . . ;, - . . 
level or the TSH recepior: 
. . . 
... ... 
·'· ,. 
· . · ~ : -T~e·~e ·~tu.di~s··s~ggest. that :~pon -~i~d~·g ~o t~·~·· !~~~ptor T~H ~ppears to ,undergci 
, . • . ; " • • • • • • "- • t • s ........ • 
' . ·c6nsfderable conrorination~.l c.hanges._ These chan~es -~ppeat .to be essential for t.he . 
' - • ,'• ' ' • ' ' ' ; \ ' • I • • 
· ·.; .ln'du.ction. ·or· .adenylate,"cycl~e· activ;ltion~ It .also appears that some . hormon~ 1 · 
·.-: ·_. ·do~ai~~ : ~re ;rrtore· ~~port'ant that. ~th'ers for r~cepto~ 'bindi~_g. ·.Thes-e d~ta . we~:~ 
.... , • , 111 ,. • • , • • • • • • • • ~ : • • •.- , , • • • • I , : -
·crucial. in suggesting· the use or these.monoclonals to raise 'anti-idiotypic antibodies 
• ' •• '. • : - t ' • • • •• • - . • • •• • _ ,. - • • • 
. .. . . . that might be expect~d to represent •,intern~l images; or the TSH subunit sites . 
~ - , -th·~~ int~~a~!~h ~h~ roi~ep_oor: .· •: . . .:( :' . __ - .· 
., • • : ; • • . . • . •• . . . • J • • • . • ' • ; · • • ' 
: · ·8~3.a ... Prope~tlea_ or the lnterac~~on"s be.tween TSH-sttbunlt specific 
• ,. • .. • • • QJ • • • . :. ... 
. · . ldl~typle/ antl~ldlotyple antlbo~Ue_s -
. ' . -~ . 
, • 0 • ; • , • - · • • • • • • • • 
. . _ lmmu_~og_lo~ulins obtained from·- the rabbits immtinjzed . with. either· TS.28 or 
t. • • • • 
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:• • H • • • ' .·· ;; .... ~ombt~atiOJ! .·exhibi_ied biolo~cai' a~·tivity~ 'I;~is corr..espo~ded. to lgs r~o·~ ~Iie ~ . . .'. 
r::. · · · · · ·t\_··.· 1 · . ·rab-blt .imfnuoized · ~it~ .~ TS2s.· (~anti~:id)'·_~d one.''~aJ>bi.t _im~uni~_e_d wi.ih .··ac73 . · ~­
Jt' · ..... · · ;·(~antl~id). ·;These two lgs' ·in· c~nibinati~D:· ~ere .· ~sed iii the experimenis . to be · · · · . · ~ ... 
~{..,..~ . ...... ' ' . , .. ' ·t .; , , . r ·· ·~ • • . · _. . . . . ' ::,'_.~·.:. ~/,·:. .. .. . .--_ described. ~ · · · ·· · · · 
lJ :. ' • ~ . . • . . . • . ·. ·, . 
/':,. . ' · .: ,• I ' ,,' . ' • . t "" . . . :! 
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3.3.2.1. B_!ndlng of antl-ldlotyple antibodies wlth TS28 and GC73 
. . 
The anti-idiotypic antibody pi'epar~tions were . tested · for binding . to the 
. . . 
complementary monoclonal antibodieS. cr-~nti-id bound 31'.6%· (SD 2.1} or the 
125I-TS28 ( '""SO,OQO cpm). ~anti-id. bound 58.6% (SD 16.0) of the 125I-GC73 
. . . ,. 
( -..50,000 cpm). NR-1~ used ~ control bound only 18% or_ ihe radioac.tivity in the 
:~ase of 125i-TS28 and 8% of the radioaciivity .· in the case of ~~5I-GC73. 
• - - - 4 Radiolab~led N-rat-Jg bound 20.5 (SD 3.5) of the o-"'·anti-id and 14.4 (SD 4.7) of 
the p.anti-id added (Table 3.5). 
3.3.2.2. EfTect of._the antl-ldlotypes on the binding or 1261-hTSH to 
· TS28 and QC73 
To establish if a-anti-id and P..linti-id lg preparations comprise •internal image• .-
. ' .. •· . antih~die~ their effect on .the binding of 1251-~TSH . to TS28 _and· GC73 was 
studied. · a-anti-id hi conce.ntrations of .up to 500 ,gfml was unable to inhibit tlie. -
' . 
bin.ding or the r'adiolabeled . ligand to TS28 or GC73. By contrast· ~anti~ -id 
' -· - - . . . 
dispfaced tb_e binding o( 1251-hTSH to GC73 in a dose dependent ina~ner . . At; a ; · 
# ' • ' I • • I , -. . 
· dose-of &00 pg/ml 48.2% of . th~ label .. ~as: . displaced. P:-.anti-id l!ad no ·errect in . 
- . . . . . '"" . . . . . 
displacing r'adiolabeled ligand boun_<!_ to '1:828 {Table: 3.6). These findin~s sugg·est 
that only P:anti-i.d _represents_ a. t.rue ~ int'ernal image. anti-i.d~otype . . 
- . 
3.3.3. Bioactivity of TSH-s:ubunlt spectnc anti- ldlotyplc antibodies ' · 
·. 3.3.3.1. EfTe~t of antl-ld~ ~~.th~ ~lndlng .or 1261-bTSB. to porcine 
' . . t 
. thrrold plasma . membr.ne~. ·,~ ' 
Neither a-an·~Hd· n~r P:M:1ti-i-d nor ~heir combinations were cApabie ·or inhlbitfog 
th~ bi~di~g .or 1251-bTSH ~to porcine. thyroid pj~~a memb~ane~ above tbat ·~aused· 
. . . : - . . ,_ 
by NR-Ig .. P .orcine thyroi.d pla8maJmembrane bound 14%. (SD ·1;3) of the addpd 
~2~~bTSH. ( ~2o:ooo cpm ~9.5. pM). Jgs fro~ . the r~bbits iminu~ized .'with GC7a· . ... 
. . (2S~ .a.rid 500 .~g/ml) - ariddof tho~e ·~mu.nize4 "fith Ts.2s. {250 a~d 5~ ·~~gfmU were. · 
used for competition assays. _Neither Qf -th.e fou·r lgs. altered, ~he binding or the 
_ ·. 12~-bTSH. to the ll!embrane preparaii~~~. NR·Ig (250- ~and soo ',sg/ml) wls also 
.. 
/ 
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1~5I~TS28 (TC)• . 
+ · a-anti-id (500 ugtml) 
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125I:N-rat Ig (TC)* 
. 
+ a~al}ti-id (~ ugtml) . 
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+ ~-anti-id (500 ugt~) 
... 







































. •: 'totai"-clnlfits;-Percent-of binding from total co\mts. 
. . 
. . 
·~ - . . 




(%) ± ·s.u. 
. 
. 
31.6 ± 2.1 
-· 
18.0 ± 5.1 
~ r· 
58.6 ± ' 16.0' 
. 
• 




. 20.5 ± 3.5 
. 
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TaJ>le 3-6: 
. - . . ; 125 . 






. ... . . 




' - Binding I .... .. 
(%) ± SEM 
-
- . 
125I-hTSH . + TS28 (100 ~~~) -~ 65 ± 0.5 
- ' 
+ TS28 + .a -anti-id 71 ± 0.5 
(12§ ug/Inl) 
'' 
+ TS28 + a~antl-id - 70 i 0.5 
. ·. (2_50 u'g/ml) ~ 
. \ . .. 
· + .TS28 f ' a-anti-id . . 71 1.5. ± 
(500 ug/ml)' . ·\, . 
-. 





125 ; .' . . - - . 
.J-hTSH +: G:C ~73 (100 ugtml) - - 63 ±.2 
........ 
~ . . . ' . 
' 
_ ~: .. + GC73 + . ~:-anU-id . . 59 -± 1 
-· 
. 
., . ., ~125 ug/ml) _. . . . ' 
' 
·.+ · GC13 :+ ~-anti-id • .. , 54 ± 1 
-
. (250 UlVIftl). , . / . -~ . ' . . 
-
+ GC73 + ·13-anti-id 32 ± 0.5· ' 
(~~gtml) . · . / . 
' 
- -





•:._p 0.05 campared ·~ tot.aHxmnd in absence of anti-idiofypes, 
.-
(Mann Whitney.U~ Test). 
. . . 
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- '> ·. - . . - . . un~~Je ~ •• :.: - dbpJaceLt \1: radioactiv~~ bou~d. ~our pi;ble ,· - i . ;· 
.. . combinations between ·antibodies ·rais~d. against TS28 arid· -those raised 'against 
:.:. GQ73 (equimolar ~ixtur"!' ror final co~\Y ... tr~ti~os or ~So ·~d 500 pg!ml) were . 
... ,. ' also unab~e to- dlSplac.e . 1261-_bTSJ:I .from bu~dmg to porcme thyro1d plasma 
, . . 
~. ' 
I • ' 
·-· 
' . ' 
; ·. : 
·;. ·.: .. 
I -~ 
' -
:-··' .. . 






v ' i . 
., _ 
...... · .. ~ 
'·· . 
. ·, 
' :· . . ' \ ' . ' . . . 
membr~nes. . ~~~I-b::rsH ~in,ding i~ .t~e pr~ence. of .the a-anti·i~. (500 pg/m~j ~as 
14% .(s}? 1.s): ·~11: the ~~e~ence·o~ t~-~nt~·id cs~<l pg/ml) t~·e binding was i4.7%. (so 
1.7.). With NR-Ig (500 _#Jg/ml)·the binding wu:·.~omparable .at··.I3.7% (SD 2.3): 
. : . . . 
• ' • • I • \ . -
3.3.3.2. ·Binding or radlolabeled a-antl-ld and radlolabeled P..antl-ld to 
. . · . ' · . . ·. : . · .... ,_ - . ~ . 
. porcine thyrol.d: pi~~ a }Dem~ranes. ·,, . 
'· , _. 
·Examina;ion or ... the· binding .or 125i labeled·· a ~nci p.anti-id·s' :i~ p~rcine thyroid. 
--~~~rna · membra~~ ~a8 . done : ~s'ing 100· #~ or ·purified p6~cine . tbyroidJpi~a 
• me~~~aoes -a~.d ~~IJ,oOO ~)imof tb~ ~~~ed ~iiti~o~!es (2.11) .. ~byr6i~ ~~"!'~~ 
·. membrane bound 3.1% of the 125I-~ant1-1d. ' Thts bmdmg wa8 diSplaced 10 a dose. \ . . . : . . . ' . . . . . : ' ' . . . . ~ ' . . . . . ' .... 
· depe.ndent ~ii~ner by . both -unlabeled bTSH and unla~eled· .. ~an.ti-id :· bTSH {500 . 
. · .. . ~-t:J /~I)·di~~la~e~. -~s~··o(th~·. radi_o~ct~~ity :bo~~d ·. (Fi~. ~p.: ·p~iRb~led Cl'"~~ti-id (i_~ 
· · mgfml) dis.place.d ·41%.or the Jab.el bo~nd (Fig ~.10). · . .. ·: · · · . '· 




, '0 · • 
' .. .. 
. ' .. ' • 
. . ...... 
' . . 
. ' 
·,· 
. .. ' · . 
.. 
:·- . 
. ~ .. · . "' · . . . . . ' .. ~. ·. . . . ·.... . . . . .. . . .·. ·. . . . ' . . 
Using, 125I-p.a'ntHd 2;~ % bound tri tbyro~d pla.Sma ·m.enibt_an~s. Both unlabeleq ·' > 
• . • • t ' . • • • • 
bTS.H. ·and . uniabeled P.anti~i'd· produced . dose depen.dent ... displac·~inent .or the! . . . ; ·· 
• .... ·.. • • ' • • • .:. •. f • • ". • • .. 0 • . • • • ,' ' • . . ~ ' • - . ' . 
label~d .· ligand. bTSH {500 mU/ml) · displ.aced 34% (Fig 3.Q) ·and· unlabeled . " . . · .... ·. 
·· ~a~·u.id (l .~gh~I): ts6% ~rth~:~ad~oactivi~y bouri~l'(Fig a. to). ·. · . > · .. ·. · . · · · · ' : .'~ .. 
. - . ( . . " . - . . 
.. 
' . 
. . ~- .·In oth~r experimenb ~rial am~~~t~ or -~anti~id ~nd P.:a~ti~id w~re .Jdded in the : ··. • ·. ·· · 
,. • • ; , • . ' • , ~ ' . • • ' . . , • • . , . • • • • , I • , , • , , • • ' ,' ' 
. same test tube to achieve an 'amount· or radioactivity =equal to. that obtain'ed with . •. 
. ·.: . . . ' . . . . , . . . ' • . ' . . .. . . . . '. . ; . . .. ·. . . .. .. ~- . . .. ... ' ' : ' 
· . each .antibody aJone · (I'V5Q,OOO ·.cp.m). . The ·binding oT the an'tibodies .. to ·thyr6id : 
.·. ~ 
: ;: 
' • • t, . ,-_: 
. . . . - . . 
r~:. ~ . · . , plasm~ nie~br~~ W.aS:' _ .dditi~e; 5_2% of i~e · radi~acti~e : ~iibodies_ b·O~D:d ·to . · . . · ,: ~ ' .:_.-.. :.; 
; ..'' 6 • • • .. . • .. • • . . • \. • . ' . : • • .- ' . .. -. w ' ..1:. - ' # . ,• ' . . . ' . . . . . . ·.· . •. ·. :' 
i ~:. thyroid plasma membrane· p_reparations .. . Forty per~en·t of. ilie :·rad,ioactivity ·w&S ·_. · · .. . · :.-
, _. • • • ' • • : .. • • • • • • • • • ' ' • • •• f • • • • • • • -"' • • • ' • •• .. . •• •• • . . .. 
:/.-:. . . . . ~is~l~ced . h! 500;. mU.(mi ·: o~ :br.~H · .(~i_g: ~J~). ID 'e~perim~n~ · ~~~e~Jn ::~he ·,- sl!Jile\ ·: . · ·.: . . ~--~~ 
... .. batc.h . of p~rcin~ -~h.Y~?id .elas.~~·. ~~!Qbrane 1.7.% of_. ~.251-NR~Ig_.(~~O,~ _:c.i>m) ._: .. .. · : ·. ~:~:.~. 
:·:· . . WaS found to bind. and .riati.ve bTSH d~pj&~ only· 8% o(tbe. riidio~cti~lty bound . · . . .- _: · ... . . ·.· 
~(:·. · . ·~· . ·~ c~i~a.o)~ .. ·:. · ... _.·. ~- ':.\ .:.-:· .. · .··. · .... · , ~~· ... :·~ .. _.' ... ·- . ~: .. · .. ··:< ... :. < ·.: . ·.·"·-.. ·., .. : ·.> · .·• .. ~·: .. · 
r: ".;.·._ ..::.· f. . ·· · .. ... ~.<· , .· ... ... :.·.-:· ..... ..  \ ... . . ·. ·. ··· .... ... : .,:.·.-..... .. . · .· '·<.>·· · .~· ... · . ·'> . .. · ·:· ·;:~ 
.~! ~:G' ,• .. ' . ~' . ! . . • :· ' : • . . .. ~ ' ·. ~ .. . . ·· .. 4.: ., . . : ·.· ...... · 
~'t:~;,~~;':{~ (,(:·:;v~;;c,.:: ,:/; ~ U. ; .. ::· , . ; . :;;;:. ·:.,;; { : ~-. i :.'::., ,~·,: :: ~ ;; _'. , ~.\, ,·~ ;;: · · ;, :{ :•: :. ' : .. '. :s:::·: .. ; .;, ·.: ..,:., J.6J ~~~~-~$Jltr,. ~)~:~\ ... r~! J.~ ;J;: .. \t;-."~~ t_'t) :~}~.;~~t?.;\.t-&~· ·,1, ,("1;:\'t) r·, :~.;o ~;-. : '4·~~~t )~\l· -:,:'_:.1; .. ;;!~\.~·.1 .\~L~jj!~~.~ ~~:;.1.,_!;-$/1 ·: ~~;·)~· 0 ·: l~\,~o }.~";J~}l.~,.l"'".,·;,,~ ·-'.~'("r~,, ";·-.':,1-~';,;~~ ;-:.;!:t:;~'-t,.~~~.:/, ·~ ~ .. :_.,~~!'~.."~ •," ~'•' ~~ ~)'j"r';)~ ~ ' ~ ' ' ~ - " - ~· ..... '1, ' u.. • f "'l.o II'\;{, ol'l' •_r , , 't• ... ._.., : _-......... ... "Jf lf' >ool o •lfl:, ., .-#~'} ,. • • I I'~ 'r# 
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Figure 3-9: Binding or.125I-a.:anti-id and ~2.5 
~d displacement by bTSH. . -
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':· .: These results sh~w. th~t a1and tJ-antHds...bind to thyroid plasma-membranes. Tie .·: . 
. •' .. ·. . . . . . . 
displacement of .~hi~ binding by native TSH suggests spe~iricity for its ~e~ptpr. · . 
. / . . . : .- ' . . . . 
. The fact that the binding of the two antibodies appears .to be independent wlien 
.. . . . ' . ~ -- ' . . . ' . ' . . 
tested in com~ination·suggests -~he presence of two distinct ~binding·site~:Finally,, 
as _showxf .in figure 3.9, it can be stated th~t the- binding· of - 1 ~51-NR~Ig t~ ~~~rna· 
. ' 
;:. ·.:.- . 
floi"' 
~ • • • J 
membranes is lower than. the residual bound anti-ids even in the·presence of large · 
. ,. . . . . ... 
amounts Qf native bTSH. This suggests either .. that part ·or the anti-ids are bo~nd L ·. 
to m~mbrane sites ot~er than those bi~di~g:TSH or .more likely that· a fraction of · .. ': . . 
. ' . 
~-:- -~ . 
: ·. . .... . th'e antibodies ~ve ·boun,d irreversibly. The _latter possibility is strengthen~d ·~y 
' the fa.~t th_at tbe residual a~o~nt of bound. radioactivity is higher in the tests in 
. . .· . ' ' . . . ~ .· .... . - . 
which the combination of antibodies· was used. 
·:;. . . ( _ 3.3.3.~. Efr~et of ~ant~·ld:~d-. ~anti-id ~n _the thy~~_ld flasm&_~ -~ -
;: ·· · ·membrane-bound AC ~ctlvlty : . . · · · 
·._.·· ·:.·-.;.· 
'. ' .-·. ;~ -
•0 . ' ., 
' . , '. ' 
' , . . · 
'. . 
. \ • 
' \ 
, . 
. - " 
'\ 
·· , ' 
.. 
. . . : 
····. ,, 
~. • '1 
., 
. . ,.,. 
. _ :, 
:.,: :~• ·, , • , ·.· ' . • ·. , . . •• .. · , . ' .I ,' ' • ' , •, ' ' , • , ' , , ' 
y;:.:.: · To· determine th.biological actiyity' .or these . antibodies, tlieir effect on ' tlie' ·' · ·. :· · 
:: -~··· ~ . .· . _.activity of' the · thyr~id· pias~a. : memb.~ane bound AC. was iriv~stigate·d: a.t 37°C in· .· · · · · : ... ·· . /··~./ 
·:··:.. . the pr~sen~e- ·of .lO.pM Gpp[~p (2.5)• W~e~· 2.50 pg/ml 'of--cr~ti~fd o~ . ,8-anti-ii :.·.. · _:·:L 
·~·:. : .  .., ·we~e ~ested ·ai~ne they·. ·~a~sed inhibitiq~ cir ·th_e basal a~tivit~ -~~ -AC; &.8% i~ th.e .. ::·· :::-
').. • ' • • • • • ' o ' • • I ' ~ • • • 
: . . · ·. · -- case of a-anti-id . and 7.5% for · ~anti-id (Fig ·3.11 shows the results of a · typical 
~-:·---· ~-·- -·--~- .., _____ ..:_ __ , __ _ .:__ __ ______ . __ ..:____ . -;--- -- ·---- - - - - .. ·- - .. . ~-- ------- ·--,---~-.:..· ~· __:· 
experiment) .. W~en. both antibodies wer~ __ tested in~ equimpla.r c~mbina.ti~ns (125 . · 
- ~ . . . . . . .. ,. . . . . 
pgfml of each) the mixture-produced a marked enhancement or the· AC activity, 
90% stimulation was obsgr.ved ·.(Fig 3.11)' . . This value- -~~ e~ivale.nt to .that . 
... . . ' ... 
·induced by 200 mU/ml -of bTSH. bTSH (250 mU/~1) produced a. 101 %. · 
. sti~ulation . fro~·· bas~l (Fig 3.11 ). NR:.Jg '< 2~0 . l'g/.rpl), used ·~ ~on trol, ca~;ed ~n . . . 
. . 
. ' . 
;' : . 
f, •·. 
. I 
• ' .. 
. . .... . 
.. - · .. 
~· ·> 
. ·· . 
~pprqxfmat~ly 5&.% inhibition frqm the bls•a1 ~al.ue. ·. 
. . . - . . . ... . ' .' . .. . . 
. .. ~ ... 
. :·: 
. . . . ' . ~ .. 
~:·;~ . ·. . ·rh~se ~estiTts suggest ·a cooperativ~ Interaction .. betwe~n the&e\wo .antibodies in .. ; 
~ k . ' . pro~Otin:g Ac ac~i'V&ti; in that ~ither or them altine,depreSsed' the ACactivitt' - ~ .· ·. : 
::;( .· : · · bui in· co~bi~_atior,1 -th were able _to enhance it muc~ ·more than . add_iti~ely. .: 
·:: ·::,~ ~ ·. : ·· . . · ·: See~i~gly tbe .bindhig or .o~e anti~i·d increases tpe arrinity of the c:>ther for .specifiC! .-. . · · 
f:~ :. -' : · . ~ , .. · ·. sites on th.e· thyroid plaSma rriembrane. .. . . . -. ~' :_;;~ 
.. :.{,·~.· . • · ••.. · • . \ r \ , , j • . . • .• , . • : ~ .-
- • ' • ' ... • • • • • • • • • J ' • . ; ' . . 
.{~t:-:--~-~ •. . .' ., Cl • • ' • .'.: !; 
!•"'·· ~ . • • • ... · • ~ - . . .•. •• · :,.·. 
v-:-"'-... ·.. .- :... . . I . . . . ... ~{:\\ ... ,.:· · ..' ~ < .. ... ~ ·' ·1.. . ' ' \ ' ' . , ' ·.:· .. J ~~i~~)~iJJfKL·.·~:; J{.;:,: ; • ,.:: ~); .. , .. ~);; .• (. J.·:\;. . ., .:-:. ,,, i2···. , _ -. ·:.: .-,,:,; 1 ;-~:.: • .' ••• ,; :; ·, · ; : . .•· .• :- -~ -~. · ,,. :··: .•• ·;;.~( ·i:~~~,;]j 
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thyroid eplthe lal cells · · ~ ., 
I 
Ra:di~acti:ve iodide uptak:e by_ thyroid epithelial cells. _was me~ut.ed ·after tbcs,e 
cells were iriCu~ate~ lo J hours with either bTSH, ~ o~ .~'"~ti-idS or NR..fg and • 
tb~ ~\the pres~nce or 1 1N - or ~0 ~inutes. The .time' ~4 hour_s . ~as chosen 
. .. · because o_f the results _obtained in previous experiments (3.1.5), which 
demon~trated o~ti~al u~tak~· . after · this · -incubation · period. a-antl-id in 
conce~tration~· or up to .-soq p.gfml had no effect. on sti~ulating rad~ola~ele~ iodide 
• uptake: P,.anti-id. in ·similar·\concentrations p~oduced a 7.8%-uptake. a--anti-id plus 
I I ~ . . . 
, ~an~i·i1 (250 pg/_mi of eacli).,prod_uced ·a 8.33% uptake. Nfi;..Ig (500 p.gfml) bli,d ~o 
: . !'rrect. b:SH (100 mU/nJ) p~oduced a .10% uj>~a~e. whiCh• was . not impio~ed 
. when 200 mU/ml of bTSH· ~~reused ('fable 3.7) · , . · - · . . . "· 
a.3.a.i. 'E~Oet Or ,;.anti~~ , And 1'-antl-ld oil th~ organli~tl: of eoltur~~ ' •• 
• ·l. 
. . . . thyro.ld eplthelt~~ cells . . . . .. : . . .· . ·. . ' : ' ~ . . . 
. T~e : effect. o;. ~he ant1~idiolypes ·on ~he org~nization -~r eti:It~red ~by~ocY.t~s w~ -
·. . . . . . . . \ . . . ' . . · . . · 
·studied. ov~r ·a period ·or _7 ~ays. The ~ells cUitured hi.·the .presence or cran~i-id 
.(250 pgfml) 0~ ~-lg (2so · \pgf~l) . grew. as unifor~· rnon~iayers. p..anti-id (250 
pgfml), h~wever• ~ro~~te~ ihe :· organi~~ti~n 9r small folli~ular structu.res. The . • 
ad,dition to the culture medihm or ~qual amounts ofcra:nti-id and .8-anti-id _(.12'5 . . 
. . . '\ . . . .. . . . ' ' 
pgfmJ ,0~ ·_ea_ch) pr~moted_ \the org~t;liZa~ion .· of ;larger . f~l.Jicp.l~r struc,tures 
C.~mpar~b~~ __ but CQI?Sist~nt~y sraller.~han ~h~~e· obta~~ed_ :Wlif~ eel~ Were CUJ~ured_ . 
·w1th: IOO mU/ml of- TSH lF1g 3.12). ThiS mformatlon .-~ obtamed by stmple 
I . \ . . • o • " . 
observatioi?. No :specific niet~otl t~ measure "the sizes: of ~l.licular ~tructures_ . 
:W~ -deviced. The -follicular .st~uct~re~· rorJiled .Wer~ active ·in prpd~cing colloid. by 
. I . • . I ' . . 
. day 7 in cUlture as iS ~emonst~ated by' tb~ abu~dance . or ~AS positive material· 
. ·. i ·. ' . . . . ~ . 
·contain~d in the central area .ol the ·newly Corrried lol1icles (Fig 3.13). · . 
I • . i . .. , 
--
. , 
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Table 3-7: Eff~ of a-anti-id, ~-anti-id and NR-Ig on the ~o-i1xline ~ptak~ 
. ' . 
··-




Concentrations (%) ± SEM 
Control 5 .3 ± 0.5 _. 
TSH -100 10.0 ± 1 
mU/ml 200 1o.a ·~o!s_ 
a~anti·id. 250 5.9 ± 0.3 
· .ug/ml 
.50Q . 5 .9 ± .0 .2. 
{j·anti~iq · · ~ ... 250 6.1 '± 0.5 
Ug/ntl 500 7.8 ± 0.4: 
a-anti-id · .~ :250 . 8.1 ± .1 . .3 . 
. + f3 -anti·id. .50() 8.3 ·± ·0.2 
__ ·,NRig •' • 250 -6.7, ± ·o.a 

















.. . ·m 
. . . 
~l05 from basal,t>r .compared to those obt.aiped in presence of NR-Ig 
. . • ' . 
(Mann W!Utriey U TeSt)~ 
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Figure 3-12: Effect of TSH and TSH subw1it specific anti-idiotypic antibodies on the 
organization of thyrocytes after 7 days in culture. 
a: a -anti-id (similar picture was obtained with NR-Ig). b: TSH. c: {3-anti-id. 
d: a -anti-id + {3-anti-id. Follicular structures are observed in band d. Smaller follicular 
formation can be observed in c. 
107 
Figure 3-13: PAS and PAS-haem alum staining of thyrocytes cultured in the presence 
of TSH for seven days. 
a: PAS-haemalum. b: PAS. c: PAS-haemalum. 
Arrows indicate the PAS positive colloid in a and the follicular structures in b and c. 
(Staining and pictures kindly performed by Dr. G .E. Fahraeus-van Ree, Thyroid Research 
Laboratory, M.U.N., Nfld.). 
~.-.;_ .. :.~~~ :?;:; , ;?; ,:, '(;~ r., ... ~ ;· ''"' ·~ : ··: '5:::~";'7:'"'' • . '.·· CC"'!:. , . ·.· .•.• :":' .· ~·;;:::? :~· ~.;: :' •'~ '·:i~f'>''-~ :•:r~:' ~ ''''\ ·;r~\r:;?i:~.~.: .. _ 
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- :' 3.3.:J~8. Interaction.~ ·o-~tt.~td ~d f)-anti-id. wlth protein blots or~ . :J:: .·  
. ~ . .......,. .. ....  
thyroid plasm~ mem))r~.!B ~ . \ 
-.. : 
The final exp.erimimt. carried o~t ~ith , a and .f foanti:ids inves~iga~d the -
• 
- . . . -in~eractroD ot _individual antibo.~ies .~r .their. c~binatio~s _.with protein bJo.ts or ~ .-
. . poJ;:cine thyroid pl~ma membrane, to . . !est their eapacity to -bind to· the 
.· .. : 
, . 
. . - . . \ 
iri_tmobilized rece~tor_ band. It was o~erved that ne1the.r a-atiti·id ( · 1 mg/mi) nor 
't~--anti-id . (1 rngirnl) alone, p:r:odueed positiy~ reactions at' the Mr-; Ig7,6oo band 
. . . - ~ 
levei (Fig 3.14,· Ian4es 3 · ~nd 4). The· combination or . ~qual a~ounts o[ both 
~ . , . . - .. . . 
antibodies · (50~ml. of eac~~~ ho~ever ~.., ploducesl a cle~~iy ~ositive b~n·d ~t the '!'" 
. Ml" -~ . ID7 ,000 holorec.eptor prot~no ~and (Fig a:14, .Ia~~ 5)>1t apJ?_ears 'th.at the 
binding: ~~ ~h~)f!div . i~ual _a~ti~ids ·to .:thi~. ban~ ~as ~r~r~!atively_'t~~-~W~ity .and ~ 
they. could havJ .been (Ii~sociated with the high .salt concentration. present in the 
I . · . · , · · ' • ~ · _. 
buffer us~ (2iJO ·~ Nac'l). The CQmb.ination df the ·two anii-idiotypes appclfre'd 
;- . . .· . ..., , .... ..; ~ . . .. · .. ~ ' 
. - to have enhanced . eacp otliers . af(inity- for. the .r'~ceptor in 'k~eping · with their 
, ~- .c~perativ~ intl!ricti~. · : It· is . i~piicit -in ttiis ·~x~a~ation. tbat·the ·i~'mobilizci 
' ... . . . ·.. \ - -. . ' . '-... . 
. ·r~ceptor is · ip aoll)e ~ay-:· ~ap~ble . o1 ~nde~ing certain t~te or ~conrormatio~al 
. • • . \ • 0 - • . 
changes upon interaction, witli. one antibody to increase the affinity of binding to 
. . ... . .. 
the site recognized by· the sec~~d .antibod)'. It could al!io be }>ossible that the two 
-antibodies are capable to' iht'eract ll witli - each other in" a - c;ertain . rasbio'it that 
I •• • . - .. 
proVides a conform.ation with a higher ·arri~ity for the receptor . 
~ .' , ~ . ·. J, 
. 
.. 
3.3.4. Discussto~ ot .the ·-results in:vestlgatlng tJte bioactivity or the ~ 
.. .. ·. ' ' .. 
. · ,AJpha~6ht1-ld ""and the Beta-antl-ld i&ntlbodl~ 
The findings descrih~·d · sugg't that · these,.,a~tibodies ·deli~~r. tw~ .separate but 
.co~p~.r~ti~e ··signals. upo~ · biq_diii~ to t\e rec-~ptor. Thes~ are likei~ec~a-ry (or · 
• • • 4 .. .. 
-the c.onformational · clianges · which trigger the receptQr medi~ted events. That 
• a . • ' • • • 
,. ~anti-id ~rausmit~ the hormone. specific. ~i~ri.ls is suggested by th~ fact that it -
-: exh~bited ~me biol9gical -ac'tivjty .~n . j~ own in som~· of tlf~ situatt~ns exami~ed • 
' ·:By ·contrast ' a-anti~id does ... not seem k> have su~h· an .. ~rrect, ·but appears. w 
· q ·.' -. ' - ' : • . • ' 
·io.cie·ase 'the hin4ing 'activity ~of~a~ti-id. This can .bc'~cbieved ·by mQdulation.or " 
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the 'FSH-R. s~cb ·as. to enhance the .binding. affinity for ~a~ti-id. Another 
. . . . ·. ' . . . 
'possil)ility is ~hai a-anti-id modulate$ · iJ-'anti-id to produce a · conformation 
. ·., ~ .. . . 
recognizable to the TSH receptor:'i'his function. appears t.o require certain ~Jpecific . 
. . 
.: .structure because o!her .anti~odies tested were unable to trigger similar .activation 
as did this- mixture or anti-idiotyp~. The ·latte~· could even explain why a • n~n­
internal iqtage• aliti-idiotyp~ · is ·capable 'oi enhancing th~· •internal image• anti-
. . . 
idiotyp_e iQ produc~g its biological activities. . 
.. . 
Another _important ,observation is:_ the functional ·· dissociation between the 
_· in~bility or these antibodies , to i~hii>it 125hbTSH-. binding to thyr~~-d ·plasma 
. . 
_ membranes and their P<?Sitive ; infitienc~ on· AC activation. These results are 
consisteril ·w~th the se~egation .or each function to different rec.eptor domains. 
~ . . . 
. . . . . . ' ~ . . . . 
This prqposal is substantiated by the finding tha~ some monoclGnal antibodies 
raised~a~iinst the TSH-R inhibited 12~-bTS_H . binding but ~e~e unabi~ · to induce 
·AC'. ac~~vaiion; while oth~;s ~~d : t~e opposiie effec( (Valente, Vitti, ·Yayjn-,,Y~vi.b,~ 
Rotella, .Grollma~, Toccafondi a~d Kohn;·IQS2): 1 • : • · •• • • - • 
. . ,. . 
. . 
.. 
. ', :. ' 
. .. 
. · ' In summary the ~nti-TSIJ·-subunit·.-specific &:nt.i-idiotypi~ ·antibodies-represent iii-~ 
. · ~ombi-~ati~n; :.fsu .. R. · spec_iri~ .ag~nistic ~-antibod-ies, · c~pabte. Qr bi~ding .' and .. oi~ 
' ' ' .. • I ; • ' ,' • • ' • • 
. activating post bin~ing events. The .results obtained .su-ggests that the anti- · 
· idiotypic . an'tib~dy ~P-proa~h .des·crib.ed ·here repr~sents· a g~d mJdet ror the ~tudy , .. 
& ' • • • • • :·~, 'I ~~ • ' f -- ' • 1 
. ' or. the roles TSH·.- ~ununits ma.y have in ~~ hormone-receptor interaction. The 
.dat~ obtained -~uggests that the iJ su~unit " lfas a partictila~ly important role i~ 
. . . . ' ' , ~ . ' . 
speCific sign~l delivery .. The a subunit may tunc.iion ·as . a. stabilizer which 
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3.4. ·BIOSYNTHESIS OF THE TSH RECEPTOR .. 
.Tbe mix~ure or ~anti-icj ~d .-,_~ti-id d~cribed abov~:(a·.a) .was shown ·to be 
specific~ for the TSH-it As .shown above (3.3.3.6}, · th'e com~in!ltion of these. 
antibodies interacted with the Mr.....,· 1Q7,000 TSH holorecep_t'or band on sucrose · 
. . 
gradient purifted po~cine thyroid plasma membrane protein blots · using ~he 
enzyme linked ~inimuno-binding technique prev1ously described (2.1.7). This 
. r 
' property was to be us_ed,_ there_fore, to dete~t the TSH:.R in ·a sys_tem designed to 
study tlte rate ofreceptor synthesis al}d its turn9ver in bi9SYn\hctically labeled 
' . . 
tbyrocytes -in -vitro (2.18). 
3.4.1. Interaction or. the mixture_ ~r Alpha-antl-ld and Beta-antl-ld wlth ' 
~ protein blots or p~rcin~ thyrocyte' who)~ ~eeli lysate \ 
. . ' . .. ' 
. . . 
' . . 
I . ' • • ' • ., • • 
The 'usefu~n~ ot_this SY.Stem to s~udy t~e-~ynt_hesis and tur~~ver_~f- t~~ /fceptor .. 
was investigated first' by testing·· the abilit;cy . or ,the . mixture ' or O:.anti-i~ and . 
p-a~ti:.id to ident~fy _. specffic rec.ept.or rel~~e~ ptptein -~and~~ o'n prot~,in bl~t~ or 4 .. 
thyro.cyte ·.~hole .. ·~ell _·Iypat.~. -~ When this .e·xp~rlmerit. w&S carried oui~ :the · .result or . 
.the int~r~c.tion or thes~ 'a:ntib_odies-~ith the whole cell •Jysai!3 protein blots showed . 
• ' t ' • • • • ' 
a · great number of positive bands: (Fig ·a.l~, ·lane 2). ·This findhig , was in sharP. . 
• - ' • • o • ' S • • • I ' • ' .~ • I o • ... • • • • .-
' contrast to the alnios~ •singie band • . positive reaction · ob.tainf!<l when · purified 
plasma membrane was use_d (Fig 3.14: lane 5). ·several or these bands were also 
. .. . . ' ~ 
positiv.e wlien NR-Ig w~ used in the system indicating thei'r non-specific nature. 
- --- -.. . .. 
. It was consider.ed•possibl~ that ·the, positive· responses obse~ved in some or these 
- . . 
bands may 'be g~nerate_d b:y ntl~Urally ~ccurring ~ntibodies against dirferent 
intracellular -compon-ents found in ihe control rabbit serum. ·. 
. . .. .· .. . 
. ' 
. • _· :·:\~ 
' . 
. , . 
I • , • ' 
. . 
. } 
·.· : : 
-· .. .. , 
... · . ; 
-... 
. . . 
,. . . .. ~ ·, ' 
' . . . . 
I • ' ' ' :: 
·. :,._:~ 
: . ~ 
' ' I ' ' ' ~· 
. . . ~ . 
· .. ··\~ 
.·. :: __:·<. 
' • .' ~ f 
• 
•. 
~ . : 
. . ~·:. 
... • 
'· - . 
--
•l' 
' ' ~ .' ~. 
. For . a definitive identification of the receptor rela~ed bands anic,m.g t-his ·great · · · \ ·: '.::": 
, • , ' ol \ '- ,: I . . ' ' . · 
number or unrelated proteins, inhibition ·studi~s ·were done. Protein · blots were •. . :~ ; 
. • • i • • •• ' 
preincubated with. either_ bTSH f(U/ml), HCG (1000 UJml) or insulin (1~ U/ml) ), . · .>~ 
pri~r to, the addit.ion or _the antibodf ~~iure. C~ntrol ~xperiinents c~nsistent.ly , . - , ~ . 
: .· s}lowt!~ $ faintly p~sitive but . ~tiil easiiy ide~ti.riabl~ . brnd. ~t' the ~r~ ·197,000_ . . .· ·. ~< 
. ' . . ' ' . ,. . . .. . _,J . . : \•, :.<~_~:_~);,· 
,• .'· · . . ' . . ···:J 
., ' .. f . :-: . _:, ~':-: .;_. 
" . : ' I • •: ' • ~i·~,\_ ! ... );iMr:  :":i ,,;~i.:·.~; _;;;L;.: .. •· '··c.· .•• -~.;. • .!,::-~. ,: ~:. ,·· , ' . :: .~ ) : .· ...  " L; >~·:. ·, c; .• ;~. ~ ~, :~·: ;~ :;,,) •; .·'.:~; .:. ;; ; : · .. , , · . , :.:, :,<·~~ 
111 
1 3 4 5 6 
197K._ 
Figure 3-14: Interaction of TSH, TSH subunit specific anti-idiotypic antibodies and 
NR-Ig wih thyroid plasma membrane protein blots. 
1: Coomassie blue stained protein bands. 2: TSH (1 U/ml). 3: a -anti-id (1 mg/ml). 
4: ,6-anti-id (1 mg/ml). 5: a -anti-id + ,6-anti-id (1 mg/ml). 6: NR-Ig (1 mg/ml). Note 
the positive bands at the Mr- 197,000 in lanes 2 and 5. 
:~~~~f~?ti>(~:::::·.\-:7:>-~ ·::· .. ~_. ... ~~ ':··:. , ..,· .. :···>:':'1· '· 
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• 4 • • 
·1ev~ig 3.1~, lane. 2·). This ba~d completely dis~ppeared in pape~ pr~tre~ted 
I • 
with bTSH ·(Eig' 3.15, ·lane 3), .HCG partially diminished· its hitensity (Fig .3.15, 
' ' C> 
lane 5) and inJ.ulin .had no effect (Fig 3.15, lane 4) .. Other bands at the .lev~l or tic · 
. r 
Mr"" lOS,OOO Jnd Mr.-..70~000 were also displace!ble with bTSH suggesiing th~t 
theY. ~ere ~Is~ t:ela.~ed to the receptor prpteins (Fig 3.15; lanes 2 and · 3}. T-heir 
· appearence, 'however, .-was in~on,istent i.n that they. were pres.ent_ ~n some_ 
experiments while they were absent in- otliers. "Also .a great number of unrelated 
. , . 
bands· localized in the· surrounding ar·eas ma<h! detection a8 well as determination 
- . 
of the r·"'aio'a~tive content unr~liable. Th\se reasons precluded their usc for further 
• . I 
. - ·~~periments. Under. these circumsta~ces only the holoreceptor ban~ was 
considered suitable to use in the studies of the synthesis and turnover or the TSH· 
~ . . ' 
R. 
3 ••• 2. Synthesis or the TSB-R .· . 
I 
• 
• •. ~ ,j 
. ... -~ .. 
I I ' : 
. .:. 
. ..~ . .· ', ._ 
... . l 
:, ..... 
-· 
.. · .. · 
·· .. 
. Iri · initial experim~nt~ the: rate ,of. synthesis of the TSH-R ·was . explored h :\: 
~ . . thyr~cytes 'c'ult~r~d ~ the.presenc~ ·of TS-H (100 m.U/mlf for ~·2. bour~ . ·.pri~r to ·. · - :~·: 
.:. ' • ~ ·l&beliDg a~d in t~;rocy~. cuitilr~diri th~ absenc.e.of TSH}bese.two gr~ups ~r . · : ; ; 
.. 
·, ' 
' .-· .. 
. ' -
·.·· . 






· 4· . . 
:~·. . . 
- . ....-: ,: cells were later . biosy:fltheb.cally labeled With ID1!diUm contammg (~H)-leucmc and · ,. · , · . : : ... 
. . . . . : . . . . . . I . , . . . :, 
processed as previous}~ describ~d ·(2.18) . . T_he. T~H~R . band wy identifie'd as/ · ·· ~.~::_ 
desc;ibed in 2.19. Basalle~els of [3H]·leucine 1ncorporation' w~re co~sidered as the 
. . . 
level of radioacti.vity detected i~ the r-eceptor band at ~0 ' time• incubation, i.e. ' . 
. " - . 
. cells chilled at 4°C ·as soon as the· (3Hj-Jeuc_ine was added. Within 3.0 ;minutes of 
. . . - . . 
·., 
die addition of · the [3H)-Ieucin~ supple~ented medium · a significant amount of 
. . .. . " 
labeled -·reeeptor · was 'detected in both· groups or cells. The maximum level .. of ) I ' • • 2', 
. . - .. . . . . ' ' . . . .. . . . .. ' . 
~ 'stimulation of. receptor labeling. was ·detected after .3 hours .. or incubatiop w!th 
• ' ' . .. -- i\ . . - • ' • : -.· 
. [~Hkle~ci~~ enriched me~~um in TSH ~timulated cells. The control cells achieved .:-
. - ' . . . ' . - y--
. . . ' & similar level or re~~pior labeling but this result was not acbieted until the firth' 
. . . ' . . . ... . . .. . 
I ' ·,. h~ur o_r incubation with·'. the rad~oa~tive :mediu~ (Fig' 3.16 shows an . exp~riment -
• •• 4 :> 
• - - .- .. - · ·with 
0 
4'. ·, parallels, • ~hen the exp'eriment was ' .repeated similar\ r~ults were •: ~ , ' , I 
obt~illed.( Ap~r~xim~.to:IY. i>ne 'hour af~dbr _m~imal i~~eling ~···Is ,..w·;· . ' '< ::; 
: · . _•c.ht~ved,_. a s~~ad:. ~.eql~~~ 1~ the · percen.tage .~! ·\p.e~tfic label_mg was _obsc~.v~d · •.n. .- ·:~·\:! ~; 
' j • • • • • l-· . . . . . . ' ..... ·.~~ 
. . , I .. 
'': . . .· J ' .. ':.}' 
~·.\ .· .. . : ·-. ' \· . .· ... ' : : .. :.·<i~ 
~~1~~;., .~~.::. ,~~·:), ~~:· :{;··.:;;·,!>·_:·_:·::· . .:-::,::::. :·:~. :.:'·.:~ ;;_;; i: :~::. ~-··: .:~··:. \.::i:;:~:,::,~~,~.: ;. j\._.~~:.:1~ : . : :·:··:.;: :~~;: -:.·.;:.: .~-~-:·~·.:·, :~ .,: . ;. :.:~·~·: :: :· .<:~·:j.~·~~-: :-:·:,:::·. :,: ;:. ~~;· ·:.-: .L .·\ 1. ~ ·;~ ~~ .. :::::: ;·,~ .. ::>~·: .. :{·.:~~:~~ 
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Figure 3-15: Int ration ofTSH and T H subunit specific anti-icliotypic antib eli s with 
thyrocyte whole cell lysat protein blots. 
1: TSII. 2: a -anti-id + {3-anti-id. 3: a -anti-id + {3-anti-id in hloL-; pretreated with TSII. 
4: a -anti-id + {3-anti-id in blots pretreated with insulin. 5: a -anti-id + {3-anti-id in 
blots pretreated with II G. Positive bands at the Mr - 197,000 ares en in lanes 1, 2 
4 and 5. 
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arid thiS con~inued . up ·to 8 .~ours the longest period or both groups . or. cells 
observation (Fig 3.i6) . 
. . \ . . 
Some important feat~res of figure 3.16 deserve comment. A . •left ·shirt· .• of.the 
cm:ve representing the. rate of receptor . synthesis ·in TSH .siimulated cells when 
. . 
. compared to non-stiinulat~d c~lls is seen. This suggests that TSH promotes an 
acceleration of the rate of . synthesis or its receptor. The most significant 
difference between the 2 curves is obtained at 3 hours of labeling~ With _this in 
mind · th~ cells ~sed in all oth,er experiments investigating the rates or synthesis. as 
··~ ~ . . . 
well as the turnover ·were labeled for 3 hours . 
. ; . 
3.4 .• 2.1. Th:~~ dependen~ .efTects of TSH on the synthesis of the TSH-R · 
The· effeCt~ on r.e~eptor synthesis. of the· addi~ian ~r. TSH ~o· the cuiture ... medium 
. · far different . time intervals was next examin:ed. 'It was observ~d that when TSH 
. .. .. . . - .· ' 
(lOOmU /ml) ~as: adp~<l for . only . the. period or labeling (3. hours) th·e rate . or 
.. ' ' . ' . . . . : . . . . ' . . . f .. 
. receptor ·. synthes~: ·was no, differe·nt. from · that ·or contr.ols (Fig 3.17). ~o~~ver·, 
\\!lien. TSH w~ pr~serit for. 12' hours .pri.or' t~ le.beling'·as well ·as ~uri~g labeling.( a· . 
. . . .. . . . . 
total of 15 hours.) the rate ~r receptor synthesis .was clearty·. a:~celerated (Fig 3.t7) . 
Ev~~ .though ~he· lag ·ti~~ ·kineti~s .for this. re~po.~s~ was not studied i~ det.~ll the · 
'results obt~ined . in ibese· e~perimen\s " suggest t.hat. for accel~~~tio~ or' r~ce~tor 
synthesis to occur, it is nec~ssary··.for U'SH to b~ in contaci with the thyroeytes for . 
, • . . . . . I . . - . . . . . 
a relatively prolonged period .or time. \ 
u.2.2. EITec~ Or 1114••• ~r TSH on the s;ynthesls ra~ ~r the 
.. .. TS~.H-11: . ·- _ ~ . . . . . . . . .. .., • ·.. . . . . ·. .. 
The erre~~; o . · er~nt- do~es of TSH ~n receptor synibesis were n~x~ . stu~li~d to · 
.. aetermin{i'r ''i e ate or synthesis ~as do~e dep~qdent.- Th~ maximAl aeeeler~tio.Ii, . 
• ' 't II 
. ·w$8 obtained ·· with 100 mU/ml or TSH, · 250 inU/ml .in.itjally produced . an . 
. . . . . . I . 
. . accentuated shift of the ~ynthes.iS rate. cur:ve 'toward~ the left~ but a pr,emature . . 
. falling<.orr .. ~a:s o~serv~d . . At~ 500. inU/~1 .the ' ~-~~ODS~ o~iained ~as . ~.~~st. 
· identic.al to that _ ol*in~d at 5o mUfml (Fig. 3.18). The results slio~n represent\ 
' ' . . ,' •' ·. " ' .. 
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.. ~(<" · Figure 3-16: · Effect of TSH_.(l2 hours ofP.rl,incubation) on the, synthesis rate 
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~~:· of the TSH-R .. 
;i.i·:~:,. Receptor synth~startS at 30 rilinutes in bo~·gro~ps. The maximallai>eling is achie~ed . > :{!. ~~-.. ~.. . a~· a ·hpu~ m ·~H ~~~a~·~lls, and-at 5 h~~~In ~~trol ~Us. Note ~e .:i~rr~Mi;; · .. :<} 
i~\ of t~~e BYrit~~~ rate ~~ iri ~H stiinUJa~ ~us. .. . . . . .. . . :~ 
~~~~·.· ·: .. . .. · N.~ 4; •:p < . 0.~2oo~paredtot:heValue~fco~trolceiJscManriWhi~iuTest); .. bars ... · :·~:~:. 
-.. .. ~ • . '~ ,· • . .. --- • } ·. . . . ~ 0' ' '. . • • ·.:~ -~ ~(::: : .. ... : : < · represent.± S.D.- from :mean: . <:~~~~ 
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Figure 3-1?: Effect of sholt tenn TSH stimulation (3 hours) vs. ltledium' ~erm 
. . 
stimulation (15 hours) pn the TSH-R syrithesis rate. Meditim tet:m ' 
:· "".· 
. ~ st~ui~tim1 _~cc~l~rates th~,ra~ - of syn~~iS: : sho~ tenn_rnwatio~ has no effec~. 







Test); bars represent s.n: from. mean .. 
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. . :· .. 117 . 
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.. 
·due' to the clo8e~ess of the ·different_, curves~ .. Sinrllar. results we~e . obtained .in 
rep~;ted· .ex~er~~~nis~·increB..'iin.g·d~es _of TSH. ~ppear to 'st~ula;e .. acc~leration of 
the.· r"eptOr synthesiS . up' to.· 100 niU/ml. Pa8t_ ~his dose the response~ &.!e 
diminished, 'i.e. · tliere. iS ·Ja n~m-linear·, dose . respe>nsivene5s for TSH on -tecep_toP 
sy~tbesls; ···. · · · · . !~- --: ·  ... . . . 
. ~· . 
___-, - o I 
.. 3.4;2.-a:Determbiat~o~ pf,stable'"and tree radloaetlve leuelne pools -In 
.A . . ' . 
eultu-:ed 'thy.roeyte~ • ·. . .,. 
. ' ~ ~ .... . . J 
Because TSH stimulates amino acid metabolism ·in thyroid cells (Dummont and 
-Vassart, 1978) it is po~ible th~t the l~uci~e pool-in TSH stiKa'~~d eel~· might be 
. . . . . . . , . . . ' . ' . 
\'lirrerent _rr?~ ~b~i ~r .cont~~l c~l~. -~~ . in~estigate: this. possibi~ity th.e tota~. leucin~ 
. . .. content · as well· as the .free leucine content -were measured in cells stimulated with· 
• 0 
. . .. • 
/ . . , 





, l o. 
.. \ - ·•. 
TSH ~nCJ · in - ~~trol c_ells (2.2().).· ~o- g,oups_ or 1SH stimulated _celJs · we~e·~tud.ied . . 
, ·:On~ :group ·r~ceived : TSH. for.· 3 . h~urs ( d~ring. lab~lirig) .·:a~d ~thers r~cei~~d .TSH . 
: •) . 
•"" \ .. 
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·~'·" . ' ' : . 
_,. . ' 
0
• J~f. ·· ~S · h~rirs ; (12· .~Jpr_~9"r t~· _Iab~ling: ~n~· d:~~~ng ~~~elin_g), _ . to .:d~~hc .  ate.-'th~ ·: :. :_ ·-: . 
·. ·. cond_iti~~s . ~~ed p~ously (3.4.2, ~A;2.'1; .3.4~2~2r T~e . total.Jeuci'ne c<:>ntent ._in ;,.. 
:.: .·. co~-t~ol and TSH ~ti~u~a.ted ceils ·w~ slightly higlie~·· in TSH'stunula_ted ceils-.than 
. , . .. . I , . , . ·. . : . ~ ·. . . oi ' 
0
-. •• in co~trol"' cells. ·Tqis · dirferen·ce. however . did· ·~ot. acliieve .statistical. si~ificance 
, .. . . ' --' ' ' . . . 
·  (p>0.5)(Table 3.sj:. The levels ~r' free leucin~ were slightly lower in'7!ells that had • 
. been stb~·iul~ted .. ~ith TSH .r~~' IS ·.hQurs wh~n~. c~mpared to. tho~e \hat we;e, 
'. ' . , ; . .; \ ' . . . . ' . . . . . ·. . ' " 
~ · .. stim~la.ted for. 3 hours. The differenc~, again, was . not found to be · statistically 
0 
. sig~iCLcani (p$0.5) (T~ble 3.8) The results verlry that the observed acceleiatio~ .or 
·. rece~to~ · 'syn'th'esis is real ~nd n~t a.n artif~c't ' du~· to a~- ·a.lter~tion of. the stable , 
. · · ie_ucin·~ ·pool in TSij s~imu.la.ted . e~ll~. : ·-' · . . 
. -
••• 1 
!;<.: .. :: ' " . -- .. 8.4.8. Turno~er or the .TSB -teeep-~1' ': 
. . , ' . . . . . . . " 
~ : · . .. · ~- PuiSe-~h.;,e experU:.e~~ere done to si.~dy .the -~urnove~ rat~ of 'the TS~-R. ' 
•.: • . . . <. . I' ' • • - • • • .. • • 
/.. 
'"'"' . 
' · . 
. .. 
·' 
, . . 




;~ ::.'' - : . 'Thyrocytes were first biosynthetically labeled for 3 ho.urs ·foliowed by a cold 
~:-;_~· . .. '. · .. medfu'ni ·~base for varying periods.· or4i~e. Th~ .effects ~r TSH si~~ulatio~· ~D the . 
~· . . .,. .. . . . . . .\.. . . ' . .... .. - . ~· . 
::,; ' -. , , .. · .. · · turnov.er ra~e _was carried out t>y ·the ·addition of 100 mU /ml or ihe· hormone for.;. · · 
:i..:.' • , , ' • ~ ' , 6 ' ' ' ' "- • " ~ ' ' ' .-' ' • • , _ I , ' , ' 
~-~~>:-.. ' . . _ ... -< ~ari~us time' interVals and at different.'stages of the proc'edure aS described above ·, j, ~;;,:.: .·:->_' ~-- . . . \ . " :. . ' /:: 
('i· ..  ·; : '... . . . . . .. . .. . . . . ' . '.. . , 0 • • • • • / ' 
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0 TSH 50 mU/ml 
0 TS_H roo mU/ml 





, Figure 3•1.$: Effect.of differen_t doses of'fSI:J on the synth~ rate of ~e TSH R. Responses 
' . 
to ~creas~g doses of ~H indieate ~at th~· optimal ~oes ~ obtain- a hlgh~ 
value at ± 3 h is. 100 mU/ml. · · \ . - ) 
N - 4;·. ·~: p < 0.05 _as c~mp~ed to control values at simijar times #'~ • 
. . 
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Table 3·8: · Thyrocyte leucine poOl. 
Total leucine content 
I umoL'l07 _cells ± S.D. 
• 
Control 993 ± 67 
_TSH (3llours~ IOQO ± 33 





235 ± 10 
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:·: , · , . (2:18). The data obtaiiltid .from these · experiments were f~ted into exponentjal ..... 
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o~tained. The hair lifes were calc.ulated at the SO% point or th~ linear regression 
-.. ..- ,, } 
curve. · 
.: 
. - . 
In control cells ( c·uJtured in the ·absence of TSH) the receptor had a calcu'lated 
' , - . 
half life of 240 ~in.utes (Fig 3.19 a). When TSH .was added either during the 12 .., 
' ~ 
hours pr-ior to labeling, _12 ~ours prior to labeling and labeling, or throughout. the 
procedure (prior and during labeling and during the c'hase) the hair life of the 
• 4 • 
rec~pto.r w~ increased to a. calc~.tlated mean value or 360 1minutes (Fig .3.19 b,c 
. . 
and d). 'The .pr~sence or,·TSH in the medium appeared . to contribute iQ. .prolo~ging 
. f" . . .• • 
the half life- or the r~ceptor but the length of the time for whi_ch the hormone was 
present did ~ot appear. to have· any infiuenc,e on the-recept9r's hair life.Jt is likely · 
. that· ~~~ ·~rolo~gati~n ot t.h~·. halr.lire o~~. T~H·R · i~ ~h~ pr~se~;e . ~~Slf c~~ ~t . .' 
least. b~ . part'la.~ly explamed by the achtevement or. stable hormo~e-recep_tor - -" 
complexes as hrur· been previously described for the TSH .receptor · in isolated 
. . . 
. me~bran..es (B.renn~n et ~1., IQSO). ~ 
.. 
All the findings d~scribed so far regarding the synthesis and- tu.i'nover of the 
. . 
TSH-R suggest a. positive infiuence of TSH. Tbese resulf.s-seem, to contradict ·niost . 
' - . . 
of~the r~ports in the literature that suggest that TSH stimulation. leads to receptqr 
· . •down r~gulatio~:'{Lissitzk.y(e"t al,, .1973; Witte and M,cKenzie, 19Sl; Rapoport 
a.nd Adams, 1976);_;t~uthors li'~ve measured receptor numbers 8s number or 
bin~ing sites available for 1251-TSH ·binding thus exc~4ing all o~cupied receptors. 
''!he method used i~ the .present .. studies can detect .all ·the immunologically 
competent receptors that. r~olve at the Mr-- 1g1,oo6 protein. band. 'this should . 
. - . . . , ' , ~ . . . . 
include receptors that were o~cupied by hormone 88 well . ~ some-partially 
. . ' . . ' . . 
· · · 'syn~hesiZ'ed receptors that . are immunologic~lly identifiable. It .is poSsible then-, 
I f : ' ' ' • ' • • ' • ' 
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systerni and~ that one. group ·of findings does not necessarily contradict the other. . ., 
.· . . . · .. · - . • ~ . • ' . ' • . - ·· . _ '_, .. <' 
. To substantiate this · contention· the binding or radiolabeled TSltto v1able • 
~ .. . ·, . · ...:..~ 
~.:. ,, ~ . ·: ~ 
•f. .... • ' I f • : '.l,,~ ;C.~:.-.'~.· .... ' . • , • ' , :..~ • I , . ' ' 'It· 
.. .. . ~: ' . ~;-~~ 
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·FigUre 3-19: Turnover of the TSH-R 
\. ' . . 
~:: ·-·\ a: no TSH. b:~TSH fo~ pr_eincubatio~ 
·, ·. ~ c: TSH for .Prein.,cubation an~ Ia~ ling. 
~;:l: '-' \ . labeling Md. c~: . ._J.. _· • }~ ' . ·· 
:/T · 100%: M~al.lricorporatiqn of .(3H) leUrJ.ne ~to ~ep~?r protein !if~r 3h of b~qsyri: 




;;\/ .· " . thetic labe~culve fitting: llne~r 'regression using a program that cO~puteS the least. 1 .· · 
~/ ·. . . . . . . . . I . :-.....  ~h.:. · . f,. . ~~are . Ot·· ~i· n ~ or d~ta points. . . · · -~ ·• . · · · .. · · · :·. }-::~: 
~~!:( . ,.· Half.llfe (tl/2; ;_; Val~e of X ·at y~50 .from x•O. , · :~.~ 
&.··· .. ~ · · ' .... ' .·· .· ·· . ,· ' ' \. '- . ' ·· ~ . .. . . .;: .. ·,;.; 
~~~. \::~/> ; . , .  :::c, ,:,;i\ :,_,d·~> ~-/ :'; ·:' :, :~:> . '; '·-.·  ~ : ~ :; ; .i' : :; ' ·: .. ; :... ~. ; . : .. ·. '/ :, ·.· <: ·. ·. ·. :,, ·.::J}~ ~ .,,~·~rJ'v}..,.f.:~:;\~~";T~;.~-: .... ·.::"''..1' '\ -IL:!>I "'~::.~.::~:.-;.;_-. . ~:' ·~lt.' 'L~!J/,A.,~.r ·1) r,;,!.)' ' ) ... - ~l-"\k~l:;~: .. ;-86\ ,;,, .~>~s.f;·\· !i: ;,_,~{.-~~:~ .-;· , :·,':{~~;ff~t;. .!=:.··~, :~·=·· l~:.~i·:~; .~,;;·1),~~;.;·A~·" 
. ·\ 
',. ~ ' ( 
d: TSH for preincubatiol), 
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3.4.4 • . 12~-bTSB ~lndlng. ~dispersed thyr~eytes eultured~~eaence 
and -absence' of 'l;'SH ' 
.t2s · . • 
:J'he binding of 1-bTSH to thyrocytes cultured in the presence of TSH for 
. ~ . 
various time inter-yals as well as cultured in the absenee of TSH wa.S carried out. 
' ~ 
. ., . .. 
Preliminary experim~n.ts·were first carried 9ut in celis cultured in the absence of 
. ·1-s:H. axto6 cells were~all~wed to re;ct with different ·amo~nts or labeled bTSH in : .-
- o o • o "' • - ' I 
the absence of un)abeled TSH .. The following results were obtaiaed: 3XI06 cells · 
reacting with sfr,{i";o~m (~1.25 pM of ~ 25i.bTSH) bound .a m~a~- or 5750 cpin. · 
. , . ·: . . ' . . . 
. I -., •·, • ·' , 
The saine. number of .c~lls and· 100,000 ..cpm bound ,a.. mean or_ 14,gao. cpm. A~ 
... 
!5«;l,OOO cpm . the_~ea~ bo~nd '\vas"-6,'780 epm and at 20~,000 a ~~an\of 17,320 · 
cpm bou~d to ·the cells .~dded.·· Thes~r~sults "j.epresent .th~ me.a~ , 'or three 
. . ' -. -- · ·--
e~periments. With tbes·e·results· i~ mind it was decided t-o proc~d·e · using 100,000 
. . 
. . 
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In these experiments 6omewhat high ·doses. of ·unlabel~d. TSH w~re_.requi~ed _for 
. . . ' . ' . 
. the displ~cemeilt ·or the radiolabeted ligand. D~ring prellmidfrf;"~xp·erhneitts lower 
aoses of unlabeled TSH were ~sed f9r displacement. At _d~ses of 10 :~d. 25 mU /ml 
~nly minimai·· displace,ment of th'e radiolabeled TSH . was observed .. At higher . 
. . .. . ., 
• , doses, how~ver, as-one can see ;from the results: in table 3.~ there was a dose-
• • ~ ~ ' • • I 
. . . 
respon~e· disp)a.cement to up· to 250 inU/ml of unlabeled TSH, this indirectly 
· de~onstrating th~ specific-ity of· t~e in-~_er~~tion .~etween t~- thyrocytes, a~d the · 
ra~ioiigan_d, . 
.In this sys~ b;nding sites ~.;erOOutd. ~ •down ·'re~:ated• in ,.SH 
stirnulated~~IG". 'I'he pe~c:ntage of binding was, diminisli:ed 'by.-45 ~ .63%· in cells 
. . . . ..;. . . . . . . 
cultured iii· the .presence of:TSH ·for 3 hours as -compared .to . the bindin·g obtained 
. i-n co~t;~l cellS (Table a.O). jn ;•:Is ~ultiued. ~ the J>•~ence 1Tsil r~r IS h~ura 
6,~ ·_ .: ~ · . -\ . . . · . · i . _ ... . L _. ~ . 
~:~ .. : ·~~ .. :. . . ,. r 
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·binding ~as decr~ased by": 20 to 64 % as-coin pared to control cells· (-Ta}?le 3.Q). 
. The dil!-er~nc.e in .·binding b~t.ween th_e · two groups of TSH. stimulated cells and 
'( .. . .. ' -
·''control cells were found tO be statistically :Significant -(p ·< 0.05). No difference, 
- ~ . . - . 
. however, was observed between the 2 TSH stimulated groups (Table 3.Q). . 
_· It ·appc~rs possible that. this" appa~ent reduction in · binding is due to irseversible 
· receptor. o~cupancy. ·.This . proposition ~ also supported :bY r~sults obtained in. a -
study that investigated b_h1din~ of radi~labeled TSH to membranes prepa~ed from 
\ . . . . . ' 
thyroid slices previously in~uba~ed in the presence or absence or TSH. -It ~as 
observed iliat al~ost all .·th-~ binding sites which were lost due to preincubation 
. ~ . - - . - . . . 
' with TSJ:I could be recovered ·by washing· .the m~mbra~es with 0.5 M NaCI to · . 
' remove e~~!.io~sly bi;n:ind native' TSH ('_Vitte ~nd McKenzie, _1981), .at least up to 
.a. perio_d .or in_cubatio~ ·- or i4 hours. After : th~t time it appeared tbat .the complex . 
bad . b~co~e·irr~ver~ibly . :bou~d.r It ~as ~Iii~~ssible to test a similar experikent in 
• • • ' • • • • ' ' • l • . ~ .. 
. our· system 'due to obvious,. effects : th~t' the- high concentra'tion or NaCl or other 
. . . . . : . . . 
: metb.ods u~ed . tq diss~ciat~ b~un~ -hor~one would· hav:e on the. viability- of the eel-
used . 
·. 
· 3.4.6. Sum!p&r;Y ot the expe~l~ents ·on ';('~H-R ~losynthesls 
-·· - . . ' 
~· 
~ Tb·ese experiments have provided evidence .::that TSH has a\ p~si.tive infiu~nce on -
... : • ~ • • • ": ' • • • • ·_ . • • '!\ 
,. t_he synthesis and trrnover of~ its receptor in_ isolated porcine thyrocytes ·in vitro. 
' _- .These. findings ~ight prove bnport~~t in e~plaining .. c~r.taf~ ·physiological ·resp~nses· 
• ~ • _. • ' ' ... ~ ' ' • • ' I • 
ol the thyroi~ gland whim inereas.ed levels or circulating 'I:SH o~ TSAb are present 
· · in individuals with eitb,er TSH producin¢ tumors or Graves' ~~eas~ respectively h . -
A p~siiive .i~fiuenee ~t 'these s.timulatois ~ on re~eptor biosynthesis can perhaps be 
· antiei~ated· .when the known r~ul~ of gl~.nd ~--v~rs.timulation .-is hyperthyroidism: 
' ' • • • • l • I Q Th~ work -. reports ·a · first s~ep'- ~wards the -under~tahding cif th_is · ~omplica.ted 
, , ,.. · ~~bjeet •. _Obviously more· work . will be required .before-. definite answers. can be . 
'-"' -·· . .. . . 
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Table 3-9: · Disptac;ement by native TSH'of 1251-bTSH binding to dispersed thyro.c~es 
cultured in the presence· and ~nee of TSH. 
. ) ., .
Cohtrol . TSH 3h (100 mU/ml) TSH 16h (1~ mUiml) 
' 
TSH ~ binding CE_m - binding ce,m blndirlg 
mU/ml X ·% X % X· ' % ;.. 
-
--~ 
~ - ·-· · 
l 0 14360 
;o 6.5• . 
· 661J) 
-_6_.1"" ~ . !----- . 
'• ~i- . 50 \ -- 7398- .4080 4.2·" 6100 .. 6.3 
. .....-- ' I 
' 
... ~~72 . ~ 100 . 4.4 3311 - .. 3.4 5076 6.'3 ~ / '~.8 • -. ' 2692 '2822 2.9 , . 4022 4.2 . . . , . 500 ''1941 ' 2.0 ' 1220 . .1.3- 1562 1.6' 
·- .. . 
TC: 96754 cpm 
·A 
•: p ( 0.05 (significant decrease in %bin~ as compared to% binding in control cells) 
Control: cells cultuied ~ absence of TSH-
TSH 3~: cells cUitured_in presence of TSH for 3,h. 
. ' ' 
-· .' 
TSH 15h: cells cultured in presend! of TSH for 15h. · 
. . . . 
\ N .. -6 (para'itels) l .·. . 
... 
,~ . . .... 
cpmX: COlT fpr background bipding. 
.. : T' '"• 
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CONCLUSIONS 
· 1· Anti-idiotypic antibodies were raised to anti-TSH a~d to anti-TS~ subunit 
. 
specific monoclonal antibodies. Both .of t~ese types of anti-idiotypic antibodies 
·were demo.nstrated to be agonists at tl1e level of .the TSH receptor. It is possible ~o 
. . . 
produ~e ~nti-idiotypic_ anti~odies with . TSH-like aCtivity. 
2· These· 'int-i-idioiypic antibodies .'were· userui in.-· the detection of the· recepto~ 
. ' ' . . 
protein un.der specific experimehtal ·-cpnditions . 
. ' . . ~ , · .. 
.. ... . 
a-· The usef~lQess of ariti-idiotypic antibodies in studyin~ diffe~ent characteristics 
' ' • I ' - ' • ' • ' • • • .,. 
of tlie hormone-receptor interaction has also been deiJ1o.nstr3ted. The study of .the . 
' . . . . 
•. respectiv~· .r.gJe~_9l !he ·subunits of TSH ·in_ the hor_mone:-receptor interaction· was . 
. . ... . . . . . . . 
·. previously round . to be -dirricult . because· or . the . kpown lack or ~ activity of the 
. . I . • 
dissociated ·subunits of ·the · hormone.A.nti-idiotypic antibodies raised ~gains( 




_.f. St~dies . ·with TSH-subunit_ specific anti-idiotypic anti~ol!ies favor important 
,roles .ror both su~units -o~ TSH in ihe b~r~~ne-re~eptOr interac~~on, ,8 _ suhu-;i~ ~--
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t~~smiUe~, o~ the_, h~rm<?~~ -sp~ciric signals a1,1d a* subunit a!> st~ilizer or the . : : .-: .. i: 
· hormone-receptor interaCtion. · · · , . · · ·\i 
.. , . ~ . ' . . . : . . . . . ~ 
·:, · 5- Iu Jhe :s;udi~ Iu"vO!viug t~ intera~tion or spoutaDeously oeCuuing anti- · ·<~ 
\ . :· . thyroid ·~iibodles and protein blois o(. thyroid ' plasma. memb~anes i~ w~· ·s~~·n .. ,' . . . "<}i 
~?.: :, that IgSrtom paJe~ts ~ith.Gr~:~· Disease M!dHashbnoto;~ thy~oidit~ both i>iud ·.·. . . .··!f~ 
f:.\,/ . . . . . . .. J . . . . • '>' >~ 
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, . . 
interact ~ith the TSH receptor,· but that th'e ·epitopes involved appe~r ·to be at 
• • .. 
aifferent levels in the rec.ept~r. : 
. 
6- Studi~s done on the synthesis and turnover or the TSH-R.,suggest that TSH~ 
has a. ~.efinite role in the ·regulation or its own receptor. The hormone ac~elerated ·  
·the synthesis of its ·own receptor an~ prolonged its half lire. The$e :_results may be 
important in interpreting the onset or hyperthyroidism· in cases or. exc~eding 
' .. . .... . , ' . 
amounts .o( circulathig TSH ~op. the presence of TSAb: · However, rurt~er 
experimentation is required~· 
·\ ' 
7- Many ·factors 'appea.- to 'be of i~portance w~en ·raising antl-iai~typic 
. .. . . . . \ . . ' ··. 
a~tibodies. T~e· .choice of appropriate adjuvants, appropriate labo'ratory 8.1;1imals . 
; , ' t ' . I • 
for imiimnization,·-time. or sample collections an,d possible assays .used to ·mo~itor 
th~ 'bio~ctiyity .or the products, are. all of great -~iiniri~~nce: S6me animalS.· a.ppea.r .: 
to· be bette.r that ·others .. in'·prodttcing antib~dy materials. Rats. appeared .·t~ · be 
• · . .. . I 
' "t>etter ~han mice- as TSH responda.nts. The time ~ :sample collection. js, also very 
. . . . .. . 
importa'nt. The _dirt~re~Cf betw~en having an agonist antibody instead or an 
antagonistic anti.body c~n dep,end ~nly. on the time or sample collection. So ·ra.r, all 
. . . . . . 
th~e parameters .were determined by .sir~ple obs~rvatio.n. The adequate timi~g for 
sample coll~cti~n was ~etermined by multiple sarrlpling. 
g.. A p~oble~ that pne inight-envision - ~bich could b~ or particular irnportarice is 
the limited quantityo of antibodies produc~d by the immunized· animal. Obv.iously, 
. . because or the. polyc)onai n~ture ' or .the ~ntibodies e~cb ne~· batch or antibodie~· 
. \ . . . . . 
. pro_du~ed will ·require e/tensiye testin~ ·or _iheir bioactivi~y b~f~re they· c'a.n be 
utilized in oth.er experi~ental si~uation"s. · _ · · . ""'- · 
. . -··· . ·. 
·'I .· . 
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